Document:

nwpx20160818_10q.htm

Exhibit 10.1

 

 

August 1, 2016

 

Aaron Wilkins

Northwest Pipe Company

5721 SW Columbia Way

Suite 200

Vancouver, WA 98661

 

 

Northwest Pipe Company, an Oregon corporation (the “Company”), considers the establishment and maintenance of a sound and vital management to be essential to protecting and enhancing the best interests of the Company and its shareholders. In this connection, the Company recognizes that, as is the case with many publicly held corporations, the possibility of a Change in Control (as defined in Section 3 hereof) may exist and that such possibility, and the uncertainty and questions which it may raise among management, may result in the departure or distraction of management personnel to the detriment of the Company and its shareholders. Accordingly, the Board of Directors of the Company (the “Board”) has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of members of the Company’s management to their assigned duties without distraction in circumstances arising from the possibility of a Change in Control of the Company.

 

In order to induce you to remain in the employ of the Company, this letter agreement (“Agreement”), which has been approved by the Board, sets forth the severance benefits which the Company agrees will be provided to you in the event your employment with the Company is terminated in connection with a Change in Control of the Company under the circumstances described below. The Company and you have entered into a prior letter agreement regarding change in control severance benefits dated July 30, 2015. Upon your signature of this Agreement, the prior letter agreement shall be amended and restated in its entirety in the form of this Agreement.

 

1.     Right to Terminate. The Company or you may terminate your employment at any time, subject to the Company’s obligations to provide the benefits hereinafter specified in accordance with the terms hereof.

 

2.     Term of Agreement. This Agreement shall commence on the date hereof and shall continue in effect until July 31, 2017; provided, however, that commencing on August 1, 2017 and each August 1 thereafter, the term of this Agreement shall automatically be extended for one additional year unless at least ninety (90) days prior to such August 1 date, the Company or you shall have given notice that this Agreement shall not be extended; provided, however, that this Agreement shall continue in effect for a period of twenty-four (24) months beyond the term provided herein if a Change in Control shall have occurred during such term. Notwithstanding anything in this Section 2 to the contrary, this Agreement shall terminate if you or the Company terminate your employment prior to the earlier of Shareholder Approval (as defined in Section 3 hereof), if applicable, or a Change in Control.

  

 

 

 

 

3.     Change in Control; Shareholder Approval; Person.

 

3.1     For purposes of this Agreement, a “Change in Control” shall mean the occurrence of any of the following events:

 

3.1.1     The consummation of:

 

(a)     any consolidation, merger or plan of share exchange involving the Company (a “Merger”) other than a Merger which would result in securities of the Company ordinarily having the right to vote for the election of directors (“Voting Securities”) outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities of the surviving entity or a parent of the surviving entity) more than 50% of the combined voting power of the Voting Securities of such surviving entity or parent outstanding immediately after the Merger; 

 

(b)     any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all, or substantially all, the assets of the Company: or 

 

(c)     the adoption of any plan or proposal for the liquidation or dissolution of the Company.

 

3.1.2     At any time during a period of two consecutive years, individuals who at the beginning of such period constituted the Board (“Incumbent Directors”) shall cease for any reason to constitute at least a majority thereof unless each new director elected during such two-year period was nominated or elected by a vote of at least two-thirds (2/3rds) of the Incumbent Directors then in office and voting (with new directors nominated or elected by two-thirds (2/3rds) of the Incumbent Directors also being deemed to be Incumbent Directors); or

  

 

Page 2

 

 

3.1.3     Any Person [(as hereinafter defined)] shall, as a result of any purchase or other acquisition of Company Shares from anyone other than the Company, have become the beneficial owner (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of Voting Securities representing twenty percent (20%) or more of the combined voting power of the then outstanding Voting Securities.

 

Notwithstanding anything in the foregoing to the contrary, unless otherwise determined by the Board, no Change in Control shall be deemed to have occurred for purposes of this Agreement if (1) you acquire (other than on the same basis as all other holders of the Voting Securities) an equity interest in an entity that acquires the Company in a Change in Control otherwise described under subparagraph 3.1.1 above, or (2) you are part of a group that constitutes a Person which becomes a beneficial owner of Voting Securities in a transaction that otherwise would have resulted in a Change in Control under subparagraph 3.1.3 above.

 

3.2     For purposes of this Agreement, “Shareholder Approval” shall be deemed to have occurred if the shareholders of the Company approve an agreement entered into by the Company, the consummation of which would result in the occurrence of a Change in Control.

 

3.3     For purposes of this Agreement, the term “Person” shall mean and include any individual, corporation, partnership, group, association or other “person,” as such term is used in Section 13(d)(3) or Section 14(d)(2) of the Securities Exchange Act of 1934, as amended, other than the Company or any employee benefit plan(s) sponsored by the Company.

 

4.     Termination Following Shareholder Approval or Change In Control. If a Change in Control occurs and at any time after the earlier of Shareholder Approval, if applicable, or the Change in Control and on or before the second anniversary of the Change in Control, your employment is terminated, you shall be entitled to the benefits provided in Section 5.3 hereof unless such termination is (a) because of your death, (b) by the Company for Cause or Disability or (c) by you other than for Good Reason (as all such capitalized terms are hereinafter defined).

 

4.1     Disability. Termination by the Company of your employment based on “Disability” shall mean termination because of your absence from your duties with the Company on a full-time basis for one hundred eighty (180) consecutive days as a result of your incapacity due to physical or mental illness, unless within thirty (30) days after Notice of Termination (as hereinafter defined) is given to you following such absence you shall have returned to the full-time performance of your duties.

 

4.2     Cause. Termination by the Company of your employment for “Cause” shall mean termination upon (a) the willful and continued failure by you to substantially perform your reasonably assigned duties with the Company consistent with those duties assigned to you prior to the Change in Control (other than any such failure resulting from your incapacity due to physical or mental illness) which failure shall not have been corrected within thirty (30) days after a demand for substantial performance is delivered to you by the Chairman of the Board or President of the Company which specifically identifies the manner in which such executive believes that you have not substantially performed your duties and such notice is delivered within ninety (90) days of such circumstances, or (b) the willful engaging by you in illegal conduct which is materially and demonstrably injurious to the Company. For purposes of this paragraph 4.2, no act, or failure to act, on your part shall be considered “willful” unless done, or omitted to be done, by you in knowing bad faith and without reasonable belief that your action or omission was in, or not opposed to, the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by you in good faith and in the best interests of the Company. Notwithstanding the foregoing, you shall not be deemed to have been terminated for Cause unless and until there shall have been delivered to you a copy of a resolution duly adopted by the affirmative vote of not less than two-thirds (2/3rds) of the entire membership of the Board at a meeting of the Board called and held for the purpose (after reasonable notice to you and an opportunity for you, together with your counsel, to be heard before the Board), finding that in the good faith opinion of the Board you were guilty of the conduct set forth above in (a) or (b) of this paragraph 4.2 and specifying the particulars thereof in detail.

 

4.3     Good Reason. Termination by you of your employment for “Good Reason” shall mean termination by you of your employment with the Company based on the occurrence after Shareholder Approval, if applicable, or the Change in Control, of any of the following circumstances, provided you give Notice of Termination within ninety (90) days after notice to you of such circumstances and such circumstances are not fully corrected by the Company within thirty (30) days after your notice:

  

 

Page 3

 

 

4.3.1     a change in your status, title, position(s) or responsibilities as an employee of the Company which constitutes an adverse change from your status, title, position(s) and responsibilities as in effect immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control, or the assignment to you of any duties or responsibilities which are inconsistent with such status, title or position(s), or any removal of you from or any failure to reappoint or reelect you to such position(s), except in connection with the termination of your employment for Cause, Disability or as a result of your death or by you other than for Good Reason;

 

4.3.2     a reduction by the Company in your base salary as in effect on the date hereof or as the same may be increased from time to time except for across-the-board salary reductions similarly affecting all management personnel of the Company and all management personnel of any Person in control of the Company;

 

4.3.3     the failure by the Company to continue in effect any Plan (as hereinafter defined) in which you are participating immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control (or Plans providing you with at least substantially similar benefits) other than as a result of the normal expiration of any such Plan in accordance with its terms as in effect immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control, or the taking of any action, or the failure to act, by the Company which would adversely affect your continued participation in any of such Plans on at least as favorable a basis to you as is the case immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control or which would materially reduce your benefits in the future under any of such Plans or deprive you of any material benefit enjoyed by you immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control;

 

4.3.4     the failure by the Company to provide and credit you with the number of paid vacation days to which you are then entitled in accordance with the Company’s normal vacation policy as in effect immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control;

 

4.3.5     the Company’s requiring you to be based more than twenty-five (25) miles from where your office is located immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control except for required travel on the Company’s business to an extent substantially consistent with the business travel obligations which you undertook on behalf of the Company prior to the earlier of Shareholder Approval, if applicable, or the Change in Control;

 

4.3.6     the failure of the Company to pay to you any portion of your compensation or compensation under any deferred compensation program of the Company; 

  

 

Page 4

 

 

4.3.7     the failure by the Company to obtain from any Successor (as hereinafter defined) the assumption or assent to this Agreement contemplated by Section 6 hereof within thirty (30) days after a Change in Control; 

 

4.3.8     any material breach of this Agreement by the Company; or

 

4.3.9     any purported termination by the Company of your employment which is not effected pursuant to a Notice of Termination satisfying the requirements of paragraph 4.4 below (and, if applicable, paragraph 4.2 above); and for purposes of this Agreement no such purported termination shall be effective.

 

For purposes of this Agreement, “Plan” shall mean any compensation plan such as an incentive, stock option or restricted stock plan or any employee benefit plan such as a thrift, pension, profit sharing, medical, disability, accident, life insurance, or relocation plan or policy or any other plan, program or policy of the Company intended to benefit employees.

 

4.4     Notice of Termination. Any purported termination by the Company or by you following the earlier of Shareholder Approval, if applicable, or a Change in Control shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of your employment under the provision so indicated. 

 

4.5     Date of Termination. “Date of Termination” shall mean the date your employment with the Company is terminated following the earlier of Shareholder Approval, if applicable, or a Change in Control, which date shall be determined as follows: (a) if your employment is to be terminated for Disability, thirty (30) days after Notice of Termination is given (provided that you shall not have returned to the performance of your duties on a full-time basis during such thirty (30) day period), (b) if your employment is to be terminated by the Company for Cause, the date on which a Notice of Termination is given, and (c) if your employment is to be terminated by you or by the Company for any other reason, the date specified in the Notice of Termination (which, in the case of termination for Good Reason shall be not less than thirty (30) days nor more than sixty (60) days from the date such Notice of Termination is given), unless an earlier date has been agreed to by the party receiving the Notice of Termination either in advance of, or after, receiving such Notice of Termination. Notwithstanding anything in the foregoing to the contrary, if the party receiving the Notice of Termination has not previously agreed to the termination, then within thirty (30) days after any Notice of Termination is given, or, if later, prior to the Date of Termination, the party receiving such Notice of Termination may notify the other party that a dispute exists concerning the termination, in which event the Date of Termination shall be the date set either by mutual written agreement of the parties or by the arbitrators in a proceeding as provided in Section 12 hereof; and provided, further, that the Date of Termination shall be extended by a notice of dispute only if such notice is given in good faith and the party giving such notice pursues the resolution of such dispute with reasonable diligence. You shall not be obligated to perform any services after the Date of Termination that would prevent the termination of your employment on such Date of Termination from qualifying as a “separation from service” as defined in Treasury Regulation Section 1.409A-1(h). 

  

 

Page 5

 

 

5.     Compensation Upon Termination or During Disability.

 

5.1     During any period following the earlier of Shareholder Approval, if applicable, or a Change in Control that you fail to perform your duties as a result of incapacity due to physical or mental illness, you shall continue to receive your full base salary at the rate then in effect and any benefits or awards under any Plans shall continue to accrue during such period, to the extent not inconsistent with such Plans, until your employment is terminated pursuant to and in accordance with paragraphs 4.1, 4.4 and 4.5 hereof. Thereafter, your benefits shall be determined in accordance with the Plans then in effect.

 

5.2     If your employment shall be terminated for Cause or as a result of your death following the earlier of Shareholder Approval, if applicable, or a Change in Control of the Company, the Company shall pay you your full base salary through the Date of Termination at the rate in effect just prior to the time a Notice of Termination is given plus any benefits or awards (including both the cash and stock components) which pursuant to the terms of any Plans have been earned or become payable, but which have not yet been paid to you. Thereupon the Company shall have no further obligations to you under this Agreement.

 

5.3     If a Change in Control occurs and after the earlier of Shareholder Approval, if applicable, or the Change in Control and on or before the second anniversary of the Change in Control your employment with the Company shall be terminated (a) by the Company other than for Cause or Disability or (b) by you for Good Reason, then, you shall be entitled to, and shall be paid, without regard to any contrary provisions of any Plan, a severance benefit as follows:

 

5.3.1     Within five (5) days of the Date of Termination, the Company shall pay your full base salary through the Date of Termination at the rate in effect just prior to the time a Notice of Termination is given plus any benefits or awards (including both cash and stock components) which pursuant to the terms of any Plans have been earned or become payable, but which have not yet been paid to you (including amounts which previously had been deferred at your request);

 

5.3.2     as severance pay and in lieu of any further salary for periods subsequent to the Date of Termination, within five (5) days of the later of the Date of Termination or the Change in Control, the Company shall pay to you in a single payment an amount in cash equal to (i) the higher of (A) one (1) time your annual base salary at the rate in effect just prior to the time a Notice of Termination is given, or (B) one (1) time your annual base salary in effect immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control, plus (ii) one (1) times the average of the cash bonuses paid to you during the previous three (3) years;

  

 

Page 6

 

 

5.3.3     for a twelve (12) month period after the Date of Termination (specifically including a Date of Termination that occurs after Shareholder Approval and prior to a Change in Control), the Company shall arrange to provide you and your dependents with life, accident, medical and dental insurance benefits substantially similar to those which you were receiving immediately prior to the earlier of Shareholder Approval, if applicable, or the Change in Control. Notwithstanding the foregoing, the Company shall not provide any benefit otherwise receivable by you pursuant to this paragraph 5.3.3 to the extent that a similar benefit is actually received by you from a subsequent employer during such twelve (12) month period, and any such benefit actually received by you shall be reported to the Company;

 

5.3.4     any and all outstanding equity compensation awards (whether options, restricted stock units or otherwise) under any Plan held by you shall immediately vest and become exercisable in full; provided, however, that if the award agreement for any such award provides different vesting terms on a change in control of the Company, the terms of the award agreement shall control and this paragraph 5.3.4 shall not apply; and

 

5.3.5     within five (5) days of the Date of Termination, the Company shall pay you for any vacation time earned but not taken at the Date of Termination, at an hourly rate equal to your annual base salary as in effect immediately prior to the time a Notice of Termination is given divided by 2080.

 

5.4     Notwithstanding any other provision in this Agreement or any other agreement or arrangement between the Company and you with respect to compensation or benefits (each an “Other Arrangement”), if any portion of the Specified Benefits (as defined below) would be subject to the excise tax payable by you imposed by Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended, or any successor provisions (the “IRC”), and if you would receive a greater after-tax benefit from the Capped Benefit (as defined below) than from the Specified Benefits, the Capped Benefit shall be paid to you in lieu of the Specified Benefits. The “Specified Benefits” are the amounts (including the monetary value of any non-cash benefits) otherwise payable pursuant to this Agreement and any Other Arrangement. The “Capped Benefit” equals the Specified Benefits, reduced by the minimum amount necessary to prevent any portion of the Specified Benefits from being a “parachute payment” as defined in IRC Section 280G(b)(2). For purposes of determining whether you would receive a greater after-tax benefit from the Capped Benefit than from the Specified Benefits, there shall be taken into account any excise tax that would be imposed under IRC Section 4999 and all federal, state and local taxes required to be paid by you in respect of the receipt of such payments. If you receive the Capped Benefit, you may determine the extent to which each of the Specified Benefits shall be reduced. The parties recognize that there is some uncertainty regarding the computations under IRC Section 280G which must be applied to determine the Capped Benefit. Accordingly, the parties agree that, after the severance benefit is paid, the amount of the Capped Benefit may be retroactively adjusted to the extent any subsequent Internal Revenue Service regulations, rulings, audits or other pronouncements establish that the original calculation of the Capped Benefit was incorrect. In that case, amounts shall be paid or reimbursed between the parties so that you will have received the severance benefit you would have received if the Capped Benefit had originally been calculated correctly. Moreover, in determining whether you will receive the Specified Benefits or the Capped Benefit, any potential tax consequences to the Company under IRC Section 280G or otherwise will not be taken into account. 

  

 

Page 7

 

 

5.5     Except as specifically provided above, the amount of any payment provided for in this Section 5 shall not be reduced, offset or subject to recovery by the Company by reason of any compensation earned by you as the result of employment by another employer after the Date of Termination, or otherwise. Your entitlements under Section 5.3 are in addition to, and not in lieu of any rights, benefits or entitlements you may have under the terms or provisions of any Plan.

 

6.     Successors; Binding Agreement.

 

6.1     The Company will seek to have any Successor (as hereinafter defined), by agreement in form and substance satisfactory to you, assume the Company’s obligations under this Agreement or assent to the fulfillment by the Company of its obligations under this Agreement. This Agreement will be binding upon and inure to the benefit of the Company and any Successor (and such Successor shall thereafter be deemed the “Company” for purposes of this Agreement), but will not otherwise be assignable, transferable or delegable by the Company. For purposes of this Agreement, “Successor” shall mean any Person that succeeds to, or has the practical ability to control (either immediately or with the passage of time), the Company’s business directly, by merger, consolidation or purchase of assets, or indirectly, by purchase of the Voting Securities or otherwise.

 

6.2     This Agreement shall inure to the benefit of and be enforceable by your personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If you should die while any amount would still be payable to you hereunder if you had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to your devisee, legatee or other designee or, if there be no such designee, to your estate.

 

7.     Fees and Expenses. The Company shall pay all legal fees and related legal expenses incurred by you as a result of (i) your termination following the earlier of Shareholder Approval, if applicable, or a Change in Control (including all such fees and expenses, if any, incurred in contesting or disputing any such termination) or (ii) your seeking to obtain or enforce any right or benefit provided by this Agreement.

 

8.     Survival. The respective obligations of, and benefits afforded to, the Company and you as provided in Section 5, 6, 7 and 12 of this Agreement shall survive termination of this Agreement.

 

9.     Notice. For the purposes of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid and addressed to the address of the respective party set forth on the first page of this Agreement, provided that all notices to the Company shall be directed to the attention of the Chairman of the Board or President of the Company, with a copy to the Secretary of the Company, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.

  

 

Page 8

 

 

10.     Miscellaneous. No provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in a writing signed by you and the Chairman of the Board or President of the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or of compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not expressly set forth in this Agreement. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Oregon.

 

11.     Validity. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.

 

12.     Arbitration. Any dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration in Portland, Oregon by three arbitrators in accordance with the rules of the American Arbitration Association then in effect. Judgment may be entered on the arbitrators’ award in any court having jurisdiction; provided, however, that you shall be entitled to seek specific performance of your right to be paid until the Date of Termination during the pendency of any dispute or controversy arising under or in connection with this Agreement. The Company shall bear all costs and expenses arising in connection with any arbitration proceeding pursuant to this Section 12.

 

13.     Related Agreement.

 

13.1      You and the Company are parties to a Long Term Incentive Plan Agreement dated as of April 19, 2016 (“LTIP Agreement”). The LTIP Agreement provides for a cash severance benefit payable to you and continuation of your health insurance benefits if your employment is terminated without cause (as defined therein) before the final regular payroll date of 2017, and these benefits are payable regardless of whether a Change in Control occurs. If you become entitled to severance benefits under both the LTIP Agreement and Section 5.3 of this Agreement, you shall be entitled to receive a cash severance equal to the larger of the cash severance benefit under the LTIP Agreement or the benefit provided under Section 5.3.2 of this Agreement, without duplication, and you shall be entitled to continuation of health insurance benefits for the longer of the period provided for under the LTIP Agreement or the period provided for under Section 5.3.3 of this Agreement, without duplication. For the avoidance of doubt, the LTIP Agreement shall be considered an Other Arrangement for purposes of Section 5.4 of this Agreement.

 

13.2     Except as provided in this Section 13, nothing in this Agreement shall prevent or limit your continuing or future participation in any plan, program, policy or practice provided by the Company and for which you may qualify, nor shall anything in this Agreement limit or otherwise affect such rights as you may have under any contract or agreement with the Company. Amounts which are vested benefits or which you are otherwise entitled to receive under any plan, policy, practice or program of, or any contract or agreement with, the Company at or subsequent to this Agreement shall be payable in accordance with such plan, policy, practice or program or contract or agreement except as explicitly modified by this Agreement.

  

 

Page 9

 

 

14.     Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same instrument.

 

15.     409A Interpretation.  This Agreement (and all payments and other benefits provided under this Agreement and provided under any other agreement incorporated by reference) are intended to be exempt from the requirements of IRC Section 409A to the maximum extent possible, whether pursuant to the short-term deferral exception described in Treasury Regulation Section 1.409A-1(b)(4), the involuntary separation pay plan exception described in Treasury Regulation Section 1.409A-1(b)(9)(iii), or otherwise.  To the extent IRC Section 409A is applicable to such payments and benefits, the Company intends that this Agreement (and such payments and benefits) comply with the deferral, payout and other limitations and restrictions imposed under IRC Section 409A.  Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall be interpreted, operated and administered in a manner consistent with such intentions. 

 

16.     Payments to Specified Employee.  Notwithstanding any other provision of this Agreement to the contrary, you shall not be entitled to any payment pursuant to this Agreement prior to the earliest date permitted under IRC Section 409A.  If at the time of your termination of employment, you are a “specified employee,” as defined in Treasury Regulation Section 1.409A-1(i) and determined using the identification methodology selected by the Company from time to time, or if none, the default methodology under IRC Section 409A, and a payment or benefit provided for in this Agreement would be subject to additional tax under IRC Section 409A if such payment or benefit is paid within six (6) months after your termination, then such payment or benefit required under this Agreement shall not be paid (or commence to be paid) during the six (6) month period immediately following your termination, but shall instead be accumulated and paid to you (or, if you have died, to your estate) on the earlier of (i) the tenth (10th) business day following your death or (ii) the first (1st) business day of the seventh month following your termination of employment.

 

If this Agreement correctly sets forth our agreement on the subject matter hereof, kindly sign and return to the Company the enclosed copy of this Agreement which will then constitute our agreement on this subject.

 

	
 
	
Sincerely,
	
 

	 	 	 
	 	 	 
	 	 	 
	 	Scott J. Montross	 
	 	President and Chief Executive Officer 	 
	
 
	
 
	
 
	
 

	
AGREED AND ACCEPTED:
	
 
	
 
	
 

	 	 	 	 
	 	 	 	 
	 	 	 	 

Page 10EX-10.1

 Exhibit 10.1 
  

	
	 

  
  
  

AMETEK, INC. 
  

 
  

					
		 	  

NOTE PURCHASE AGREEMENT
  
	 	

  
 DATED AS
OF OCTOBER 31, 2016 
  
  

 
 €300,000,000 1.34% SERIES P SENIOR
NOTES DUE OCTOBER 31, 2026 
 €200,000,000 1.53% SERIES Q
SENIOR NOTES DUE OCTOBER 31, 2028 
 £150,000,000 2.59%
SERIES R SENIOR NOTES DUE NOVEMBER 23, 2028 

£75,000,000 2.70% SERIES S SENIOR NOTES DUE NOVEMBER 23,
2031 

 TABLE OF CONTENTS 

 

									
	 	 	 	  	 	  	Page	 
			
	 1.
	 	THE NOTES	  	 	1	  
			
	 2.
	 	SALE AND PURCHASE OF NOTES	  	 	2	  
			
	 3.
	 	CLOSINGS	  	 	2	  
				
		 	3.1.	  	First Closing	  	 	2	  
		 	3.2.	  	Second Closing	  	 	2	  
		 	3.3.	  	Failure of the Company to Deliver; Failure to Satisfy Closing Conditions	  	 	3	  
			
	 4.
	 	CONDITIONS TO CLOSINGS	  	 	3	  
				
		 	4.1.	  	Representations and Warranties	  	 	3	  
		 	4.2.	  	Performance; No Default	  	 	3	  
		 	4.3.	  	Compliance Certificates	  	 	3	  
		 	4.4.	  	Opinions of Counsel	  	 	4	  
		 	4.5.	  	Purchase Permitted By Applicable Law, etc.	  	 	4	  
		 	4.6.	  	Sale of Other Notes	  	 	4	  
		 	4.7.	  	Payment of Special Counsel Fees	  	 	4	  
		 	4.8.	  	Private Placement Number	  	 	5	  
		 	4.9.	  	Changes in Corporate Structure	  	 	5	  
		 	4.10.	  	Funding Instructions	  	 	5	  
		 	4.11.	  	Proceedings and Documents	  	 	5	  
			
	 5.
	 	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	 	5	  
				
		 	5.1.	  	Organization; Power and Authority	  	 	5	  
		 	5.2.	  	Authorization, etc.	  	 	6	  
		 	5.3.	  	Disclosure	  	 	6	  
		 	5.4.	  	Organization and Ownership of Shares of Subsidiaries	  	 	6	  
		 	5.5.	  	Financial Statements, etc.	  	 	7	  
		 	5.6.	  	Compliance with Laws, Other Instruments, etc.	  	 	7	  
		 	5.7.	  	Governmental Authorizations, etc.	  	 	8	  
		 	5.8.	  	Litigation; Observance of Agreements, Statutes and Orders	  	 	8	  
		 	5.9.	  	Taxes	  	 	8	  
		 	5.10.	  	Title to Property; Leases	  	 	9	  
		 	5.11.	  	Licenses, Permits, etc.	  	 	9	  
		 	5.12.	  	Compliance with ERISA	  	 	9	  
		 	5.13.	  	Private Offering by the Company	  	 	10	  
		 	5.14.	  	Use of Proceeds; Margin Regulations	  	 	11	  
		 	5.15.	  	Existing Indebtedness; Future Liens, etc.	  	 	11	  
		 	5.16.	  	Foreign Assets Control Regulations, etc.	  	 	11	  
		 	5.17.	  	Status under Certain Statutes	  	 	12	  
		 	5.18.	  	Environmental Matters	  	 	12	  
		 	5.19.	  	Ranking	  	 	13	  
			
	 6.
	 	REPRESENTATIONS OF THE PURCHASERS	  	 	13	  
				
		 	6.1.	  	Purchase for Investment	  	 	13	  
		 	6.2.	  	Source of Funds	  	 	14	  

  
 i 

 TABLE OF CONTENTS 

(continued) 
  

									
	 	 	 	  	 	  	Page	 
			
	 7.
	 	INFORMATION AS TO COMPANY	  	 	15	  
				
		 	7.1.	  	Financial and Business Information	  	 	15	  
		 	7.2.	  	Officer’s Certificate	  	 	18	  
		 	7.3.	  	Inspection	  	 	19	  
			
	 8.
	 	PREPAYMENT OF THE NOTES	  	 	19	  
				
		 	8.1.	  	Optional Prepayments	  	 	20	  
		 	8.2.	  	Notice of Prepayment; Make-Whole Computation	  	 	20	  
		 	8.3.	  	Allocation of Partial Prepayments	  	 	20	  
		 	8.4.	  	Maturity; Surrender; etc.	  	 	20	  
		 	8.5.	  	Purchase of Notes	  	 	21	  
		 	8.6.	  	Make-Whole Amount	  	 	21	  
		 	8.7.	  	Prepayment in Connection with a Change of Control	  	 	29	  
		 	8.8.	  	Prepayment in Connection with the Disposition of Certain Assets	  	 	29	  
			
	 9.
	 	AFFIRMATIVE COVENANTS	  	 	30	  
				
		 	9.1.	  	Compliance with Laws	  	 	30	  
		 	9.2.	  	Insurance	  	 	31	  
		 	9.3.	  	Maintenance of Properties; Books and Records	  	 	31	  
		 	9.4.	  	Payment of Taxes	  	 	31	  
		 	9.5.	  	Corporate Existence, etc.	  	 	31	  
		 	9.6.	  	Ranking	  	 	32	  
			
	 10.
	 	NEGATIVE COVENANTS	  	 	32	  
				
		 	10.1.	  	Certain Financial Conditions	  	 	32	  
		 	10.2.	  	Liens	  	 	33	  
		 	10.3.	  	Disposition of Assets	  	 	34	  
		 	10.4.	  	Merger, Consolidation, etc.	  	 	35	  
		 	10.5.	  	Transactions with Affiliates	  	 	37	  
		 	10.6.	  	Terrorism Sanctions Regulations	  	 	37	  
			
	 11.
	 	EVENTS OF DEFAULT	  	 	37	  
			
	 12.
	 	REMEDIES ON DEFAULT, ETC.	  	 	39	  
				
		 	12.1.	  	Acceleration	  	 	39	  
		 	12.2.	  	Other Remedies	  	 	40	  
		 	12.3.	  	Rescission	  	 	40	  
		 	12.4.	  	No Waivers or Election of Remedies, Expenses, etc.	  	 	41	  
			
	 13.
	 	REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES	  	 	41	  
				
		 	13.1.	  	Registration of Notes	  	 	41	  
		 	13.2.	  	Transfer and Exchange of Notes	  	 	41	  
		 	13.3.	  	Replacement of Notes	  	 	42	  

  
 ii 

 TABLE OF CONTENTS 

(continued) 
  

									
	 	 	 	  	 	  	Page	 
			
	 14.
	 	PAYMENTS ON NOTES	  	 	42	  
				
		 	14.1.	  	Place of Payment	  	 	42	  
		 	14.2.	  	Home Office Payment	  	 	42	  
			
	 15.
	 	EXPENSES, ETC.	  	 	43	  
				
		 	15.1.	  	Transaction Expenses	  	 	43	  
		 	15.2.	  	Survival	  	 	44	  
			
	 16.
	 	SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT	  	 	44	  
			
	 17.
	 	AMENDMENT AND WAIVER	  	 	44	  
				
		 	17.1.	  	Requirements	  	 	44	  
		 	17.2.	  	Solicitation of Holders of Notes	  	 	44	  
		 	17.3.	  	Binding Effect, etc.	  	 	45	  
		 	17.4.	  	Notes Held by Company, etc.	  	 	45	  
			
	 18.
	 	NOTICES	  	 	45	  
			
	 19.
	 	REPRODUCTION OF DOCUMENTS	  	 	46	  
			
	 20.
	 	CONFIDENTIAL INFORMATION	  	 	46	  
			
	 21.
	 	SUBSTITUTION OF PURCHASER	  	 	47	  
			
	 22.
	 	MISCELLANEOUS	  	 	48	  
				
		 	22.1.	  	Successors and Assigns	  	 	48	  
		 	22.2.	  	Construction	  	 	48	  
		 	22.3.	  	Jurisdiction and Process	  	 	48	  
		 	22.4.	  	Payments Due on Non-Business Days	  	 	49	  
		 	22.5.	  	Severability	  	 	49	  
		 	22.6.	  	Accounting Terms; Change in GAAP	  	 	49	  
		 	22.7.	  	Obligation to Make Payments in Relevant Currency	  	 	50	  
		 	22.8.	  	Exchange Rate	  	 	51	  
		 	22.9.	  	Counterparts	  	 	51	  
		 	22.10.	  	Governing Law	  	 	51	  

  
 iii 

 Schedules and Exhibits 

 

					
	Schedule A	 	      --      	 	Information as to Purchasers
			
	Schedule B	 	--	 	Defined Terms
			
	Schedule 4.9	 		 	Changes in Corporate Structure
	Schedule 5.4	 	--	 	Subsidiaries of the Company, Ownership of Subsidiary Stock, etc.
	Schedule 5.5	 	--	 	Financial Statements
	Schedule 5.8	 	--	 	Litigation
	Schedule 5.12	 	--	 	Compliance with ERISA
	Schedule 5.15	 	--	 	Existing Indebtedness
	Schedule 5.18	 	--	 	Environmental Matters
	Schedule 8.6	 	--	 	Swap Certificate
			
	Exhibit 1	 	--	 	Form of 1.34% Series P Senior Notes due October 31, 2026
	Exhibit 2	 	--	 	Form of 1.53% Series Q Senior Notes due October 31, 2028
	Exhibit 3	 	--	 	Form of 2.59% Series R Senior Notes due November 23, 2028
	Exhibit 4	 	--	 	Form of 2.70% Series S Senior Notes due November 23, 2031

 AMETEK, INC. 

1100 Cassatt Road 
 Berwyn,
Pennsylvania 19312-1177 
 €300,000,000 1.34% SERIES P SENIOR NOTES
DUE OCTOBER 31, 2026 
 €200,000,000 1.53% SERIES Q SENIOR
NOTES DUE OCTOBER 31, 2028 
 £150,000,000 2.59% SERIES R
SENIOR NOTES DUE NOVEMBER 23, 2028 
 £75,000,000 2.70%
SERIES S SENIOR NOTES DUE NOVEMBER 23, 2031 
  

As of October 31, 2016 
 To each of
the Purchasers 
 listed in Schedule A hereto: 

Ladies and Gentlemen: 

AMETEK, INC., a Delaware corporation (together with its permitted successors and assigns hereunder, the
“Company”), agrees with each of the purchasers whose names appear at the end hereof as follows: 
  

	1.	 THE NOTES. 

The Company will authorize the issue and sale of: 

(a)      €300,000,000 aggregate principal amount of its 1.34% Series P
Senior Notes due October 31, 2026 (including any amendments, restatements or modifications from time to time thereof and all notes delivered in substitution or exchange for any such note pursuant to this Agreement, the “Series P
Notes”); 
 (b)      €200,000,000 aggregate principal amount of
its 1.53% Series Q Senior Notes due October 31, 2028 (including any amendments, restatements or modifications from time to time thereof and all notes delivered in substitution or exchange for any such note pursuant to this Agreement, the
“Series Q Notes”); 
 (c)      £150,000,000 aggregate
principal amount of its 2.59% Series R Senior Notes due November 23, 2028 (including any amendments, restatements or modifications from time to time thereof and all notes delivered in substitution or exchange for any such note pursuant to this
Agreement, the “Series R Notes”); and

(d)      £75,000,000 aggregate principal amount of its 2.70% Series S
Senior Notes due November 23, 2031 (including any amendments, restatements or modifications from time to time thereof and all notes delivered in substitution or exchange for any such note pursuant to this Agreement, the “Series S
Notes”)). 
 The Series P Notes, the Series Q Notes, the Series R Notes and the Series S Notes are sometimes
referred to herein collectively as the “Notes,” and each of the Notes is sometimes referred to herein individually as a “Note.” The Series P Notes, the Series Q Notes, the Series R Notes and the Series S Notes
shall be substantially in the respective forms set out in Exhibits 1, 

 
2, 3 and 4. Certain capitalized and other terms used in this Agreement are defined in Schedule B; references to a “Schedule” or an “Exhibit”, unless otherwise
specified, refer to a Schedule or an Exhibit attached to this Agreement. 
  

	2.	 SALE AND PURCHASE OF NOTES. 

Subject to the terms and conditions of this Agreement, the Company will issue and sell to each Purchaser and each Purchaser
will purchase from the Company, at the Closings provided for in Section 3, Notes in the principal amount and of the series and at the Closings specified below such Purchaser’s name in Schedule A at the purchase price of 100% of the
principal amount thereof. The Purchasers’ obligations hereunder are several and not joint obligations and no Purchaser shall have any liability to any Person for the performance or non-performance of any obligation by any other Purchaser
hereunder. 
  

	3.	 CLOSINGS. 

  

	 	3.1.	 First Closing. 

The sale and purchase of the Series P Notes (each purchaser of Series P Notes, a “Series P Purchaser”) and
the Series Q Notes (each purchaser of Series Q Notes, a “Series Q Purchaser” and, together with the Series P Purchasers, collectively, the “First Closing Purchasers”) to be purchased by each of the First
Closing Purchasers shall occur at a closing (the “First Closing”) on October 31, 2016 (the date of the First Closing being referred to herein as the “First Closing Date”) at the offices of Morgan, Lewis &
Bockius LLP, 101 Park Avenue, New York, New York 10178 at 10:00 a.m., local time. At the First Closing, the Company will deliver to each First Closing Purchaser the Notes to be purchased by such First Closing Purchaser at the First Closing in
the form of a single Note for each series of Notes to be purchased by such First Closing Purchaser (or such greater number of Notes of each applicable series in denominations of at least €500,000 as such First Closing Purchaser may request),
dated the First Closing Date and registered in such First Closing Purchaser’s name (or in the name of its nominee), against delivery by such First Closing Purchaser to the Company or its order of immediately available funds in the amount of the
purchase price therefor by wire transfer of immediately available funds for the account of the Company as set forth in the funding instructions required by Section 4.10.
  

	 	3.2.	 Second Closing. 

The sale and purchase of the Series R Notes (each purchaser of Series R Notes, a “Series R Purchaser”)
and the Series S Notes (each purchaser of Series S Notes, a “Series S Purchaser” and, together with the Series R Purchasers, collectively, the “Second Closing Purchasers”) to be purchased by each of the Second
Closing Purchasers shall occur at a closing (the “Second Closing”, and together with the First Closing, being sometimes referred to herein, collectively, as the “Closings” and individually as a
“Closing”) on November 23, 2016 (the date of the Second Closing being referred to herein as the “Second Closing Date”, and together with the First Closing Date, being individually referred to herein as a
“Closing Date”) at the offices of Morgan, Lewis & Bockius LLP, 101 Park Avenue, New York, New York 10178 at 10:00 a.m., local time. At the Second Closing, the Company will deliver to each Second Closing

  
 2 

 
Purchaser the Notes to be purchased by such Second Closing Purchaser at the Second Closing in the form of a single Note for each series of Notes to be purchased by such Second Closing Purchaser
(or such greater number of Notes of each applicable series in denominations of at least £500,000 as such Second Closing Purchaser may request), dated the Second Closing Date and registered in such Second Closing Purchaser’s name (or in
the name of its nominee), against delivery by such Second Closing Purchaser to the Company or its order of immediately available funds in the amount of the purchase price therefor by wire transfer of immediately available funds for the account of
the Company as set forth in the funding instructions required by Section 4.10. 
  

	 	3.3.	 Failure of the Company to Deliver; Failure to Satisfy Closing Conditions. 

If at either Closing the Company shall fail to tender the applicable Notes to any Purchaser as provided above in this Section
3, or any of the conditions specified in Section 4 shall not have been fulfilled to such Purchaser’s reasonable satisfaction in connection with such Closing, such Purchaser shall, at its election, be relieved of all further obligations under
this Agreement with respect to such Closing, without thereby waiving any rights such Purchaser may have by reason of such failure or such nonfulfillment. 
  

	4.	 CONDITIONS TO CLOSINGS. 

Each Purchaser’s obligation to purchase and pay for the Notes to be sold to such Purchaser on a Closing Date is subject
to the fulfillment to such Purchaser’s reasonable satisfaction, prior to or on such Closing Date, of the following conditions: 
  

	 	4.1.	 Representations and Warranties. 

The representations and warranties of the Company in this Agreement shall be correct (a) with respect to the First Closing, on
the First Closing Date after giving effect to the transactions contemplated by this Agreement to occur at or before the First Closing, and (b) with respect to the Second Closing, on the Second Closing Date after giving effect to the transactions
contemplated by this Agreement to occur at or before the Second Closing. 
  

	 	4.2.	 Performance; No Default. 

The Company shall have performed and complied with all agreements and conditions contained in this Agreement required to be
performed or complied with by it prior to or at such Closing. Before and after giving effect to the issue and sale of the Notes to be issued at such Closing (and the application of the proceeds thereof as contemplated by Section 5.14), no
Default or Event of Default shall have occurred and be continuing. 
  

	 	4.3.	 Compliance Certificates. 

(a)        Officer’s
Certificate.     The Company shall have delivered to such Purchaser an Officer’s Certificate, dated such Closing Date, certifying that the conditions specified in Sections 4.1, 4.2 and 4.9 have been fulfilled. 

(b)        Secretary’s
Certificate.     The Company shall have delivered to such Purchaser a certificate of its Secretary or Assistant Secretary, dated such Closing Date, certifying as to (i) the resolutions attached thereto and other
corporate proceedings relating to the authorization, execution and delivery of this Agreement and the Notes to be issued on such Closing Date, and (ii) the Company’s organizational documents as then in effect. 

  
 3 

	 	4.4.	 Opinions of Counsel. 

Such Purchaser shall have received opinions in form and substance reasonably satisfactory to such Purchaser, dated such
Closing Date (a) from Robert S. Feit, Senior Vice President and General Counsel for the Company, covering such matters incident to the transactions contemplated hereby as such Purchaser or its counsel may reasonably request (and the Company hereby
instructs its counsel to deliver such opinion to such Purchaser), and (b) from Morgan, Lewis & Bockius LLP, the Purchasers’ special counsel in connection with such transactions, covering such matters incident to such transactions as such
Purchaser may reasonably request. 
  

	 	4.5.	 Purchase Permitted By Applicable Law, etc. 

On such Closing Date, such Purchaser’s purchase of the Notes to be issued to such Purchaser on such Closing Date shall
(a) be permitted by the laws and regulations of each jurisdiction to which such Purchaser is subject, without recourse to provisions (such as section 1405(a)(8) of the New York Insurance Law) permitting limited investments by insurance companies
without restriction as to the character of the particular investment, (b) not violate any applicable law or regulation (including, without limitation, Regulation T, U or X of the Board of Governors of the Federal Reserve System) and (c) not subject
such Purchaser to any tax, penalty or liability under or pursuant to any applicable law or regulation, which law or regulation was not in effect on the date hereof. If requested by such Purchaser, such Purchaser shall have received an
Officer’s Certificate certifying as to such matters of fact as such Purchaser may reasonably specify to enable such Purchaser to determine whether such purchase is so permitted. 

 

	 	4.6.	 Sale of Other Notes. 

(a)       Contemporaneously with such Closing, the Company shall sell to each other
Purchaser, and each such other Purchaser shall purchase the Notes to be purchased by it at such Closing as specified in Schedule A. 

(b)       In the case of the Second Closing, the transactions contemplated herein with
respect to the First Closing shall have been consummated in accordance with the terms and provisions hereof. 
  

	 	4.7.	 Payment of Special Counsel Fees. 

Without limiting the provisions of Section 15.1, the Company shall have paid on or before the applicable Closing Date the
reasonable fees, charges and disbursements of the Purchasers’ special counsel referred to in Section 4.4 to the extent reflected in a statement of such counsel rendered to the Company at least one Business Day prior to such Closing Date. 

  
 4 

	 	4.8.	 Private Placement Number. 

A Private Placement Number issued by Standard & Poor’s CUSIP Service Bureau (in cooperation with the SVO) shall have
been obtained for each series of Notes. 
  

	 	4.9.	 Changes in Corporate Structure. 

Except as stated in Schedule 4.9, the Company shall not have changed its jurisdiction of incorporation or been a party to any
merger or consolidation or succeeded to all or any substantial part of the liabilities of any other entity (whether or not the transaction would be permitted by Section 10.4) at any time following the date of the most recent financial statements
referred to in Schedule 5.5. 
  

	 	4.10.	 Funding Instructions. 

At least three Business Days prior to each Closing Date, each applicable Purchaser shall have received written instructions
signed by a Responsible Officer on letterhead of the Company setting forth the instructions for the delivery of the purchase price with respect to each series of Notes to be purchased by such Purchaser on such Closing Date, including (a) the name
and address of the transferee bank, (b) such transferee bank’s SWIFT # and (c) the account name and number into which the purchase price for the applicable Notes is to be deposited. 

 

	 	4.11.	 Proceedings and Documents. 

All corporate and other proceedings in connection with the transactions contemplated by this Agreement and all documents and
instruments incident to such transactions shall be to the reasonable satisfaction of such Purchaser and its special counsel, and such Purchaser and its special counsel shall have received all such counterpart originals or certified or other copies
of such documents as such Purchaser or such special counsel may reasonably request. 
  

	5.	 REPRESENTATIONS AND WARRANTIES OF THE COMPANY. 

The Company represents and warrants to (a) each First Closing Purchaser on the First Closing Date, and (b) each Second Closing
Purchaser on the Second Closing Date: 
  

	 	5.1.	 Organization; Power and Authority. 

The Company is a corporation duly organized, validly existing and in good standing under the laws of its jurisdiction of
incorporation, and is duly qualified as a foreign corporation and is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing
could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has the corporate power and authority to own or hold under lease the properties it purports to own or hold under lease, to
transact the business it transacts and proposes to transact, to execute and deliver this Agreement and the Notes and to perform its obligations hereunder and thereunder. 

  
 5 

	 	5.2.	 Authorization, etc. 

This Agreement and the Notes to be issued at such Closing have been duly authorized by all necessary corporate action on the
part of the Company, and this Agreement constitutes, and upon execution and delivery thereof each Note to be issued at such Closing will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except as such enforceability may be limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) general principles of
equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 
  

	 	5.3.	 Disclosure. 

The Company, through its agents, J.P. Morgan Securities LLC, SunTrust Robinson Humphrey, Inc., PNC Capital Markets LLC, and
Citizens Banks, N.A., has delivered to each Purchaser a copy of a Private Placement Memorandum, dated September 2016 (the “Memorandum”), relating to the transactions contemplated hereby. The Memorandum fairly describes, in all
material respects, the general nature of the business and principal properties of the Company and its Subsidiaries. This Agreement, the Memorandum, the documents, certificates or other writings referred to in the Memorandum, or posted in
respect of the Company on website www.intralinks.com prior to October 14, 2016 in connection with the transactions contemplated hereby, as of their respective dates, and the financial statements listed in Schedule 5.5, taken as a whole (this
Agreement, the Memorandum and such documents, certificates or other writings and such financial statements being referred to, collectively, as the “Disclosure Documents”), do not contain any untrue statement of a material fact or
omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. There is no fact known to the Company that could reasonably be expected to have a Material Adverse
Effect that has not been set forth herein or in the Disclosure Documents. Except as disclosed in the Disclosure Documents or in the financial statements listed in Schedule 5.5, since December 31, 2015 there has been no change in the
financial condition, operations, business or properties of the Company or any Subsidiary except changes that individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect (it being understood for the purposes of
this Section 5.3 that any event or condition which shall cause the Company to be unable to satisfy the covenants described in Section 10.1 for any period after December 31, 2015 on a pro forma basis shall be deemed to have a Material Adverse
Effect). 
  

	 	5.4.	 Organization and Ownership of Shares of Subsidiaries. 

Schedule 5.4 contains complete and correct lists, as of the date hereof, of the Company’s (i) Subsidiaries,
showing, as to each such Subsidiary, the correct name thereof, the jurisdiction of its organization and the percentage of shares of each class of its capital stock or similar equity interests outstanding owned by the Company and each other
Subsidiary, (ii) Affiliates, other than Subsidiaries, and (iii) directors and senior officers.

(a)          All of the outstanding shares of capital stock
or similar equity interests of each Subsidiary shown in Schedule 5.4 as being owned by the Company and its 

  
 6 

 
Subsidiaries, and all such stock or equity interests of Subsidiaries acquired thereafter, have been validly issued, are fully paid and nonassessable and are owned by the Company or another
Subsidiary free and clear of any Lien. 

(b)          Each Subsidiary is a corporation or other legal
entity duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and is duly qualified as a foreign corporation or other legal entity and is in good standing in each jurisdiction in which such
qualification is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each such
Subsidiary has the corporate or other power and authority to own or hold under lease the properties it purports to own or hold under lease and to transact the business it transacts and proposes to transact. 

(c)          No Subsidiary is a party to, or otherwise
subject to any legal restriction or any agreement (other than this Agreement and customary limitations imposed by corporate law statutes) restricting the ability of such Subsidiary to pay dividends out of profits or make any other similar
distributions of profits to the Company or any of its Subsidiaries that owns outstanding shares of capital stock or similar equity interests of such Subsidiary. 
  

	 	5.5.	 Financial Statements, etc. 

The Company has delivered to each Purchaser copies of the financial statements of the Company and its Subsidiaries listed in
Schedule 5.5. All of said financial statements (including in each case the related schedules and notes) fairly present in all material respects the consolidated financial position of the Company and its Subsidiaries as of the respective
dates specified in such Schedule and the consolidated results of their operations and cash flows for the respective periods so specified and have been prepared in accordance with GAAP consistently applied throughout the periods involved, except as
set forth in the notes thereto (subject, in the case of any interim financial statements, to normal year-end adjustments). 

Neither the Company nor any Subsidiary had any material liabilities of a type required to be disclosed in financial statements
(or notes thereto) prepared in accordance with GAAP, including material obligations under Guaranties, contingent liabilities and liabilities for taxes, or any long-term leases or unusual forward or long-term commitments in respect of derivatives,
that are not reflected in the financial statements listed in Schedule 5.5 or otherwise disclosed in the Disclosure Documents. 
  

	 	5.6.	 Compliance with Laws, Other Instruments, etc. 

The execution, delivery and performance by the Company of this Agreement and the Notes will not (a) contravene, result in any
breach of, or constitute a default under, or result in the creation of any Lien in respect of any property of the Company or any Subsidiary under, any indenture, mortgage, deed of trust, loan, purchase or credit agreement, lease, corporate charter
or by-laws, or any other agreement or instrument to which the Company or any Subsidiary is bound or by which the Company or any Subsidiary or any of their respective properties may be bound or affected, (b) conflict with or result in a breach of any
of the terms, conditions or provisions of 

  
 7 

 
any order, judgment, decree, or ruling of any court, arbitrator or Governmental Authority applicable to the Company or any Subsidiary or (c) violate any provision of any statute or other rule or
regulation of any Governmental Authority applicable to the Company or any Subsidiary. 
  

	 	5.7.	 Governmental Authorizations, etc. 

No consent, approval or authorization of, or registration, filing or declaration with, any Governmental Authority is required
to be obtained by the Company or any Subsidiary in connection with the execution, delivery or performance by the Company of this Agreement or the Notes. 
  

	 	5.8.	 Litigation; Observance of Agreements, Statutes and Orders. 

(a)          Except as is disclosed in the Company’s
Form 10-K for its fiscal year ending December 31, 2015 or any Form 10-Q filed by the Company subsequent thereto (the relevant portions of which are attached as Schedule 5.8), there are no actions, suits, investigations or proceedings
pending or, to the knowledge of the Company, threatened against or affecting the Company or any Subsidiary or any property of the Company or any Subsidiary in any court or before any arbitrator of any kind or before or by any Governmental Authority
that, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. 

(b)          Neither the Company nor any Subsidiary is in
default under any term of any agreement or instrument to which it is a party or by which it is bound, or any order, judgment, decree or ruling of any court, arbitrator or Governmental Authority or is in violation of any applicable law, ordinance,
rule or regulation (including without limitation Environmental Laws, the USA PATRIOT Act or any of the other laws and regulations that are referred to in Section 5.16) of any Governmental Authority, which default or violation, individually or in the
aggregate, could reasonably be expected to have a Material Adverse Effect. 
  

	 	5.9.	 Taxes. 

The Company and its Subsidiaries have filed all federal and state income tax returns and all other Material tax returns that
are required to have been filed in any jurisdiction, and have paid all taxes shown to be due and payable on such returns and all other taxes and assessments levied upon them or their properties, assets, income or franchises, to the extent such taxes
and assessments have become due and payable and before they have become delinquent, except for any taxes and assessments (a) the amount of which is not individually or in the aggregate Material or (b) the amount, applicability or validity of which
is currently being contested in good faith by appropriate proceedings and with respect to which the Company or a Subsidiary, as the case may be, has established adequate reserves in accordance with GAAP. The Company knows of no basis for any
other tax or assessment that could reasonably be expected to have a Material Adverse Effect. The charges, accruals and reserves on the books of the Company and its Subsidiaries in respect of federal, state or other taxes for all fiscal periods
are adequate in the good faith judgment of the Company’s management. The federal income tax liabilities of the Company and its Subsidiaries have been determined by the Internal Revenue Service and paid for all fiscal years up to and
including the fiscal year ended December 31, 2012. 

  
 8 

	 	5.10.	 Title to Property; Leases. 

The Company and its Subsidiaries have good and sufficient title to their respective Material properties, including all such
properties reflected in the most recent audited balance sheet referred to in Section 5.5 or purported to have been acquired by the Company or any Subsidiary after said date (except as sold or otherwise disposed of in the ordinary course of
business), in each case free and clear of Liens prohibited by this Agreement. All leases under which the Company or any Subsidiary is a lessee that individually or in the aggregate are Material are valid and subsisting and are in full force and
effect in all material respects. 
  

	 	5.11.	 Licenses, Permits, etc. 

Except as to matters that individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect,

 (a)          the Company and its Subsidiaries own or
possess all licenses, permits, franchises, authorizations, patents, copyrights, proprietary software, service marks, trademarks and trade names, or rights thereto, that are individually or in the aggregate Material, without known conflict with the
rights of others, 
 (b)          to the knowledge of the
Company, no product of the Company or any Subsidiary infringes any license, permit, franchise, authorization, patent, copyright, proprietary software, service mark, trademark, trade name or other right owned by any other Person, and 

(c)          to the knowledge of the Company, there is no
violation by any Person of any right of the Company or any of its Subsidiaries with respect to any license, permit, franchise, authorization, patent, copyright, proprietary software, service mark, trademark, trade name or other right owned or used
by the Company or any of its Subsidiaries. 
  

	 	5.12.	 Compliance with ERISA. 

(a)          The Company and each ERISA Affiliate have
operated and administered each Plan in compliance with all applicable laws except for such instances of noncompliance as have not resulted in and could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect. Neither the Company nor any ERISA Affiliate has incurred any liability pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans (as defined in section 3 of ERISA), and no
event, transaction or condition has occurred or exists that could, individually or in the aggregate, reasonably be expected to result in the incurrence of any such liability by the Company or any ERISA Affiliate, or in the imposition of any Lien on
any of the rights, properties or assets of the Company or any ERISA Affiliate, in either case pursuant to Title I or IV of ERISA or to section 430(k) of the Code or to any such penalty or excise tax provisions under the Code or federal law or
section 4068 of ERISA or by the granting of a security interest in connection with the amendment of a Plan, other than such liabilities or Liens as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect. 

  
 9 

(b)          Except as is disclosed in the Company’s
Form 10-K for its fiscal year ending December 31, 2015 or any Form 10-Q filed by the Company subsequent thereto (the relevant portions of which are attached as Schedule 5.12), the present value of the aggregate benefit liabilities under
each of the Plans (other than Multiemployer Plans), determined as of December 31, 2015 (which is the date of the Plan’s most recently ended plan year for which such information is available) on the basis of the actuarial assumptions specified
for funding purposes in such Plan’s 2015 actuarial valuation report, did not exceed the aggregate current value of the assets of such Plan allocable to such benefit liabilities. The term “benefit liabilities” has the
meaning specified in section 4001 of ERISA and the terms “current value” and “present value” have the meaning specified in section 3 of ERISA. 

(c)          The Company and its ERISA Affiliates have not
incurred withdrawal liabilities (and are not subject to contingent withdrawal liabilities) under section 4201 or 4204 of ERISA in respect of Multiemployer Plans that individually or in the aggregate could reasonably be expected to have a Material
Adverse Effect. 
 (d)          The expected
postretirement benefit obligation (determined as of the last day of the Company’s most recently ended fiscal year in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 715-60, without regard to
liabilities attributable to continuation coverage mandated by section 4980B of the Code) of the Company and its Subsidiaries could not reasonably be expected to have a Material Adverse Effect. 

(e)          The execution and delivery of this Agreement
and the issuance and sale of the Notes at each Closing hereunder will not involve any transaction that is subject to the prohibitions of section 406 of ERISA or in connection with which a tax could be imposed pursuant to section 4975(c)(1)(A)-(D) of
the Code. The representation by the Company to each Purchaser in the first sentence of this Section 5.12(e) is made in reliance upon and subject to the accuracy of such Purchaser’s representation in Section 6.2 as to the sources
of the funds to be used to pay the purchase price of the Notes to be purchased by such Purchaser at such Closing. 
  

	 	5.13.	 Private Offering by the Company. 

Neither the Company nor anyone acting on its behalf has offered the Notes or any similar Securities for sale to, or solicited
any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any Person other than the Purchasers and not more than 35 other Institutional Investors (as defined in clause (c) of the definition of such term),
each of which has been offered the Notes at a private sale for investment. Neither the Company nor anyone acting on its behalf has taken, or will take, any action that would subject the issuance or sale of the Notes to the registration
requirements of Section 5 of the Securities Act or to the registration requirements of any securities or blue sky laws of any applicable jurisdiction. 

  
 10 

	 	5.14.	 Use of Proceeds; Margin Regulations. 

The Company will apply the proceeds of the sale of the Notes to refinance existing Indebtedness of the Company and its
Subsidiaries and for general corporate purposes. No part of the proceeds from the sale of the Notes hereunder will be used, and no part of the proceeds of such Indebtedness was used, directly or indirectly, for the purpose of buying or carrying
any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221), or for the purpose of buying or carrying or trading in any securities under such circumstances as to involve the Company in a
violation of Regulation X of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220). Margin stock does not constitute more than 1% of the value of the consolidated assets of the
Company and its Subsidiaries and the Company does not have any present intention that margin stock will constitute more than 25% of the value of such assets. As used in this Section, the terms “margin stock” and
“purpose of buying or carrying” shall have the meanings assigned to them in said Regulation U. 
  

	 	5.15.	 Existing Indebtedness; Future Liens, etc. 

Schedule 5.15 sets forth a complete and correct list of all outstanding Indebtedness of the Company and its Subsidiaries as of
June 30, 2016 (and including each guarantor thereof), since which date there has been no Material change in the amounts, interest rates, sinking funds, installment payments or maturities of the Indebtedness of the Company or its Subsidiaries.
Neither the Company nor any Subsidiary is in default in, and no waiver of default is currently in effect in respect of, the payment of any principal or interest on any Indebtedness and no event or condition exists with respect to any Indebtedness of
the Company or any Subsidiary that would permit (or that with the giving of notice or the lapse of time, or both, would permit) one or more Persons to cause such Indebtedness to become due and payable before its stated maturity or before its
regularly scheduled dates of payment. 
 Neither the Company nor any Subsidiary has agreed or consented to cause or permit
in the future (upon the happening of a contingency or otherwise) any of its property, whether now owned or hereafter acquired, to be subject to a Lien not permitted by Section 10.2. 

 

	 	5.16.	 Foreign Assets Control Regulations, etc. 

(a)       Neither the Company nor any Controlled Entity (i) is a Blocked Person, (ii) has
been notified that its name appears or may in the future appear on a State Sanctions List or (iii) is a target of sanctions that have been imposed by the United Nations or the European Union. 

(b)     Neither the Company nor any Controlled Entity (i) has violated, been found in violation of,
or been charged or convicted under, any applicable U.S. Economic Sanctions Laws, Anti-Money Laundering Laws or Anti-Corruption Laws or (ii) to the Company’s knowledge, is under investigation by any Governmental Authority for possible violation
of any U.S. Economic Sanctions Laws, Anti-Money Laundering Laws or Anti-Corruption Laws. 

  
 11 

 (c)      No part of the proceeds from the sale of
the Notes hereunder: 
 (i)        constitutes or will constitute
funds obtained on behalf of any Blocked Person or will otherwise be used by the Company or any Controlled Entity, directly or indirectly, (A) in connection with any investment in, or any transactions or dealings with, any Blocked Person, (B) for any
purpose that would cause any Purchaser to be in violation of any U.S. Economic Sanctions Laws or (C) otherwise in violation of any U.S. Economic Sanctions Laws; 

(ii)       will be used, directly or indirectly, in violation of, or cause
any Purchaser to be in violation of, any applicable Anti-Money Laundering Laws; or 

(iii)      will be used, directly or indirectly, for the purpose of making any
improper payments, including bribes, to any Governmental Official or commercial counterparty in order to obtain, retain or direct business or obtain any improper advantage, in each case which would be in violation of, or cause any Purchaser to be in
violation of, any applicable Anti-Corruption Laws. 
 (d)      The Company has established
procedures and controls which it reasonably believes are adequate (and otherwise comply with applicable law) to ensure that the Company and each Controlled Entity is and will continue to be in compliance with all applicable U.S. Economic Sanctions
Laws, Anti-Money Laundering Laws and Anti-Corruption Laws. 
  

	 	5.17.	 Status under Certain Statutes. 

Neither the Company nor any Subsidiary is subject to regulation under the Investment Company Act of 1940, as amended, the
Public Utility Holding Company Act of 2005, as amended, the ICC Termination Act of 1995, as amended, or the Federal Power Act, as amended. 
  

	 	5.18.	 Environmental Matters. 

Except as is disclosed in the Company’s Form 10-K for its fiscal year ending December 31, 2015 or any Form 10-Q
filed by the Company subsequent thereto (the relevant portions of which are attached as Schedule 5.18), neither the Company nor any Subsidiary has knowledge of any claim or has received any notice of any claim, and no proceeding has been
instituted raising any claim against the Company or any Subsidiary or any of their respective real properties now or formerly owned, leased or operated by any of them or other assets, alleging any damage to the environment or violation of any
Environmental Laws, except such as could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. Except as otherwise disclosed to each Purchaser in writing, and except as to matters that,
individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, 

(a)       neither the Company nor any Subsidiary has knowledge of any facts
which would give rise to any claim, public or private, of violation of Environmental Laws or damage to the environment emanating from, occurring on or in any way related to real properties now or formerly owned, leased or operated by any of them or
to other assets or their use, 

  
 12 

 (b)       neither the Company
nor any of its Subsidiaries has stored any Hazardous Materials on real properties now or formerly owned, leased or operated by any of them and has not disposed of any Hazardous Materials in a manner contrary to any Environmental Laws, and 

(c)       all buildings on all real properties now owned, leased or
operated by the Company or any of its Subsidiaries are in compliance with applicable Environmental Laws. 
  

	 	5.19.	 Ranking. 

All liabilities of the Company under the Notes will rank in right of payment either pari passu with or senior to all
other unsecured, unsubordinated Indebtedness of the Company. 
  

	6.	 REPRESENTATIONS OF THE PURCHASERS. 

 

	 	6.1.	 Purchase for Investment. 

 (a)      Each Purchaser severally represents on the date hereof and on the
Closing Date applicable to such Purchaser that it is purchasing the Notes to be purchased by it for its own account or for one or more separate accounts maintained by such Purchaser or for the account of one or more pension or trust funds and not
with a view to the distribution thereof, provided that the disposition of such Purchaser’s or their property shall at all times be within such Purchaser’s or their control. Each Purchaser understands that the Notes have not been registered
under the Securities Act and may be resold only if registered pursuant to the provisions of the Securities Act or if an exemption from registration is available, except under circumstances where neither such registration nor such an exemption is
required by law, and that the Company is not required to register the Notes. 

 (b)      Each Purchaser severally represents on the date hereof and on the
Closing Date applicable to such Purchaser that it has had the opportunity to ask questions of the officers and directors of the Company and to obtain (and that it has received to its satisfaction) such information about the business and financial
condition of the Company as it has reasonably requested. 

 (c)      Each Purchaser severally represents on the date hereof and on the
Closing Date applicable to such Purchaser that it is an “accredited investor” within the meaning of Rule 501(a)(1), (2), (3), (7) or (8) (to the extent all of the equity owners of such Purchaser are “accredited investors” of the
type described in clauses (1), (2), (3) or (7) of Rule 501(a)) under the Securities Act.

  
 13 

	 	6.2.	 Source of Funds. 

Each Purchaser severally represents on the date hereof and on the Closing Date applicable to such Purchaser that at least one
of the following statements is an accurate representation as to each source of funds (a “Source”) to be used by such Purchaser to pay the purchase price of the Notes to be purchased by it hereunder: 

(a)       the Source is an “insurance company general account”
(as the term is defined in the United States Department of Labor’s Prohibited Transaction Exemption (“PTE”) 95-60) in respect of which the reserves and liabilities (as defined by the annual statement for life insurance
companies approved by the NAIC (the “NAIC Annual Statement”)) for the general account contract(s) held by or on behalf of any employee benefit plan together with the amount of the reserves and liabilities for the general account
contract(s) held by or on behalf of any other employee benefit plans maintained by the same employer (or affiliate thereof as defined in PTE 95-60) or by the same employee organization in the general account do not exceed 10% of the total reserves
and liabilities of the general account (exclusive of separate account liabilities) plus surplus as set forth in the NAIC Annual Statement filed with such Purchaser’s state of domicile; or 

(b)       the Source is a separate account that is maintained solely in
connection with such Purchaser’s fixed contractual obligations under which the amounts payable, or credited, to any employee benefit plan (or its related trust) that has any interest in such separate account (or to any participant or
beneficiary of such plan (including any annuitant)) are not affected in any manner by the investment performance of the separate account; or 

(c)       the Source is either (i) an insurance company pooled separate
account, within the meaning of PTE 90-1 (issued January 29, 1990), or (ii) a bank collective investment fund, within the meaning of PTE 91-38 (issued July 12, 1991) and, except as disclosed by such Purchaser to the Company in writing pursuant
to this clause (c), no employee benefit plan or group of plans maintained by the same employer or employee organization beneficially owns more than 10% of all assets allocated to such pooled separate account or collective investment fund; or 

(d)       the Source constitutes assets of an “investment fund”
(within the meaning of Part VI of PTE 84-14 (the “QPAM Exemption”)) managed by a “qualified professional asset manager” or “QPAM” (within the meaning of Part VI of the QPAM Exemption), no employee benefit
plan’s assets that are managed by the QPAM in such investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same employer or by an affiliate (within the meaning of Part VI(c)(1) of the
QPAM Exemption) of such employer or by the same employee organization and managed by such QPAM, represent more than 20% of the total client assets managed by such QPAM, the conditions of Part I(c) and (g) of the QPAM Exemption are satisfied, neither
the QPAM nor a person controlling or controlled by the QPAM maintains an ownership interest in the Company that would cause the QPAM and the Company to be “related” within the meaning of Part VI(h) of the QPAM Exemption and (i) the
identity of such QPAM and (ii) the names of any employee benefit plans whose assets in the investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same employer or by an affiliate (within
the meaning of Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization, represent 10% or more of the assets of such investment fund, have been disclosed to the Company in writing pursuant to this clause (d); or

  
 14 

 (e)       the Source
constitutes assets of a “plan(s)” (within the meaning of Part IV(h) of PTE 96-23 (the “INHAM Exemption”)) managed by an “in-house asset manager” or “INHAM”
(within the meaning of Part IV(a) of the INHAM Exemption), the conditions of Part I(a), (g) and (h) of the INHAM Exemption are satisfied, neither the INHAM nor a person controlling or controlled by the INHAM (applying the definition of
“control” in Part IV(d)(3) of the INHAM Exemption) owns a 10% or more interest in the Company and (i) the identity of such INHAM and (ii) the name(s) of the employee benefit plan(s) whose assets constitute the Source have been disclosed to
the Company in writing pursuant to this clause (e); or 
 (f)        the
Source is a governmental plan; or 
 (g)       the Source is one or more
employee benefit plans, or a separate account or trust fund comprised of one or more employee benefit plans, each of which has been identified to the Company in writing pursuant to this clause (g); or 

(h)       the Source does not include assets of any employee benefit plan,
other than a plan exempt from the coverage of ERISA. 
 As used in this Section 6.2, the terms “employee benefit
plan,” “governmental plan” and “separate account” shall have the respective meanings assigned to such terms in section 3 of ERISA. 
  

	7.	 INFORMATION AS TO COMPANY. 

The Company covenants that so long as any of the Notes are outstanding or any Purchaser has an obligation to purchase Notes
hereunder: 
  

	 	7.1.	 Financial and Business Information. 

The Company shall deliver to each holder of Notes that is an Institutional Investor (and, during the period from and after the
First Closing Date through the Second Closing Date, to each Purchaser of Notes to be issued and sold at the Second Closing): 

(a)     Quarterly Statements -- within 60 days (or such shorter period as is
15 days greater than the period applicable to the filing of the Company’s Quarterly Report on Form 10-Q (the “Form 10-Q”) with the SEC regardless of whether the Company is subject to
the filing requirements thereof) after the end of each quarterly fiscal period in each fiscal year of the Company (other than the last quarterly fiscal period of each such fiscal year), duplicate copies of, 

 (i)         a consolidated balance sheet of the Company
and its Subsidiaries as at the end of such quarter, and 

 (ii)        consolidated statements of income and cash flows of
the Company and its Subsidiaries, for such quarter and (in the case of the second and third quarters) for the portion of the fiscal year ending with such quarter, 

  
 15 

 setting forth in each case in comparative form the figures for the corresponding
periods in the previous fiscal year, all in reasonable detail, prepared in accordance with GAAP applicable to quarterly financial statements generally, and certified by a Senior Financial Officer as fairly presenting, in all material respects, the
consolidated financial position of the Company and its Subsidiaries and their results of operations and cash flows, subject to changes resulting from year-end adjustments, provided that delivery within the time period specified above of copies of
the Company’s Quarterly Report on Form 10-Q prepared in compliance with the requirements therefor and filed with the SEC shall be deemed to satisfy the requirements of this Section 7.1(a), provided, that the Company shall be deemed
to have made such delivery of such Form 10-Q if it shall have timely made such Form 10-Q available on “EDGAR” and on its home page on the worldwide web (at the date of this Agreement located at: http//www.AMETEK.com) and shall have given
each Purchaser and each holder of Notes notice of such availability on EDGAR and on its home page in connection with each delivery prior to such deadline (such availability and notice thereof being referred to as “Electronic
Delivery”); 
 (b)     Annual Statements -- within 105 days or such
shorter period as is 15 days greater than the period applicable to the filing of the Company’s Annual Report on Form 10-K (the “Form 10-K”) with the SEC regardless of whether the Company is subject to the filing requirements
thereof) after the end of each fiscal year of the Company, duplicate copies of 

(i)         a consolidated balance sheet of the Company and its
Subsidiaries as at the end of such year, and 

(ii)        consolidated statements of income, changes in
shareholders’ equity and cash flows of the Company and its Subsidiaries for such year, 
 setting forth in each case in
comparative form the figures for the previous fiscal year, all in reasonable detail, prepared in accordance with GAAP, and accompanied by 

(A)      an opinion thereon of independent public accountants of recognized
national standing, which opinion shall state that such financial statements present fairly, in all material respects, the consolidated financial position of the Company and its Subsidiaries and their results of operations and cash flows and have
been prepared in conformity with GAAP, and that the examination of such accountants in connection with such financial statements has been made in accordance with generally accepted auditing standards, and that such audit provides a reasonable basis
for such opinion in the circumstances, and 
 (B)      a certificate of such
accountants stating whether, in making their audit, they have become aware of any condition or event that then constitutes a Default or an Event of Default (insofar as they relate to accounting and financial matters in Section 10), and, if they
are aware that any such condition or event then exists, specifying the nature and period of the existence thereof (it being understood that such accountants shall 

  
 16 

 
not be liable, directly or indirectly, for any failure to obtain knowledge of any Default or Event of Default (insofar as they relate to accounting and financial matters in Section 10)
unless such accountants should have obtained knowledge thereof in making an audit in accordance with generally accepted auditing standards or did not make such an audit), 

provided that the delivery within the time period specified above of the Company’s Annual Report on Form 10-K for
such fiscal year (together with the Company’s annual report to shareholders, if any, prepared pursuant to Rule 14a-3 under the Exchange Act) prepared in accordance with the requirements therefor and filed with the SEC, together with the
accountants’ certificate described in clause (B) above (the “Accountants’ Certificate”), shall be deemed to satisfy the requirements of this Section 7.1(b), provided, further, that the Company shall be deemed to have made
such delivery of such Form 10-K if it shall have timely made Electronic Delivery thereof, in which event the Company shall separately deliver, concurrently with such Electronic Delivery, the Accountants’ Certificate; 

(c)     SEC and Other Reports -- promptly upon their becoming publicly
available, one copy of (i) each financial statement, report, notice or proxy statement sent by or to the Company or any Subsidiary to or by its principal lending banks as a whole (excluding information sent to such banks in the ordinary course of
administration of a bank facility, such as information relating to pricing and borrowing availability) or to its public Securities holders generally, and (ii) each regular or periodic report, each registration statement (without exhibits except as
expressly requested by such holder), and each prospectus and all amendments thereto filed by the Company or any Subsidiary with the SEC and all press releases and other statements made available generally by the Company or any Subsidiary to the
public concerning developments that are Material, provided, that, the Company shall be deemed to have made such delivery of the documents referred to in clause (ii) if it shall have timely made Electronic Delivery thereof. 

(d)     Notice of Default or Event of Default -- promptly, and in any event
within five days after a Responsible Officer becoming aware (i) of the existence of any Default or Event of Default, (ii) that any Person has given any notice with respect to a claimed default hereunder or (iii) that any Person has given any notice
with respect to a claimed default of the type referred to in Section 11(g), a written notice specifying the nature and period of existence thereof and what action the Company is taking or proposes to take with respect thereto; 

(e)     ERISA Matters -- promptly, and in any event within ten days after a
Responsible Officer becoming aware of any of the following, a written notice setting forth the nature thereof and the action, if any, that the Company or an ERISA Affiliate proposes to take with respect thereto: 

(i)         with respect to any Plan, any reportable event, as
defined in section 4043(c) of ERISA and the regulations thereunder, for which notice thereof has not been waived pursuant to such regulations as in effect on the date hereof; or 

  
 17 

 (ii)        the taking
by the PBGC of steps to institute, or the threatening by the PBGC of the institution of, proceedings under section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Plan, or the receipt by the Company or any
ERISA Affiliate of a notice from a Multiemployer Plan that such action has been taken by the PBGC with respect to such Multiemployer Plan; or 

(iii)       any event, transaction or condition that could result in the
incurrence of any liability by the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans, or in the imposition of any Lien on any of the rights,
properties or assets of the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or such penalty or excise tax provisions, if such liability or Lien, taken together with any other such liabilities or Liens then existing, could
reasonably be expected to have a Material Adverse Effect; 

(f)     Governmental Filings -- promptly, and in any event within thirty days
after a Responsible Officer becoming aware of the institution of any proceeding or filing against the Company or any Subsidiary with respect to, or the receipt of notice by the Company or any Subsidiary of potential liability or responsibility for
violation or alleged violation of any federal, state or local law, rule or regulation, the violation of which could reasonably be expected to have a Material Adverse Effect, a written notice setting forth the nature thereof and the action, if any,
that the Company proposes to take with respect thereto; and 
 (g)     Requested Information -- with reasonable promptness, such other data and information relating to the business, operations, affairs, financial condition, assets or properties of the Company
or any Subsidiary or relating to the ability of the Company to perform its obligations hereunder and under the Notes, in each case as from time to time may be reasonably requested by any such Purchaser or holder of Notes. 

 

	 	7.2.	 Officer’s Certificate. 

Each set of financial statements delivered to a Purchaser (prior to the Second Closing Date) or a holder of Notes pursuant to
Section 7.1(a) or Section 7.1(b) shall be accompanied by a certificate of a Senior Financial Officer setting forth (which, in the case of Electronic Delivery of any such financial statements, shall be by separate concurrent delivery of such
certificate to each Purchaser (prior to the Second Closing Date) and holder of Notes): 

(a)     Covenant
Compliance -- the information (including reasonably detailed calculations) required in order to establish whether the Company was in compliance with the requirements of Sections 10.1 to 10.3, inclusive, during the quarterly or annual period
covered by the statements then being furnished (including with respect to each such Section, where applicable, the calculations of the maximum or minimum amount, ratio or percentage, as the case may be, permissible under the terms of such Sections,
and the calculation of the amount, ratio or percentage then in existence); and 

  
 18 

 (b)     Event of Default -- a
statement that such Senior Financial Officer has reviewed the relevant terms hereof and has made, or caused to be made under his or her supervision, a review of the transactions and conditions of the Company and its Subsidiaries from the beginning
of the quarterly or annual period covered by the statements then being furnished to the date of the certificate and that such review shall not have disclosed the existence during such period of any condition or event that constitutes a Default or an
Event of Default or, if any such condition or event existed or exists (including, without limitation, any such event or condition resulting from the failure of the Company or any Subsidiary to comply with any Environmental Law), specifying the
nature and period of existence thereof and what action the Company or any Subsidiary shall have taken or proposes to take with respect thereto. 
  

	 	7.3.	 Inspection. 

The Company shall permit the representatives of each Purchaser (prior to the Second Closing Date) and each holder of Notes
that is an Institutional Investor: 
 (a)     No Default -- if no Default or
Event of Default then exists, at the expense of such Purchaser or holder and upon reasonable prior notice to the Company, to visit the principal executive office of the Company, to discuss the affairs, finances and accounts of the Company and its
Subsidiaries with the Company’s officers, and, with the consent of the Company (which consent will not be unreasonably withheld) its independent public accountants, and (with the consent of the Company, which consent will not be unreasonably
withheld) to visit the other offices and properties of the Company and each Subsidiary, all at such reasonable times as may be reasonably requested in writing; and 

(b)     Default -- if a Default or Event of Default then exists, at the
expense of the Company to visit and inspect any of the offices or properties of the Company or any Subsidiary, to examine all their respective books of account, records, reports and other papers, to make copies and extracts therefrom, and to discuss
their respective affairs, finances and accounts with their respective officers and independent public accountants (and by this provision the Company authorizes said accountants to discuss the affairs, finances and accounts of the Company and its
Subsidiaries), all at such times and as often as may be reasonably requested. 
  

	8.	 PREPAYMENT OF THE NOTES. 

Interest on the Notes shall be payable at the rates and at the times set forth in the Notes. As provided therein, the entire
unpaid principal balance of each Note shall be due and payable on the stated maturity date thereof. In addition, the Company may make optional prepayments in respect of the Notes and under certain circumstances may be required to offer to
prepay the Notes, all as hereinafter provided. 

  
 19 

	 	8.1.	 Optional Prepayments. 

The Company may, at its option, upon notice as provided in Section 8.2 and allocated as provided in Section 8.3, prepay at any
time all, or from time to time any part of, the Notes of any series (in a minimum principal amount of €5,000,000 or £5,000,000, as applicable, and otherwise in multiples of €1,000,000 or £1,000,000, as applicable) at 100% of
the principal amount of such series of Notes to be so prepaid, together with interest accrued thereon to the date of such prepayment, plus the Make-Whole Amount (if any), plus any Swap Reimbursement Amount or minus any Net Gain applicable to each
Note to be prepaid, determined for the prepayment date with respect to such principal amount.
  

	 	8.2.	 Notice of Prepayment; Make-Whole Computation. 

The Company will call Notes for prepayment pursuant to Section 8.1 by giving written notice thereof to each holder of a Note
to be so prepaid, which notice shall be given not less than 30 nor more than 60 days prior to the date fixed for such prepayment (which shall be a Business Day) and shall specify the amount so to be prepaid and the date fixed for such
prepayment. Each such notice of prepayment shall be accompanied by a certificate of a Senior Financial Officer as to the estimated Make-Whole Amount (if any) due in connection with such prepayment for each Note held by such holder (calculated
as if the date of such notice were the date of the prepayment), setting forth the details of such computation. Notice of prepayment having been so given, the aggregate principal amount of the Notes as specified in such notice, together with
interest accrued thereon to the date of such prepayment, plus an amount equal to the Make-Whole Amount (if any), plus any Swap Reimbursement Amount or minus any applicable Net Gain for each such Note shall become due and payable on the specified
prepayment date. 
 Two Business Days prior to the date fixed for any prepayment pursuant to Section 8.1, the Company will
furnish to each holder of Notes a certificate signed by a Senior Financial Officer setting forth in reasonable detail the manner of calculation of the Make-Whole Amount as of the specified prepayment date for each Note held by such holder. 

 

	 	8.3.	 Allocation of Partial Prepayments. 

In the case of each partial prepayment of the Notes pursuant to Section 8.1, the principal amount of the series of Notes to be
prepaid shall be allocated among all of the Notes of such series at the time outstanding in proportion, as nearly as practicable, to the respective unpaid principal amounts thereof not theretofore called for prepayment. 

 

	 	8.4.	 Maturity; Surrender; etc. 

In the case of each prepayment of Notes pursuant to this Section 8, the principal amount of each Note to be prepaid shall
mature and become due and payable on the date fixed for such prepayment (which shall be a Business Day), together with interest on such principal amount accrued to such date and the applicable Make-Whole
Amount, if any, plus any Swap Reimbursement Amount or minus any Net Gain applicable to such Note. From and after such date, unless the Company shall fail to pay such principal amount when so due and payable, together with the interest and Make-Whole
Amount, if any, plus any Swap Reimbursement Amount or minus any Net Gain applicable to such Note as aforesaid, interest on such principal 

  
 20 

 
amount shall cease to accrue. Any Note paid or prepaid in full shall be surrendered to the Company and cancelled and shall not be reissued, and no Note shall be issued in lieu of any prepaid
principal amount of any Note. 
  

	 	8.5.	 Purchase of Notes. 

The Company will not and will not permit any Affiliate to purchase, redeem, prepay or otherwise acquire, directly or
indirectly, any of the outstanding Notes except upon the payment or prepayment of the Notes in accordance with the terms of this Agreement and the Notes. The Company will promptly cancel all Notes acquired by it or any Affiliate pursuant to any
payment or prepayment of Notes pursuant to any provision of this Agreement and no Notes may be issued in substitution or exchange for any such Notes. 
  

	 	8.6.	 Make-Whole Amount. 

(a)        Make-Whole Amount for the Non-Swapped Notes. The
term “Make-Whole Amount” means with respect to any Non-Swapped Note, an amount equal to the excess, if any, of the Discounted Value of the Remaining Scheduled Payments with respect to the Called Principal of such Non-Swapped Note
over the amount of such Called Principal, provided that the Make-Whole Amount may in no event be less than zero. For the purposes of determining the Make-Whole Amount with respect to any Non-Swapped Note, the following terms have the following
meanings: 
 “Called Principal” means, with respect to such Non-Swapped Note, the
principal of such Non-Swapped Note that is to be prepaid pursuant to Section 8.1 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires. 

“Discounted Value” means, with respect to the Called Principal of such Non-Swapped Note, the
amount obtained by discounting all Remaining Scheduled Payments with respect to such Called Principal from their respective scheduled due dates to the Settlement Date with respect to such Called Principal, in accordance with accepted financial
practice and at a discount factor (applied on the same periodic basis as that on which interest on such Non-Swapped Note is payable) equal to the Reinvestment Yield for such Non-Swapped Note with respect to such Called Principal.

“Non-Swapped Euro Note” means any Note denominated in Euros other than the Swapped Euro
Notes. 
 “Non-Swapped Note” means any Note other than the Swapped Notes. 

“Non-Swapped Sterling Note” means any Note denominated in Sterling other than the Swapped
Sterling Notes. 
 “Reinvestment Yield” means, 

  
 21 

 (i)        with respect to the Called
Principal of a Non-Swapped Sterling Note, 0.50% over the yield to maturity implied by 
 (A) the yields
reported, as of 11:00 A.M. (London time) on the second Business Day preceding the Settlement Date with respect to such Called Principal, on the Bloomberg Financial Markets display generated by typing ‘UKT’ and touching the F2 or GOVT key
for actively traded gilt-edged securities having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date, or 

(B) if such rate is not reported as of such time or the rate reported is not ascertainable, the average of
the rates for actively traded gilt-edged securities having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date as determined by two financial institutions that make regular markets in gilt-edged
securities and financial products based upon gilt-edged securities, as shall be agreed between the Company and the holders of at least 51% of the aggregate principal amount of the Non-Swapped Sterling Notes, exclusive of any such Non-Swapped
Sterling Notes then owned by the Company or any of its Affiliates (the “Majority Holders of Non-Swapped Sterling Notes”) or, following the occurrence and continuance of an Event of Default, as reasonably determined by the Majority
Holders of Non-Swapped Sterling Notes; 
 such implied yield will be determined, if necessary, by (1) converting quotations
to bond-equivalent yields in accordance with accepted financial practice and (2) interpolating linearly between (x) the actively traded gilt-edged security with the maturity closest to and greater than such Remaining Average Life and (y) the
actively traded gilt-edged security with the maturity closest to and less than such Remaining Average Life; and 

(ii)        with respect to the Called Principal of a Non-Swapped Euro
Note, 0.50% over the yield to maturity implied by 
 (A) the mid-point between the bid-side and ask-side
yields shown on the display designated as “Page PXGE” (or such other display as may replace Page PXGE) on Bloomberg Financial Markets as of 10:00 a.m. New York time on the second Business Day preceding the Settlement Date with respect to
such Called Principal for Bundesobligationen having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date, or 

(B) if such yields are not reported as of such time or the yields reports as of such time are not
ascertainable, the average of the rates for actively traded Bundesobligationen having a maturity equal to the Remaining Average Life of such Called Principal as of such Settlement Date as determined by two financial institutions that make regular
markets 

  
 22 

 
in Bundesobligationen and financial products based upon Bundesobligationen, as shall be agreed between the Company and the holders of at least 51% of the aggregate principal amount of the
Non-Swapped Euro Notes, exclusive of any such Non-Swapped Euro Notes then owned by the Company or any of its Affiliates (the “Majority Holders of Non-Swapped Euro Notes”) or, following the occurrence and continuance of an Event of
Default, as reasonably determined by the Majority Holders of Non-Swapped Euro Notes; 
 such implied yield will be
determined, if necessary, by (1) converting quotations to bond-equivalent yields in accordance with accepted financial practice and (2) interpolating linearly between (x) the actively traded Bundesobligationen with the maturity closest to and
greater than such Remaining Average Life and (y) the actively traded Bundesobligationen with the maturity closest to and less than such Remaining Average Life. 

(iii)      The Reinvestment Yield for any Non-Swapped Note shall be rounded to
the number of decimal places as appears in the interest rate of such Non-Swapped Note. 

“Remaining Average Life” means, with respect to the Called Principal of such Non-Swapped
Note, the number of years obtained by dividing (i) such Called Principal into (ii) the sum of the products obtained by multiplying (A) the principal component of each Remaining Scheduled Payment with respect to such Called Principal by (B) the
number of years (computed on the basis of a 360 day year comprised of twelve 30 day months and calculated to two decimal places) that will elapse between the Settlement Date with respect to such Called Principal and the scheduled due date of such
Remaining Scheduled Payment. 
 “Remaining Scheduled Payments” means, with respect to the
Called Principal of such Non-Swapped Note, all payments of such Called Principal and interest thereon that would be due after the Settlement Date with respect to such Called Principal if no payment of such Called Principal were made prior to its
scheduled due date, provided that if such Settlement Date is not a date on which an interest payment is due to be made under the terms of such Non-Swapped Note, then the amount of the next succeeding scheduled interest payment will be reduced by the
amount of interest accrued to such Settlement Date and required to be paid on such Settlement Date pursuant to Section 8.1 or Section 12.1. 

“Settlement Date” means, with respect to such Called Principal of such Non-Swapped Note, the
date on which such Called Principal is to be prepaid pursuant to Section 8.1 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires. 

“Swapped Euro Note” means a Swapped Note denominated in Euros. 

“Swapped Note” has the meaning set forth in Section 8.6(b).

  
 23 

 “Swapped Sterling Note” means a Swapped Note
denominated in Sterling. 
 (b)       Make-Whole Amount for the
Swapped Notes.  The term “Make-Whole Amount” means, with respect to any Swapped Note, an amount equal to the excess, if any, of the Swapped Note Discounted Value with respect to the Swapped Note Called Notional Amount
related to such Swapped Note over such Swapped Note Called Notional Amount, provided the Make-Whole Amount may in no event be less than zero. All payments of Make-Whole Amount in respect of any Swapped Note shall be made in Dollars. For the purposes
of determining the Make-Whole Amount with respect to any Swapped Note, the following terms have the following meanings: 

“New Swap Agreement” means any cross-currency swap agreement pursuant to which the holder of
a Swapped Note is to receive payment in Dollars and which is entered into in full or partial replacement of an Original Swap Agreement as a result of such Original Swap Agreement having terminated for any reason other than a non-scheduled prepayment
or a repayment of such Swapped Note prior to its scheduled maturity. The terms of a New Swap Agreement with respect to any Swapped Note do not have to be identical to those of the Original Swap Agreement with respect to such Swapped Note. 

“Original Swap Agreement” means, with respect to any Swapped Note, (i) a cross-currency swap
agreement and annexes and schedules thereto (an “Initial Swap Agreement”) that is entered into on an arm’s length basis by the original purchaser of such Swapped Note (or any affiliate thereof) in connection with the execution
of this Agreement and the purchase of such Swapped Note and relates to the scheduled payments by the Company of interest and principal on such Swapped Note, under which the holder of such Swapped Note is to receive payments from the counterparty
thereunder in Dollars and which is more particularly described in the Swap Certificate delivered by each holder of Notes on or prior to the applicable Closing Date, (ii) any Initial Swap Agreement that has been assumed (without any waiver,
amendment, deletion or replacement of any material economic term or provision thereof) by a holder of a Swapped Note in connection with a transfer of such Swapped Note and (iii) any Replacement Swap Agreement; and a “Replacement Swap
Agreement” means, with respect to any Swapped Note, a cross-currency swap agreement and annexes and schedules thereto with payment terms and provisions (other than a reduction in notional amount, if applicable) identical to those of the
Initial Swap Agreement with respect to such Swapped Note that is entered into on an arm’s length basis by the holder of such Swapped Note in full or partial replacement (by amendment, modification or otherwise) of such Initial Swap Agreement
(or any subsequent Replacement Swap Agreement) in a notional amount not exceeding the outstanding principal amount of such Swapped Note following a non-scheduled prepayment or a repayment of such Swapped Note prior to its scheduled maturity. Any
holder of a Swapped Note that enters into, assumes or terminates an Initial Swap Agreement or Replacement Swap Agreement shall within a reasonable period of time thereafter deliver to the Company a Swap Certificate describing such Initial Swap
Agreement or Replacement Swap Agreement. 

  
 24 

 “Swap Agreement” means, with respect to any
Swapped Note, an Original Swap Agreement or a New Swap Agreement, as the case may be. 
 “Swap
Certificate” means a certificate substantially in the form of Schedule 8.6 hereto. 

“Swapped Note” means any Note that as of the applicable Closing Date is subject to a Swap
Agreement. A “Swapped Note” shall no longer be deemed as “Swapped Note” at such time as the related Swap Agreement ceases to be in force in respect thereof. 

“Swapped Note Called Notional Amount” means, with respect to any Swapped Note Called
Principal of any Swapped Note, the payment in Dollars due to the holder of such Swapped Note under the terms of the Swap Agreement to which such holder is a party, attributable to and in exchange for such Swapped Note Called Principal and assuming
that such Swapped Note Called Principal is paid on its scheduled maturity date, provided that if such Swap Agreement is not an Initial Swap Agreement, then the “Swapped Note Called Notional Amount” in respect of such Swapped Note shall not
exceed the amount in Dollars which would have been due to the holder of such Swapped Note under the terms of the Initial Swap Agreement to which such holder was a party (or if such holder was never party to an Initial Swap Agreement, then the last
Initial Swap Agreement to which the most recent predecessor in interest to such holder as a holder of such Swapped Note was a party), attributable to and in exchange for such Swapped Note Called Principal and assuming that such Swapped Note Called
Principal is paid on its scheduled maturity date. 
 “Swapped Note Called Principal”
means, with respect to any Swapped Note, the principal of such Swapped Note that is to be prepaid pursuant to Section 8.1 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires. 

“Swapped Note Discounted Value” means, with respect to the Swapped Note Called Notional
Amount of any Swapped Note that is to be prepaid pursuant to Section 8.1 or has become or is declared to be immediately due and payable pursuant to Section 12.1, as the context requires, the amount obtained by discounting all Swapped Note Remaining
Scheduled Swap Payments corresponding to the Swapped Note Called Notional Amount of such Swapped Note from their respective scheduled due dates to the Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount, in
accordance with accepted financial practice and at a discount factor (applied on the same periodic basis as that on which interest on such Swapped Note is payable) equal to the Swapped Note Reinvestment Yield with respect to such Swapped Note Called
Notional Amount. 

  
 25 

 “Swapped Note Reinvestment Yield” means, with
respect to the Swapped Note Called Notional Amount of any Swapped Note, 0.50% over the yield to maturity implied by 

(i) the yields reported, as of 10:00 A.M. (New York City time) on the second Business Day preceding the
Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount, on the display designated as “Page PX1” (or such other display as may replace Page PX1) on the Bloomberg Financial Markets for the most recently issued
actively traded on the run U.S. Treasury securities having a maturity equal to the Swapped Note Remaining Average Life of such Swapped Note Called Notional Amount as of such Swapped Note Settlement Date, or 

(ii) if such yields are not reported as of such time or the yields reported as of such time are not
ascertainable (including by way of interpolation), the Treasury Constant Maturity Series Yields reported for the latest day for which such yields have been so reported as of the second Business Day preceding the Swapped Note Settlement Date with
respect to such Swapped Note Called Notional Amount, in U.S. Federal Reserve Statistical Release H.15 (or any comparable successor publication) for applicable U.S. Treasury securities having a constant maturity equal to the Swapped Note Remaining
Average Life of such Swapped Note Called Notional Amount as of such Swapped Note Settlement Date;
 such implied yield will
be determined, if necessary, by (A) converting U.S. Treasury bill quotations to bond-equivalent yields in accordance with accepted financial practice and (B) interpolating linearly between (x) the applicable U.S. Treasury security with the maturity
closest to and greater than the Swapped Note Remaining Average Life of such Swapped Note Called Notional Amount and (y) the applicable U.S. Treasury security with the maturity closest to and less than such Swapped Note Remaining Average Life. 

(iii)       The Swapped Note Reinvestment Yield shall be rounded to the
number of decimal places as appears in the interest rate of such Swapped Note. 
 “Swapped Note
Remaining Average Life” means, with respect to any Swapped Note Called Notional Amount, the number of years obtained by dividing (i) such Swapped Note Called Notional Amount into (ii) the sum of the products obtained by multiplying (A) the
principal component of each Swapped Note Remaining Scheduled Swap Payments with respect to such Swapped Note Called Notional Amount by (B) the number of years (computed on the basis of a 360 day year comprised of twelve 30 day months and calculated
to two decimal places) that will elapse between the Swapped Note Settlement Date with respect to such Swapped Note Called Notional Amount and the scheduled due date of such Swapped Note Remaining Scheduled Payments. 

  
 26 

 “Swapped Note Remaining Scheduled Swap
Payments” means, with respect to the Swapped Note Called Notional Amount relating to any Swapped Note, the payments due to the holder of such Swapped Note in Dollars under the terms of the Swap Agreement to which such holder is a party
which correspond to all payments of the Swapped Note Called Principal of such Swapped Note corresponding to such Swapped Note Called Notional Amount and interest on such Swapped Note Called Principal (other than that portion of the payment due under
such Swap Agreement corresponding to the interest accrued on the Swapped Note Called Principal to the Swapped Note Settlement Date) that would be due after the Swapped Note Settlement Date in respect of such Swapped Note Called Notional Amount
assuming that no payment of such Swapped Note Called Principal is made prior to its originally scheduled payment date, provided that if such Swapped Note Settlement Date is not a date on which an interest payment is due to be made under the
term of such Swapped Note, then the amount of the next succeeding scheduled interest payment will be reduced by the amount of interest accrued to such Swapped Note Settlement Date and required to be paid on such Swapped Note Settlement Date pursuant
to Section 8.1 or Section 12.1. 
 “Swapped Note Settlement Date” means, with respect to
the Swapped Note Called Notional Amount of any Swapped Note Called Principal of any Swapped Note, the date on which such Swapped Note Called Principal is to be prepaid pursuant to Section 8.1 or has become or is declared to be immediately due and
payable pursuant to Section 12.1, as the context requires. 

(c)          Swap Breakage.  If any Swapped
Note is prepaid pursuant to Sections 8.1, 8.7 or 8.8 or has become or is declared to be immediately due and payable pursuant to Section 12.1, then: 

(i)      any resulting Net Loss in connection therewith shall be reimbursed to
the holder of such Swapped Note by the Company in Dollars upon any such prepayment or repayment of such Swapped Note (such amount payable under this clause (i) herein referred to as the “Swap Reimbursement Amount”); and

(ii)      any resulting Net Gain in connection therewith shall be deducted (A)
from the Make-Whole Amount, if any, or any principal or interest to be paid to the holder of such Swapped Note by the Company upon any such prepayment of such Swapped Note pursuant to Sections 8.1, 8.7 or 8.8 or (B) from the Make-Whole Amount, if
any, to be paid to the holder of such Swapped Note by the Company upon any such repayment of such Swapped Note pursuant to Section 12.1, provided that, in either case, the Make-Whole Amount in respect of such Swapped Note may not in any event
be less than zero. 
 Each holder of a Swapped Note shall be responsible for calculating its own Net Loss or Net Gain, as
the case may be, and Swap Breakage Amount in Dollars upon the prepayment or repayment of all or any portion of such Swapped Note, and such calculations as reported to the Company in reasonable detail shall be binding on the Company absent
demonstrable error.

  
 27 

 As used in this Section 8.6(c) with respect to any Swapped Note
that is prepaid or accelerated: “Net Loss” means the amount, if any, by which the Swapped Note Called Notional Amount exceeds the sum of (x) the Swapped Note Called Principal plus (or minus in the case of an amount paid) (y) the
Swap Breakage Amount received (or paid) by the holder of such Swapped Note; and “Net Gain” means the amount, if any, by which the Swapped Note Called Notional Amount is exceeded by the sum of (x) the Swapped Note Called Principal
plus (or minus in the case of an amount paid) (y) the Swap Breakage Amount received (or paid) by such holder. For purposes of any determination of any “Net Loss” or “Net Gain,” the Swapped Note Called Principal shall be
determined by the holder of the affected Swapped Note by converting the currency of such Swapped Note into Dollars at the current Dollar exchange rate for such currency, as determined as of 10:00 A.M. (New York City time) on the day such Swapped
Note is prepaid or accelerated as indicated on the applicable screen of Bloomberg Financial Markets and any such calculation shall be reported to the Company in reasonable detail and shall be binding on the Company absent demonstrable error. 

As used in this Section 8.6(c), “Swap Breakage Amount” means, with respect to the Swap
Agreement associated with any Swapped Note, in determining the Net Loss or Net Gain, the amount that would be received (in which case the Swap Breakage Amount shall be positive) or paid (in which case the Swap Breakage Amount shall be negative) by
the holder of such Swapped Note as if such Swap Agreement had terminated due to the occurrence of an event of default or early termination under the International Swap and Derivatives Association’s (“ISDA”) 1992 Multi-Currency
Cross Border Master Agreement or the ISDA 2002 Master Agreement, as applicable (the “ISDA Master Agreement”); provided, however, that if such holder (or its predecessor in interest with respect to such Swapped Note) was, but
is not at the time, a party to an Original Swap Agreement but is a party to a New Swap Agreement, then the Swap Breakage Amount shall mean the lesser of (x) the gain or loss (if any) which would have been received or incurred (by payment, through
off-set or netting or otherwise) by the holder of such Swapped Note under the terms of the Original Swap Agreement (if any) in respect of such Swapped Note to which such holder (or any affiliate thereof) was a party (or if such holder was never a
party to an Original Swap Agreement, then the last Original Swap Agreement to which the most recent predecessor in interest to such holder as a holder of a Swapped Note was a party) and which would have arisen as a result of the payment of the
Swapped Note Called Principal on the Swapped Note Settlement Date and (y) the gain or loss (if any) actually received or incurred by the holder of such Swapped Note, in connection with the payment of such Swapped Note Called Principal on the Swapped
Note Settlement Date, under the terms of the New Swap Agreement to which such holder (or any affiliate thereof) is a party. The holder of such Swapped Note will make all calculations related to the Swap Breakage Amount in good faith and in
accordance with its customary practices for calculating such amounts under the ISDA Master Agreement pursuant to which such Swap Agreement shall have been entered into and assuming for the purpose of such calculation that there are no other
transactions entered into pursuant to such ISDA Master Agreement (other than such Swap Agreement). 
 The
Swap Breakage Amount shall be payable in Dollars. 

  
 28 

	 	8.7.	 Prepayment in Connection with a Change of Control. 

Promptly and in any event within five Business Days after the occurrence of a Change of Control, the Company will give written
notice thereof (a “Change of Control Notice”) to the holders of all outstanding Notes, which Change of Control Notice shall (a) refer specifically to this Section 8.7, (b) describe the Change of Control in reasonable detail and
specify the Change of Control Prepayment Date and the Response Date (as respectively defined below) in respect thereof and (c) offer to prepay all outstanding Notes at the price specified below on the date therein specified (the “Change of
Control Prepayment Date”), which shall be a Business Day not less than 30 days and not more than 90 days after the date of such Change of Control Notice. Each holder of a Note will notify the Company of such holder’s acceptance or
rejection of such offer by giving written notice of such acceptance or rejection to the Company on or before the date for such notice specified in such Change of Control Notice (the “Response Date”), which specified date shall be a
Business Day not less than 30 days nor more than 60 days after the date of such Change of Control Notice. The Company shall prepay on the Change of Control Prepayment Date all of the outstanding Notes held by the holders as to which such offer
has been so accepted (it being understood that failure of any holder to accept such offer on or before the Response Date shall be deemed to constitute rejection by such holder), at the principal amount of each such Note, together with interest
accrued thereon to the Change of Control Prepayment Date, plus any Swap Reimbursement Amount or minus any Net Gain applicable to each Note to be prepaid, but without premium. If any holder shall reject such offer on or before the Response Date,
such holder shall be deemed to have waived its rights under this Section 8.7 to require prepayment of all Notes held by such holder in respect of such Change of Control but not in respect of any subsequent Change of Control. 

For purposes of this Section 8.7, any holder of more than one Note may act separately with respect to each Note so held (with
the effect that a holder of more than one Note may accept such offer with respect to one or more Notes so held and reject such offer with respect to one or more other Notes so held). 

A “Change of Control” shall be deemed to have occurred if at any time after the date of this Agreement any
Person or “group” (within the meaning of the Exchange Act and the rules of the SEC thereunder as in effect on the date hereof) shall acquire ownership, directly or indirectly, beneficially or of record, of more than 50% of the outstanding
shares of the Voting Stock or economic interests of the Company. 
 8.8.
        Prepayment in Connection with the Disposition of Certain Assets. 

(a)       Notice and Offer. In the event net proceeds of a Disposition
are to be used to make an offer (a “Transfer Prepayment Offer”) to prepay Notes pursuant to Section 10.3 of this Agreement (a “Debt Prepayment Transfer”), the Company will give written notice of such Debt Prepayment
Transfer to each holder of Notes. Such written notice shall contain, and such written notice shall constitute, an irrevocable offer to prepay, at the election of each holder, a portion of the Notes held by such holder equal to such
holder’s Ratable Portion of the net proceeds in respect of such Debt Prepayment Transfer on a date specified in such notice (the “Transfer Prepayment Date”) that is not less than thirty (30) days and not more than sixty (60)
days after the date of such notice, together 

  
 29 

 
with interest on the amount to be so prepaid accrued to the Transfer Prepayment Date. If the Transfer Prepayment Date shall not be specified in such notice, the Transfer Prepayment Date
shall be the thirtieth (30th) day after the date of such notice. 

(b)      Acceptance and Payment.   To accept such Transfer
Prepayment Offer, a holder of Notes shall cause a notice of such acceptance to be delivered to the Company not later than twenty (20) days after the date of such written notice from the Company, provided, that failure to accept such offer in writing
within twenty (20) days after the date of such written notice shall be deemed to constitute a rejection of the Transfer Prepayment Offer. If so accepted by any holder of a Note, such offered prepayment (equal to not less than such holder’s
Ratable Portion of the net proceeds in respect of such Debt Prepayment Transfer) shall be due and payable on the Transfer Prepayment Date. Such offered prepayment shall be made at one hundred percent (100%) of the principal amount of such Notes
being so prepaid, together with interest on such principal amount then being prepaid accrued to the Transfer Prepayment Date determined as of the date of such prepayment, plus any Swap Reimbursement Amount or minus any Net Gain applicable to each
Note to be prepaid. 
 (c)      Other Terms.   Each
offer to prepay the Notes pursuant to this Section 8.8 shall specify (i) the Transfer Prepayment Date, (ii) the net proceeds in respect of the applicable Debt Prepayment Transfer, (iii) that such offer is being made pursuant to Section 8.8 and
Section 10.3 of this Agreement, (iv) the principal amount of each Note offered to be prepaid, (v) the interest that would be due on each Note offered to be prepaid, accrued to the Transfer Prepayment Date and (vi) in reasonable detail, the nature of
the Disposition giving rise to such Debt Prepayment Transfer and certifying that no Event of Default exists or would exist after giving effect to the prepayment contemplated by such offer. 

 

	9.	 AFFIRMATIVE COVENANTS. 

The Company covenants that so long as any of the Notes are outstanding or any Purchaser has an obligation to purchase Notes
hereunder: 
  

	 	9.1.	 Compliance with Laws. 

Without limiting Section 10.6, the Company will and will cause each of its Subsidiaries to comply with all laws, ordinances or
governmental rules or regulations to which each of them is subject, including without limitation, ERISA, the USA PATRIOT Act, Environmental Laws and the other laws and regulations that are referred to in Section 5.16, and will obtain and maintain in
effect all licenses, certificates, permits, franchises and other governmental authorizations necessary to the ownership of their respective properties or to the conduct of their respective businesses, to the extent necessary to ensure that
non-compliance with such laws, ordinances, governmental rules or regulations or failures to obtain or maintain in effect such licenses, certificates, permits, franchises and other governmental authorizations could not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect. 

  
 30 

	 	9.2.	 Insurance. 

The Company will and will cause each of its Subsidiaries to maintain, with financially sound and reputable insurers, insurance
with respect to their respective properties and businesses against such casualties and contingencies, of such types, on such terms and in such amounts (including deductibles, co-insurance and self-insurance, if adequate reserves are maintained with
respect thereto) as is customary in the case of entities of established reputations engaged in the same or a similar business and similarly situated. 
  

	 	9.3.	 Maintenance of Properties; Books and Records. 

(a)         The Company will and will cause each of its
Subsidiaries to maintain and keep, or cause to be maintained and kept, their respective properties in good repair, working order and condition (other than ordinary wear and tear), so that the business carried on in connection therewith may be
properly conducted at all times, provided that this Section shall not prevent the Company or any Subsidiary from discontinuing the operation and the maintenance of any of its properties if such discontinuance is desirable in the conduct of its
business and the Company has concluded that such discontinuance could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

(b)         The Company will and will cause each of its
Subsidiaries to keep proper books of records and account in which full, true and correct entries in conformity with GAAP (or, in the case of any Foreign Subsidiary, in accordance with local accounting standards) and all requirements of laws shall be
made of all dealings and transactions in relation to their respective business and activities. 
  

	 	9.4.	 Payment of Taxes. 

The Company will and will cause each of its Subsidiaries to file all income tax or similar tax returns required to be filed in
any jurisdiction and to pay and discharge all taxes shown to be due and payable on such returns and all other taxes, assessments, governmental charges, or levies payable by any of them, to the extent such taxes, assessments, charges or levies have
become due and payable and before they have become delinquent, provided that neither the Company nor any Subsidiary need (a) pay any such tax, assessment, charge or levy if the amount, applicability or validity thereof is contested by the Company or
such Subsidiary on a timely basis in good faith and in appropriate proceedings and the Company or a Subsidiary has established adequate reserves therefor in accordance with GAAP on the books of the Company or such Subsidiary or (b) pay any such tax,
assessment, charge or levy if the nonpayment of all such taxes, assessments, charges or levies in the aggregate could not reasonably be expected to have a Material Adverse Effect. 

 

	 	9.5.	 Corporate Existence, etc. 

Subject to Section 10.4, the Company will at all times preserve and keep in full force and effect its corporate
existence. Subject to Sections 10.3 and 10.4, the Company will at all times preserve and keep in full force and effect the corporate or other organizational existence of each of its Subsidiaries (unless merged into the Company or a Subsidiary)
and all rights and 

  
 31 

 
franchises of the Company and its Subsidiaries unless, in the good faith judgment of the Company, the termination of or failure to preserve and keep in full force and effect such corporate
existence of any Subsidiary or any such right or franchise could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 
  

	 	9.6.	 Ranking. 

The Company will ensure that, at all times, all liabilities of the Company under the Notes will rank in right of payment
either pari passu with or senior to all other unsecured, unsubordinated Indebtedness of the Company. 
  

	10.	 NEGATIVE COVENANTS. 

The Company covenants that so long as any of the Notes are outstanding or any Purchaser has an obligation to purchase Notes
hereunder: 
  

	 	10.1.	 Certain Financial Conditions. 

The Company will not permit: 

(a)          Consolidated Debt to EBITDA --
Consolidated Debt at any time to exceed 3.50 times EBITDA for the four consecutive fiscal quarters then most recently ended; or 

(b)          Interest Coverage -- the ratio of (i)
EBITDA to (ii) Interest Expense, in each case for the four consecutive fiscal quarters then most recently ended, to be less than 2.5 to 1.00; or 

(c)          Priority Debt -- Priority Debt at any
time to exceed 15% of Consolidated Total Assets (determined as of the end of the most recently ended fiscal quarter of the Company); provided, however, that no Lien created pursuant to Section 10.2(j) shall secure Indebtedness owing under the Bank
Credit Agreement or any other note agreement to which the Company is a party unless the Notes are equally and ratably secured by all property subject to such Lien and no Subsidiary shall guaranty or otherwise become obligated in respect of such
Indebtedness unless such Subsidiary guaranties, or becomes obligated in respect of, the Notes, in each case pursuant to documentation reasonably satisfactory to the Majority Holders. Notwithstanding the foregoing, any Foreign Subsidiary may become a
borrower under the Bank Credit Agreement, so long as it is liable only for the amount of its direct borrowings thereunder, and the Company shall not be required to cause such Foreign Subsidiary to guaranty the Notes in accordance with this clause
(c), if (i) no Default or Event of Default exists and is continuing at the time such Foreign Subsidiary becomes a borrower under the Bank Credit Agreement and (ii) at such time the provision by such Foreign Subsidiary of a guaranty of the Notes
would cause the earnings of such Foreign Subsidiary to be treated as a deemed dividend to such Foreign Subsidiary’s United States parent under the Code; provided, however, that a guaranty of the Notes from such Foreign Subsidiary shall be
required to be delivered to the holders of Notes in accordance with this clause (c) on the earliest to occur thereafter of (x) a Default or Event of Default or (y) such time as the provision by such Foreign Subsidiary of a guaranty of the Notes
would not cause the 

  
 32 

 
earnings of such Foreign Subsidiary to be treated as a deemed dividend to such Foreign Subsidiary’s United States parent under the Code. For the avoidance of doubt, (1) any borrowing by a
Foreign Subsidiary under the Bank Credit Agreement shall constitute Priority Debt unless such Foreign Subsidiary shall have provided a guaranty or shall have otherwise become obligated in respect of the Notes in accordance with the terms of this
Section 10.1(c), and (2) any Indebtedness owing under the Bank Credit Agreement or any other note agreement to which the Company is a party that is secured by a Lien created pursuant to Section 10.2(j) shall cease to constitute Priority
Debt for purposes of the first sentence of this Section 10.1(c) at such time as the Notes are equally and ratably secured by all property subject to such Lien pursuant to documentation in form and substance reasonably satisfactory to the
Majority Holders, including, without limitation, an intercreditor agreement and opinions of counsel to the Company and/or any applicable Subsidiary, as the case may be, from counsel reasonably acceptable to the Majority Holders. 

If during any test period for which EBITDA is being determined any acquisition or Disposition shall have been consummated, then for purposes
of clauses (a) and (b) above EBITDA shall be determined on a pro forma basis as if such acquisition or Disposition shall have been consummated on the first day of such test period and any Indebtedness incurred or retired in connection therewith had
been incurred or retired on such first day. 
  

	 	10.2.	 Liens. 

The Company will not and will not permit any Subsidiary to create, assume, incur or suffer to exist any Lien on any asset,
whether now owned or hereafter acquired, except for the following: 

(a)         Liens of or resulting from any judgment or award, the
time for the appeal or petition for rehearing of which shall not have expired, or in respect of which any of the Company and its Subsidiaries shall at the time in good faith be prosecuting an appeal or a proceeding for a review, and for which
adequate reserves have been made; 
 (b)         Liens for
property taxes, assessments or other governmental charges which are not yet due and payable, statutory Liens of landlords and Liens of carriers, warehousemen, mechanics, and other similar liens incurred in the ordinary course of business for sums
not yet due and payable; 
 (c)         Liens incidental to the
conduct of business or the ownership of properties and assets (including Liens in connection with worker’s compensation, unemployment insurance and other like laws, warehousemen’s and attorney’s liens and statutory landlord’s
liens) and Liens to secure the performance of bids, tenders or trade contracts, or to secure statutory obligations, surety or appeal bonds or other Liens of like general nature incurred in the ordinary course of business and not in connection with
the borrowing of money, the obtaining of advances or credit or the payment of the deferred purchase price of property; provided in each case, the obligation secured is not overdue or, if overdue, is being contested in good faith by appropriate
actions or proceedings, and for which adequate reserves have been made; 

  
 33 

 (d)         leases
or subleases granted to others, easements, rights-of-way, restrictions and other similar charges or encumbrances, in each case incidental to, and not interfering with, the ordinary conduct of the business of the Company or any of its Subsidiaries,
provided that such Liens do not, in the aggregate, materially detract from the value of the affected property; 

(e)         Liens on property or assets of any Subsidiary
securing Indebtedness owing to the Company or to a Subsidiary; 

(f)         Liens existing as of the date hereof securing
Indebtedness of the Company or any Subsidiary and described on Schedule 5.15; 

(g)         any Lien existing on assets of a Person immediately
prior to such Person being consolidated with or merged into the Company or a Subsidiary or such Person becoming a Subsidiary, or any Lien existing on any assets acquired by the Company or any Subsidiary at the time such assets are so acquired
(whether or not the Indebtedness secured thereby shall have been assumed), provided that (i) no such Lien shall have been created or assumed in contemplation of such consolidation or merger or such Person becoming a Subsidiary or such acquisition of
assets, and (ii) each such Lien shall extend solely to the item or items so acquired and, if required by the terms of the instrument originally creating such Lien, other assets which are an improvement to or are acquired for specific use in
connection with such acquired Person or assets of a Person; 

(h)         Liens securing Indebtedness under Permitted
Receivables Securitization Programs, provided that the aggregate principal amount of such Indebtedness does not exceed the greater of $125,000,000 (or its equivalent in another currency), or such other amount not to exceed 15% of Consolidated
Tangible Assets (determined as of the end of the most recently ended fiscal quarter of the Company); 

(i)         Liens created in substitution of or as a replacement
for any Liens permitted by clauses (a) through (h) above, provided that a Senior Financial Officer shall have determined in good faith that the assets encumbered by such substitute or replacement Lien are substantially similar in nature to and of
equal or lesser value than the assets encumbered by the Lien that is being replaced; and 

(j)         Liens not otherwise permitted by the foregoing
clauses of this Section 10.2 securing Indebtedness of the Company or any of its Subsidiaries, provided Priority Debt does not at any time exceed 15% of Consolidated Total Assets (determined as of the end of the most recently ended fiscal
quarter of the Company). 
  

	 	10.3.	 Disposition of Assets. 

The Company will not and will not permit any Subsidiary to, directly or indirectly, sell, lease, transfer or otherwise dispose
of any of its assets (including, without limitation, capital stock of any Subsidiary) or permit any Subsidiary to issue any capital stock (collectively a “Disposition,” which term shall not include any payment of dividends) unless,
after giving effect to such proposed Disposition, the aggregate net book value of all assets of the Company and its Subsidiaries that were the subject of a Disposition during the period of 365 days ending on (and

  
 34 

 
including) the date of such Disposition (valued, in the case of any issuance of capital stock by, or sale of capital stock of, a Subsidiary, as provided in the last sentence of this Section 10.3)
does not exceed 15% of Consolidated Total Assets (as shown on the most recent consolidated balance sheet furnished pursuant to Section 7.1(b)), provided that the following Dispositions shall not be taken into account for purposes of such
calculations under this Section 10.3: 
 (a)         any
Disposition in the ordinary course of business and involving only property that is either (i) inventory held for sale or (ii) equipment, fixtures, supplies or materials no longer required in the operation of the business of the Company or any of its
Subsidiaries or that are obsolete; 
 (b)         any
Disposition by a Subsidiary to the Company or a Wholly-Owned Subsidiary; 

(c)         any Disposition otherwise permitted by Section 10.4;
and 
 (d)         any Disposition not otherwise permitted by
the foregoing provisions of this Section 10.3 for fair value to the extent that the net proceeds of such Disposition are applied within 360 days from the date of such Disposition either to (i) the acquisition, construction, improvement or
development of operating assets (excluding, for the avoidance of doubt, cash and cash equivalents) to be used in the business of the Company and its Subsidiaries or (ii) the repayment or prepayment of unsubordinated Indebtedness of the Company or a
Subsidiary (any such repayment or prepayment to include, except to the extent of any repayment of Indebtedness secured by the asset so disposed of, prepayment of Notes (at par and without payment of any Make-Whole Amount) to the extent that the
offer to prepay the Notes pursuant to Section 8.8 has been accepted as provided therein, which offered prepayment of Notes is in at least an aggregate principal amount that bears the same relation to the amount then being applied to reduce all
unsubordinated Indebtedness of the Company and its Subsidiaries as the aggregate unpaid principal amount of the Notes bears to the aggregate unpaid principal amount of all outstanding unsubordinated Indebtedness of the Company and its Subsidiaries);
provided that any prepayment in connection with any revolving credit facility or similar facility shall be counted for purposes of this clause (ii) only to the extent the commitment of such facility is permanently reduced by the amount of such
prepayment. 
 The aggregate net book value of any capital stock issued by any Subsidiary, or sold by the Company or any other Subsidiary,
shall be deemed to be, in the case of an issuance or sale of common stock, the same percentage of the net book value of such Subsidiary’s assets as such issued or sold common stock is of all outstanding common stock of such Subsidiary (after
giving effect to any such issuance) and, in the case of an issuance of Preferred Stock, the greater of the aggregate liquidation or redemption value thereof. 
  

	 	10.4.	 Merger, Consolidation, etc. 

The Company will not consolidate or merge with any other Person or convey, transfer or lease all or substantially all of its
assets in a single transaction or series of transactions to any Person except that the Company may consolidate with or merge with any other corporation or 

  
 35 

 
convey or transfer all or substantially all of its assets to a corporation or limited liability company organized and existing under the laws of the United States or any State thereof, provided
that 
 (a)         the continuing, surviving or acquiring
corporation or limited liability company (the “Surviving Person”) shall be a solvent corporation or limited liability company organized and existing under the laws of the United States or any State thereof (including the District of
Columbia), and, if the Company is not the Surviving Person, (1) the Surviving Person shall have executed and delivered to each holder of any Notes its assumption of the due and punctual performance and observance of each covenant and condition of
this Agreement and the Notes, in a form reasonably satisfactory to each holder of Notes and (2) the Surviving Person shall have caused to be delivered to each holder of any Notes an opinion of nationally recognized independent counsel, or other
independent counsel reasonably satisfactory to the Majority Holders, to the effect that all agreements or instruments effecting such assumption are enforceable in accordance with their terms and comply with the terms hereof; and 

(b)         each Subsidiary Obligor under any guaranty of the
Notes executed pursuant to Section 10.1(c) that is outstanding at the time such transaction occurs reaffirms its obligations under such guaranty in writing at such time pursuant to documentation that is reasonably acceptable to the Majority Holders;
and 
 (c)         immediately after giving effect to such
transaction, no Default or Event of Default shall have occurred and be continuing. 
 No such conveyance, transfer or lease
of substantially all of the assets of the Company shall have the effect of releasing the Company or any successor corporation or limited liability company that shall theretofore have become such in the manner prescribed in this Section 10.4 from its
liability under this Agreement or the Notes. 

  
 36 

	 	10.5.	 Transactions with Affiliates. 

The Company will not and will not permit any Subsidiary to enter into directly or indirectly any Material transaction or
Material group of related transactions (including without limitation the purchase, lease, sale or exchange of properties of any kind or the rendering of any service) with any Affiliate (other than the Company or a Wholly-Owned Subsidiary), except
(a) pursuant to the reasonable requirements of the Company’s or such Subsidiary’s business and upon terms that are no less favorable to the Company or such Subsidiary than would be obtainable in an arm’s-length transaction with a
Person not an Affiliate, (b) the Company may grant stock options, stock appreciation rights, restricted stock awards and phantom stock awards to its and its Subsidiaries’ directors in the ordinary course of business, and (c) the Company and its
Subsidiaries may pay reasonable and customary fees to their directors who are not also officers or employees of the Company or any of its Subsidiaries. 
  

	 	10.6.	 Terrorism Sanctions Regulations. 

The Company will not and will not permit any Controlled Entity to (a) become a Blocked Person, (b) have any investments in, or
engage in any dealings or transactions with, any Person if such investments, dealings or transactions would cause any Purchaser or holder of a Note to be in violation of any United States economic sanctions laws or regulations, including, but not
limited to, any OFAC Sanctions Program that is applicable to such Purchaser or holder or (c) engage in any activities that could subject such Person or any Purchaser or holder of a Note to sanctions under CISADA or under any applicable United States
federal or state law or regulation that imposes sanctions on Persons that do business with Iran or any other country that is subject to any OFAC Sanctions Program. 
  

	11.	 EVENTS OF DEFAULT. 

An “Event of Default” shall exist if any of the following conditions or events shall occur and be continuing:

 (a)         default in the payment of any principal of, or
Make-Whole Amount on or Swap Reimbursement Amount in respect of, if any, on any Note when the same becomes due and payable, whether at maturity or at a date fixed for prepayment or by declaration or otherwise; or 

(b)         default in the payment of any interest on any Note
for more than five days after such payment becomes due and payable; or 

(c)         default in the performance of or compliance with any
term contained in Section 7.1(d) or Section 10.1(b); or 

(d)         default in the performance of or compliance with any
term contained in Sections 10.1 (other than subsection (b)) to 10.4, inclusive, and such default is not remedied within 10 days after the earlier of (i) a Responsible Officer obtaining actual knowledge of such default and (ii) the Company receiving
written notice of such default from any holder of a Note (any such written notice to be identified as a “notice of default” and to refer specifically to this paragraph (d) of Section 11); or 

  
 37 

 (e)         default
in the performance of or compliance with any term contained herein (other than those referred to in paragraphs (a), (b), (c) and (d) of this Section 11) and such default is not remedied within 30 days after the earlier of (i) a Responsible Officer
obtaining actual knowledge of such default and (ii) the Company receiving written notice of such default from any holder of a Note (any such written notice to be identified as a “notice of default” and to refer specifically to this
paragraph (e) of Section 11); or 
 (f)         any
representation or warranty made in writing by or on behalf of the Company or by any officer of the Company in this Agreement or in any writing furnished in connection with the transactions contemplated hereby proves to have been false or incorrect
in any material respect on the date as of which made; or 

(g)         (i) the Company or any Subsidiary is in default (as
principal or as guarantor or other surety) in the payment of any principal of or premium or make-whole amount or interest on any Indebtedness beyond any period of grace provided with respect thereto, or (ii) the Company or any Subsidiary is in
default in the performance of or compliance with any term of any evidence of any Indebtedness or of any mortgage, indenture or other agreement relating thereto or any other condition exists, and as a consequence of such default or condition such
Indebtedness has become, or has been declared, due and payable before its stated maturity or before its regularly scheduled dates of payment; provided that it shall not constitute an Event of Default pursuant to clause (i) or (ii) of this Section
11(g) unless the outstanding principal amount of all such Indebtedness referred to in clauses (i) and (ii) above exceeds $25,000,000 (or its equivalent in another currency) at any one time; or 

(h)         the Company or any Significant Subsidiary (i) is
generally not paying, or admits in writing its inability to pay, its debts as they become due, (ii) files, or consents by answer or otherwise to the filing against it of, a petition for relief or reorganization or arrangement or any other petition
in bankruptcy, for liquidation or to take advantage of any bankruptcy, insolvency, reorganization, moratorium or other similar law of any jurisdiction, (iii) makes an assignment for the benefit of its creditors, (iv) consents to the appointment of a
custodian, receiver, trustee or other officer with similar powers with respect to it or with respect to any substantial part of its property, (v) is adjudicated as insolvent or to be liquidated, or (vi) takes corporate action for the purpose of any
of the foregoing; or 
 (i)         a court or Governmental
Authority of competent jurisdiction enters an order appointing, without consent by the Company or any Significant Subsidiary, a custodian, receiver, trustee or other officer with similar powers with respect to it or with respect to any substantial
part of its property, or constituting an order for relief or approving a petition for relief or reorganization or any other petition in bankruptcy or for liquidation or to take advantage of any bankruptcy or insolvency law of any jurisdiction, or
ordering the dissolution, winding-up or liquidation of the Company or any Significant Subsidiary, or any such petition shall be filed against the Company or any Significant Subsidiary and such petition shall not be dismissed within 60 days; or 

  
 38 

 (j)         a final
judgment or judgments for the payment of money aggregating in excess of $25,000,000 (or its equivalent in another currency) are rendered against one or more of the Company and its Subsidiaries and which judgments are not (unless fully covered by one
or more reputable and solvent insurance companies that have admitted liability in writing), within 60 days after entry thereof, bonded, discharged or stayed pending appeal, or are not discharged within 60 days after the expiration of such stay; or

 (k)         if (i) any Plan shall fail to satisfy the
minimum funding standards of ERISA or the Code for any plan year or part thereof or a waiver of such standards or extension of any amortization period is sought or granted under section 412 of the Code, (ii) a notice of intent to terminate any Plan
shall have been or is reasonably expected to be filed with the PBGC or the PBGC shall have instituted proceedings under ERISA section 4042 to terminate or appoint a trustee to administer any Plan or the PBGC shall have notified the Company or any
ERISA Affiliate that a Plan may become a subject of any such proceedings, (iii) the aggregate “amount of unfunded benefit liabilities” (within the meaning of section 4001(a)(18) of ERISA) under all Plans, determined in accordance with
Title IV of ERISA, shall exceed $25,000,000, (iv) the Company or any ERISA Affiliate shall have incurred or is reasonably expected to incur any liability pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating
to employee benefit plans, (v) the Company or any ERISA Affiliate withdraws from any Multiemployer Plan, or (vi) the Company or any Subsidiary establishes or amends any employee welfare benefit plan that provides post-employment welfare benefits in
a manner that would increase the liability of the Company or any Subsidiary thereunder; and any such event or events described in clauses (i) through (vi) above, either individually or together with any other such event or events, could reasonably
be expected to have a Material Adverse Effect. 
 As used in Section 11(k), the terms “employee benefit plan” and
“employee welfare benefit plan” shall have the respective meanings assigned to such terms in section 3 of ERISA. 
  

	12.	 REMEDIES ON DEFAULT, ETC. 

 

	 	12.1.	 Acceleration. 

(a)         If an Event of Default with respect to the Company
described in paragraph (h) or (i) of Section 11 (other than an Event of Default described in clause (i) of paragraph (h) or described in clause (vi) of paragraph (h) by virtue of the fact that such clause encompasses clause (i) of paragraph (h)) has
occurred, all the Notes then outstanding shall automatically become immediately due and payable. 

(b)         If any other Event of Default has occurred and is
continuing, the Majority Holders may at any time at its or their option, by notice or notices to the Company, declare all the Notes then outstanding to be immediately due and payable. 

(c)         If any Event of Default described in paragraph (a) or
(b) of Section 11 has occurred and is continuing, any holder or holders of Notes at the time outstanding affected by such Event of Default may at any time, at its or their option, by notice or notices to the Company, declare all the Notes held by it
or them to be immediately due and payable. 

  
 39 

 Upon any Notes becoming due and payable under this Section 12.1, whether
automatically or by declaration, such Notes will forthwith mature and the entire unpaid principal amount of such Notes, plus (i) all accrued and unpaid interest thereon (including, but not limited to, interest accrued thereon at the applicable
Default Rate), (ii) the amount by which (A) the Make-Whole Amount determined in respect of such principal amount (to the full extent permitted by applicable law) exceeds (B) the Net Gain (if any) applicable to such Notes, (iii) interest accrued
at the applicable Default Rate on any overdue payment of Make-Whole Amount in accordance with the terms of the Notes and (iv) (A) the Swap Reimbursement Amount (if any), shall be immediately due and payable, in each and every case without
presentment, demand, protest or further notice, all of which are hereby waived. The Company acknowledges, and the parties hereto agree, that each holder of a Note has the right to maintain its investment in the Notes free from repayment by the
Company (except as herein specifically provided for) and that the provision for payment of a Make-Whole Amount by the Company in the event that the Notes are prepaid or are accelerated as a result of an Event of Default, is intended to provide
compensation for the deprivation of such right under such circumstances. 
  

	 	12.2.	 Other Remedies. 

If any Default or Event of Default has occurred and is continuing, and irrespective of whether any Notes have become or have
been declared immediately due and payable under Section 12.1, the holder of any Note at the time outstanding may proceed to protect and enforce the rights of such holder by an action at law, suit in equity or other appropriate proceeding, whether
for the specific performance of any agreement contained herein or in any Note, or for an injunction against a violation of any of the terms hereof or thereof, or in aid of the exercise of any power granted hereby or thereby or by law or otherwise.

  

	 	12.3.	 Rescission. 

At any time after any Notes have been declared due and payable pursuant to clause (b) or (c) of Section 12.1, the
Majority Holders, by written notice to the Company, may rescind and annul any such declaration and its consequences if (a) the Company has paid or deposited pursuant to trust arrangements acceptable to the Majority Holders all overdue interest on
any Notes, all principal of, Make-Whole Amount, if any, and Swap Reimbursement Amount, if any, on any Notes that are due and payable and are unpaid other than by reason of such declaration, and all interest on such overdue principal and Make-Whole
Amount, if any, and (to the extent permitted by applicable law) any overdue interest in respect of the Notes, at the applicable Default Rate, (b) neither the Company nor any other Person shall have paid any amounts which have become due solely by
reason of such declaration, (c) all Events of Default and Defaults, other than the non-payment of amounts that have become due solely by reason of such declaration, have been cured or have been waived pursuant to Section 17, and (d) no judgment
or decree has been entered for the payment of any monies due pursuant hereto or to the Notes. No rescission and annulment under this Section 12.3 will extend to or affect any subsequent Event of Default or Default or impair any right consequent
thereon. 

  
 40 

	 	12.4.	 No Waivers or Election of Remedies, Expenses, etc. 

No course of dealing and no delay on the part of any holder of any Note in exercising any right, power or remedy shall operate
as a waiver thereof or otherwise prejudice such holder’s rights, powers or remedies. No right, power or remedy conferred by this Agreement or by any Note upon any holder thereof shall be exclusive of any other right, power or remedy
referred to herein or therein or now or hereafter available at law, in equity, by statute or otherwise. Without limiting the obligations of the Company under Section 15, the Company will pay to the holder of each Note on demand such further
amount as shall be sufficient to cover all costs and expenses of such holder incurred in any enforcement or collection under this Section 12, including without limitation reasonable attorneys’ fees, expenses and disbursements. 

 

	13.	 REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES. 

 

	 	13.1.	 Registration of Notes. 

The Company shall keep at its principal executive office a register for the registration and registration of transfers of
Notes. The name and address of each holder of one or more Notes, each transfer thereof and the name and address of each transferee of one or more Notes shall be registered in such register. If any holder of one or more Notes is a nominee,
then (a) the name and address of the beneficial owner of such Note or Notes shall also be registered in such register as an owner and holder thereof and (b) at any such beneficial owner’s option, either such beneficial owner or its nominee may
execute any amendment, waiver or consent pursuant to this Agreement. Prior to due presentment for registration of transfer, the Person in whose name any Note shall be registered shall be deemed and treated as the owner and holder thereof for
all purposes hereof, and the Company shall not be affected by any notice or knowledge to the contrary. The Company shall give to any holder of a Note that is an Institutional Investor promptly upon request therefor, a complete and correct copy
of the names and addresses of all registered holders of Notes. 
  

	 	13.2.	 Transfer and Exchange of Notes. 

Upon surrender of any Note at the principal executive office of the Company for registration of transfer or exchange (and in
the case of a surrender for registration of transfer, accompanied by a written instrument of transfer duly executed by the registered holder of such Note or such holder’s attorney duly authorized in writing and accompanied by the address for
notices of each transferee of such Note or part thereof), within ten Business Days thereafter the Company shall execute and deliver, at the Company’s expense (except as provided below), one or more new Notes of the same series (as requested by
the holder thereof) in exchange therefor, in an aggregate principal amount equal to the unpaid principal amount of the surrendered Note. Each such new Note shall be payable to such Person as such holder may request and shall be in the form of Note
for such series set forth in Exhibit 1, 2, 3 or 4, as the case may be. Each such new Note shall be dated and bear interest from the date to which interest shall have been paid on the surrendered Note or dated the date of the surrendered Note if
no interest shall have been paid thereon. The Company may require payment of a sum sufficient to cover any stamp tax or governmental charge imposed in respect of any such transfer of Notes. Notes shall not be transferred in denominations
of less than £500,000 or €500,000, as applicable, provided that if 

  
 41 

 
necessary to enable the registration of transfer by a holder of its entire holding of Notes of a series, one Note of such series may be in a denomination of less than £500,000 or
€500,000, as applicable. Any transferee, by its acceptance of a Note registered in its name (or the name of its nominee), shall be deemed to have made the representation set forth in Section 6.2. 

 

	 	13.3.	 Replacement of Notes. 

Upon receipt by the Company of evidence reasonably satisfactory to it of the ownership of and the loss, theft, destruction or
mutilation of any Note (which evidence shall be, in the case of an Institutional Investor, notice from such Institutional Investor of such ownership and such loss, theft, destruction or mutilation), and 

(a)         in the case of loss, theft or destruction, of
indemnity reasonably satisfactory to it (provided that if the holder of such Note is, or is a nominee for, an original Purchaser or another holder of a Note with a minimum net worth of at least $50,000,000 (or its equivalent in another currency) or
a Qualified Institutional Buyer, such Person’s own unsecured agreement of indemnity shall be deemed to be satisfactory), or 

(b)         in the case of mutilation, upon surrender and
cancellation thereof, 
 within ten Business Days thereafter the Company at its own expense shall execute and deliver, in lieu thereof, a
new Note of the same series, dated and bearing interest from the date to which interest shall have been paid on such lost, stolen, destroyed or mutilated Note or dated the date of such lost, stolen, destroyed or mutilated Note if no interest shall
have been paid thereon. 
  

	14.	 PAYMENTS ON NOTES. 

 

	 	14.1.	 Place of Payment. 

Subject to Section 14.2, payments of principal, Make-Whole Amount, if any, Swap Reimbursement Amount, if any, and interest
becoming due and payable on the Notes shall be made in New York, New York at the principal office of JPMorgan Chase Bank, N.A. in such jurisdiction. The Company may at any time, by notice to each holder of a Note, change the place of payment of
the Notes so long as such place of payment shall be either the principal office of the Company in the United States or the principal office of a bank or trust company in New York, New York. 

 

	 	14.2.	 Home Office Payment. 

So long as any Purchaser or its nominee shall be the holder of any Note, and notwithstanding anything contained in Section
14.1 or in such Note to the contrary, the Company will pay all sums becoming due on such Note for principal, Make-Whole Amount, if any, Swap Reimbursement Amount, if any, and interest by the method and at the address specified for such purpose below
such Purchaser’s name in Schedule A, or by such other method or at such other address as such Purchaser shall have from time to time specified to the Company in writing for such purpose, without the presentation or surrender of such Note
or the making of any notation thereon, except that upon written request of the Company made concurrently with or reasonably promptly after payment or prepayment in full of any Note, such Purchaser shall surrender such

  
 42 

 
Note for cancellation, reasonably promptly after any such request, to the Company at its principal executive office or at the place of payment most recently designated by the Company pursuant to
Section 14.1. Prior to any sale or other disposition of any Note held by a Purchaser or its nominee, such Purchaser will, at its election, either endorse thereon the amount of principal paid thereon and the last date to which interest has been
paid thereon or surrender such Note to the Company in exchange for a new Note or Notes pursuant to Section 13.2. The Company will afford the benefits of this Section 14.2 to any Institutional Investor that is the direct or indirect transferee
of any Note purchased by a Purchaser under this Agreement and that has made the same agreement relating to such Note as the Purchasers have made in this Section 14.2. 
  

	15.	 EXPENSES, ETC. 

 

	 	15.1.	 Transaction Expenses. 

Whether or not the transactions contemplated hereby are consummated, the Company agrees to pay all costs and expenses
(including reasonable attorneys’ fees of one special counsel and, if reasonably required, local or other counsel) incurred by the Purchasers and each other holder of a Note in connection with such transactions and in connection with any
amendments, waivers or consents under or in respect of this Agreement or the Notes (whether or not such amendment, waiver or consent becomes effective), including without limitation: (a) the costs and expenses incurred in enforcing or defending
(or determining whether or how to enforce or defend) any rights under this Agreement or the Notes or in responding to any subpoena or other legal process or informal investigative demand issued in connection with this Agreement or the Notes, or by
reason of being a holder of any Note, (b) the costs and expenses incurred in connection with the initial filing of this Agreement and all related documents and financial information and all subsequent annual and interim filings of documents and
financial information related to this Agreement, with the SVO or any successor organization succeeding to the authority thereof and (c) the costs and expenses, including financial advisors’ fees, incurred in connection with the insolvency or
bankruptcy of the Company or any Subsidiary or in connection with any work-out or restructuring of the transactions contemplated hereby and by the Notes. The Company will pay, and will save each Purchaser and each other holder of a Note
harmless from, all claims in respect of any fees, costs or expenses, if any, of brokers and finders (other than those, if any, retained by a Purchaser or other holder in connection with its purchase of the Notes). 

In furtherance of the foregoing, on each Closing Date the Company will pay the reasonable fees and disbursements and other
charges (including estimated unposted disbursements and other charges as of such date) of Purchasers’ special counsel which are reflected in the statement of such special counsel submitted to the Company at least one Business Day prior to such
date. The Company will also pay, promptly upon receipt of supplemental statements therefor, reasonable additional fees, if any, and disbursements and other charges of such special counsel in connection with the transactions hereby contemplated
(including disbursements and other charges unposted as of such date to the extent such disbursements and other charges exceed estimated amounts paid as aforesaid). 

  
 43 

	 	15.2.	 Survival. 

The obligations of the Company under this Section 15 will survive the payment or transfer of any Note, the enforcement,
amendment or waiver of any provision of this Agreement or the Notes and the termination of this Agreement. 
  

	16.	 SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT. 

All representations and warranties contained herein shall survive the execution and delivery of this Agreement and the Notes,
the purchase or transfer by any Purchaser of any Note or portion thereof or interest therein and the payment of any Note, and may be relied upon by any subsequent holder of a Note, regardless of any investigation made at any time by or on behalf of
such Purchaser or any other holder of a Note. All statements contained in any certificate or other instrument delivered by or on behalf of the Company pursuant to this Agreement shall be deemed representations and warranties of the Company
under this Agreement. Subject to the preceding sentence, this Agreement and the Notes embody the entire agreement and understanding between each Purchaser and the Company and supersede all prior agreements and understandings relating to the
subject matter hereof. 
  

	17.	 AMENDMENT AND WAIVER. 

 

	 	17.1.	 Requirements. 

This Agreement and the Notes may be amended, and the observance of any term hereof or of the Notes may be waived (either
retroactively or prospectively), with (and only with) the written consent of the Company and the Majority Holders, except that: 

(a)       no amendment or waiver of any of the provisions of Section 1, 2,
3, 4, 5, 6 or 21, or any defined term (as it is used therein), will be effective as to any Purchaser unless consented to by such Purchaser in writing; and

(b)       no such amendment or waiver may, without the written consent of
each Purchaser and the holder of each Note at the time outstanding, (i) subject to the provisions of Section 12 relating to acceleration or rescission, change the amount or time of any prepayment or payment of principal of, or reduce the rate of
interest or change the time of payment or method of computation of (x) interest on the Notes or (y) the Make-Whole Amount or the Swap Reimbursement Amount, (ii) change the percentage of (A) the principal amount of the Notes the holders of which are
required to consent to any such amendment or waiver or (B) the principal amount of the Notes that the Purchasers are to purchase pursuant to Section 2 upon the satisfaction of the conditions to each Closing that appear in Section 4 which are
required to consent to any such amendment or waiver, or (iii) amend any of Sections 8, 11(a), 11(b), 12, 17, 20, 22.7 or 22.8. 
  

	 	17.2.	 Solicitation of Holders of Notes. 

(a)       Solicitation.   The Company will provide
each Purchaser and each holder of the Notes (irrespective of the amount of Notes then owned by it) with sufficient 

  
 44 

 
information, sufficiently far in advance of the date a decision is required, to enable such Purchaser and such holder to make an informed and considered decision with respect to any proposed
amendment, waiver or consent in respect of any of the provisions hereof or of the Notes. The Company will deliver executed or true and correct copies of each amendment, waiver or consent effected pursuant to the provisions of this Section 17 to
each Purchaser and each holder of outstanding Notes promptly following the date on which it is executed and delivered by, or receives the consent or approval of, the requisite Purchasers or holders of Notes. 

(b)        Payment.   The Company will not
directly or indirectly pay or cause to be paid any remuneration, whether by way of supplemental or additional interest, fee or otherwise, or grant any security or provide other credit support, to any Purchaser or holder of Notes as consideration for
or as an inducement to the entering into by any such Purchaser or holder of Notes of any waiver or amendment of any of the terms and provisions hereof or of the Notes unless such remuneration is concurrently paid, or security is concurrently granted
or other credit support is concurrently provided, on the same terms, ratably to each Purchaser and each holder of Notes then outstanding even if such Purchaser or holder did not consent to such waiver or amendment. 

 

	 	17.3.	 Binding Effect, etc. 

Any amendment or waiver consented to as provided in this Section 17 applies equally to all Purchasers and holders of Notes and
is binding upon them and upon each future holder of any Note and upon the Company without regard to whether such Note has been marked to indicate such amendment or waiver. No such amendment or waiver will extend to or affect any obligation,
covenant, agreement, Default or Event of Default not expressly amended or waived or impair any right consequent thereon. No course of dealing between the Company and any Purchaser or holder of a Note and no delay in exercising any rights
hereunder or under any Note shall operate as a waiver of any rights of any Purchaser or holder of such Note. As used herein, the term “this Agreement” and references thereto shall mean this Agreement as it may from time to time
be amended or supplemented. 
  

	 	17.4.	 Notes Held by Company, etc. 

Solely for the purpose of determining whether the holders of the requisite percentage of the aggregate principal amount of
Notes then outstanding approved or consented to any amendment, waiver or consent to be given under this Agreement or the Notes, or have directed the taking of any action provided herein or in the Notes to be taken upon the direction of the holders
of a specified percentage of the aggregate principal amount of Notes then outstanding, Notes directly or indirectly owned by the Company or any of its Affiliates shall be deemed not to be outstanding. 

 

	18.	 NOTICES. 

All notices and communications provided for hereunder shall be in writing and sent (a) by telecopy if the sender on the same
day sends a confirming copy of such notice by a recognized overnight delivery service (charges prepaid), or (b) by registered or certified mail with return receipt requested (postage prepaid), or (c) by a recognized overnight delivery service (with
charges prepaid). Any such notice must be sent: 

(i)            if to a Purchaser or its
nominee, to such Purchaser or nominee at the address specified for such communications in Schedule A, or at such other address as such Purchaser or nominee shall have specified to the Company in writing, 

  
 45 

(ii)           if to any other holder of any
Note, to such other holder at such address as such other holder shall have specified to the Company in writing, or 

(iii)          if to the Company, to the Company at
its address set forth at the beginning hereof to the attention of the Treasurer, or at such other address as the Company shall have specified to the holder of each Note in writing. 

Notices under this Section 18 will be deemed given only when actually received. 

 

	19.	 REPRODUCTION OF DOCUMENTS. 

This Agreement and all documents relating thereto, including, without limitation, (a) consents, waivers and modifications that
may hereafter be executed, (b) documents received by any Purchaser at either Closing (except the Notes themselves), and (c) financial statements, certificates and other information previously or hereafter furnished to any Purchaser, may be
reproduced by such Purchaser by any photographic, photostatic, microfilm, microcard, miniature photographic or other similar process and such Purchaser may destroy any original document so reproduced. The Company agrees and stipulates that, to
the extent permitted by applicable law, any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not the original is in existence and whether or not such reproduction was
made by such Purchaser in the regular course of business) and any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence. This Section 19 shall not prohibit the Company, any
Purchaser or any other holder of Notes from contesting any such reproduction to the same extent that it could contest the original, or from introducing evidence to demonstrate the inaccuracy of any such reproduction. 

 

	20.	 CONFIDENTIAL INFORMATION. 

For the purposes of this Section 20, “Confidential Information” means information delivered to any Purchaser
by or on behalf of the Company or any Subsidiary in connection with the transactions contemplated by or otherwise pursuant to this Agreement that is proprietary in nature and that was clearly marked or labeled or otherwise adequately identified when
received by such Purchaser as being confidential information of the Company or such Subsidiary, provided that such term does not include information that (a) was publicly known or otherwise known to such Purchaser prior to the time of such
disclosure, (b) subsequently becomes publicly known through no act or omission by such Purchaser or any Person acting on such Purchaser’s behalf, (c) otherwise becomes known to such Purchaser other than through disclosure by the Company, any
Subsidiary or any third party known by such Purchaser to be in violation of a duty of confidentiality owed by such party to the Company or any Subsidiary or (d) constitutes financial statements delivered to such Purchaser under Section 7.1 that are
otherwise publicly 

  
 46 

 
available. Each Purchaser will maintain the confidentiality of such Confidential Information in accordance with procedures adopted by such Purchaser in good faith to protect confidential
information of third parties delivered to such Purchaser, provided that such Purchaser may deliver or disclose Confidential Information to (i) its directors, officers, trustees, employees, agents, attorneys and affiliates (to the extent such
disclosure reasonably relates to the administration of the investment represented by its Notes), (ii) its auditors, financial advisors and other professional advisors who agree or whose duties require them to hold confidential the Confidential
Information substantially in accordance with the terms of this Section 20, (iii) any other holder of any Note, (iv) any Institutional Investor to which it sells or offers to sell such Note or any part thereof or any participation therein (if such
Person has agreed in writing prior to its receipt of such Confidential Information to be bound by the provisions of this Section 20), (v) any Person from which it offers to purchase any Security of the Company (if such Person has agreed in writing
prior to its receipt of such Confidential Information to be bound by the provisions of this Section 20), (vi) any federal or state regulatory authority having jurisdiction over such Purchaser, (vii) the NAIC or any similar organization, or any
nationally recognized rating agency that requires access to information about such Purchaser’s investment portfolio, or (viii) any other Person to which such delivery or disclosure may be necessary or appropriate (w) to effect compliance with
any law, rule, regulation or order applicable to such Purchaser, (x) in response to any subpoena or other legal process, (y) in connection with any litigation to which such Purchaser is a party or (z) if an Event of Default has occurred and is
continuing, to the extent such Purchaser may reasonably determine such delivery and disclosure to be necessary or appropriate in the enforcement or for the protection of the rights and remedies under such Purchaser’s Notes and this
Agreement. Each holder of a Note, by its acceptance of a Note, will be deemed to have agreed to be bound by and to be entitled to the benefits of this Section 20 as though it were a party to this Agreement. On reasonable request by the
Company in connection with the delivery to any holder of a Note of information required to be delivered to such holder under this Agreement or requested by such holder (other than a holder that is a party to this Agreement or its nominee), such
holder will enter into an agreement with the Company embodying the provisions of this Section 20. 
 In the event that as a
condition to receiving access to information relating to the Company or its Subsidiaries in connection with the transactions contemplated by or otherwise pursuant to this Agreement, any Purchaser or holder of a Note is required to agree to a
confidentiality undertaking (whether through IntraLinks, another secure website, a secure virtual workspace or otherwise) which is different from this Section 20, this Section 20 shall not be amended thereby and, as between such Purchaser or such
holder and the Company, this Section 20 shall supersede any such other confidentiality undertaking. 
  

	21.	 SUBSTITUTION OF PURCHASER. 

Each Purchaser shall have the right to substitute any one of its Affiliates as the purchaser of the Notes that it has agreed
to purchase hereunder, by written notice to the Company, which notice shall be signed by both such Purchaser and such Affiliate, shall contain such Affiliate’s agreement to be bound by this Agreement and shall contain a confirmation by such
Affiliate of the accuracy with respect to it of the representations set forth in Section 6. Upon receipt of such notice, any reference to such Purchaser in this Agreement (other than in this Section 21), shall be deemed to refer to such
Affiliate in lieu of such original Purchaser. In the event that such 

  
 47 

 
Affiliate is so substituted as a Purchaser hereunder and such Affiliate thereafter transfers to such original Purchaser all of the Notes then held by such Affiliate, upon receipt by the Company
of notice of such transfer, any reference to such Affiliate as a “Purchaser” in this Agreement (other than in this Section 21), shall no longer be deemed to refer to such Affiliate, but shall refer to such original Purchaser, and such
original Purchaser shall again have all the rights of an original holder of the Notes under this Agreement. 
  

	22.	 MISCELLANEOUS. 

 

	 	22.1.	 Successors and Assigns. 

All covenants and other agreements contained in this Agreement by or on behalf of any of the parties hereto bind and inure to
the benefit of their respective successors and assigns (including without limitation any subsequent holder of a Note) whether so expressed or not, except that, subject to Section 10.4, the Company may not assign or otherwise transfer any of its
rights or obligations hereunder or under the Notes without the prior written consent of each holder. 
  

	 	22.2.	 Construction. 

Each covenant contained herein shall be construed (absent express provision to the contrary) as being independent of each
other covenant contained herein, so that compliance with any one covenant shall not (absent such an express contrary provision) be deemed to excuse compliance with any other covenant. Where any provision herein refers to action to be taken by
any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action is taken directly or indirectly by such Person. 
  

	 	22.3.	 Jurisdiction and Process. 

(a)         The Company irrevocably submits to the non-exclusive
in personam jurisdiction of any New York State or federal court sitting in the Borough of Manhattan, The City of New York, over any suit, action or proceeding arising out of or relating to this Agreement, or the Notes. To the
fullest extent permitted by applicable law, the Company irrevocably waives and agrees not to assert, by way of motion, as a defense or otherwise, any claim that it is not subject to the in personam jurisdiction of any such court, any
objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an
inconvenient forum. 
 (b)         The Company irrevocably
consents to process being served in any suit, action or proceeding of the nature referred to in Section 22.3(a) by mailing a copy thereof by registered or certified mail, postage prepaid, return receipt requested, to the Company at its address
specified in Section 18, or at such other address of which such holder shall then have been notified pursuant to said Section. The Company agrees that, to the fullest extent permitted by applicable law, such service upon receipt (i) shall
be deemed in every respect effective service of process upon it in any such suit, action or proceeding and (ii) shall be taken and held to be valid personal service upon and personal delivery to the Company. Notices hereunder shall be conclusively
presumed received as evidenced by a delivery receipt furnished by the United States Postal Service or any reputable commercial delivery service. 

  
 48 

 (c)         Nothing
in this Section 22.3 shall affect the right of any holder of a Note to serve process in any manner permitted by law, or limit any right that the holders of any of the Notes may have to bring proceedings against the Company in the courts of any
appropriate jurisdiction or to enforce in any lawful manner a judgment obtained in one jurisdiction in any other jurisdiction. 

(d)         THE COMPANY WAIVES TRIAL BY JURY IN ANY ACTION
BROUGHT ON OR WITH RESPECT TO THIS AGREEMENT, THE NOTES OR ANY OTHER DOCUMENT EXECUTED IN CONNECTION HEREWITH OR THEREWITH. 
  

	 	22.4.	 Payments Due on Non-Business Days. 

Anything in this Agreement or the Notes to the contrary notwithstanding (but without limiting the requirements in Section 8
that notices in respect of prepayments specify a Business Day as the date fixed for such prepayment), any payment of principal of or Make-Whole Amount (if any) or Swap Reimbursement Amount (if any) or interest on any Note that is due on a date other
than a Business Day shall be made on the next succeeding Business Day without including the additional days elapsed in the computation of the interest payable on such next succeeding Business Day. 

 

	 	22.5.	 Severability. 

Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be
ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall (to the fullest extent permitted by applicable law) not
invalidate or render unenforceable such provision in any other jurisdiction. 
  

	 	22.6.	 Accounting Terms; Change in GAAP. 

(a)         All accounting terms used herein which are not
expressly defined in this Agreement have the meanings respectively given to them in accordance with GAAP. Except as otherwise specifically provided herein, all computations made pursuant to this Agreement shall be made in accordance with GAAP and
all balance sheets and other financial statements with respect thereto shall be prepared in accordance with GAAP. Except as otherwise specifically provided herein, any consolidated financial statement or financial computation shall be done in
accordance with GAAP; and, if at the time that any such statement or computation is required to be made the Company shall not have any Subsidiary, such terms shall mean a financial statement or a financial computation, as the case may be, with
respect to the Company only. 
 (b)         For purposes of
determining compliance with this Agreement (including, without limitation, Section 9, Section 10 and the definition of “Indebtedness”), any election by the Company to measure any financial liability using fair value (as permitted by
Financial Accounting Standards Board Accounting Standards Codification Topic No. 

  
 49 

 
825-10-25 – Fair Value Option, International Accounting Standard 39 – Financial Instruments: Recognition and Measurement or any similar accounting standard) shall be
disregarded and such determination shall be made as if such election had not been made. 

(c)         If the Company shall notify the holders of Notes
(and, during the period from and after the First Closing Date through the Second Closing Date, the Purchasers of Notes to be issued and sold at the Second Closing) that the Company wishes to amend any covenant in Section 10 to eliminate the effect
of any change in GAAP on the operation of such covenant (or if the Majority Holders notify the Company that the Majority Holders wish to amend Section 10 for such purpose), then the Company and the holders of the Notes (and, during the period from
and after the First Closing Date through the Second Closing Date, the Purchasers of Notes to be issued and sold at the Second Closing) shall negotiate in good faith to make such adjustments as shall be necessary to eliminate the effect of such
change in GAAP on such covenant; provided that, until agreement is reached on such adjustments, the Company’s compliance with such covenant shall be determined on the basis of GAAP in effect immediately before the relevant change in GAAP
became effective, until either such notice is withdrawn or such covenant is amended in a manner satisfactory to the Company and the Majority Holders, and the Company shall provide to the holders of Notes, with each certificate delivered pursuant to
Section 7.2, a reconciliation showing calculations with respect to such covenant before and after giving effect to such change in GAAP. 
  

	 	22.7.	 Obligation to Make Payments in Relevant Currency. 

Subject to the provisions of Section 8.6 concerning payment in Dollars, any payment made by the Company to any holder of Notes
or for the account of any such holder in respect of any amount payable by the Company shall be made in the currency in which such Notes are denominated. Subject to the provisions of Section 8.6 concerning payment in Dollars, any amount received
or recovered by such holder other than in the currency in which such holder’s Notes are denominated (whether as a result of, or of the enforcement of, a judgment or order of any court, or in the liquidation or dissolution of the Company or
otherwise) in respect of any such sum expressed to be due hereunder or under the Notes shall constitute a discharge of the Company only to the extent of the amount of such currency which such holder is able, in accordance with normal banking
procedures, to purchase with the amount so received or recovered in that other currency on the date of the receipt or recovery (or, if it is not practicable to make that purchase on such date, on the first date on which it is practicable to do
so). If the amount of such currency so purchased is less than the amount of such currency expressed to be due hereunder or under the Notes, the Company shall indemnify such holder against any loss sustained by such holder as a result, and in
any event, the Company shall indemnify such holder against the cost of making any such purchase. These indemnities shall constitute a separate and independent obligation from the other obligations herein and in the Notes, shall give rise to a
separate and independent cause of action, shall apply irrespective of any indulgence granted by any such holder, shall continue in full force and effect despite any judgment, order, claim or proof for a liquidated amount in respect of any such sum
due hereunder and under any Note and shall survive the payment of the Notes and the termination of this Agreement. 

  
 50 

	 	22.8.	 Exchange Rate. 

For the purpose of (i) determining the percentage ownership of Notes (including Notes to be purchased at the Second Closing)
under the definition of “Majority Holders”, (ii) determining whether the holders of the requisite percentage of the aggregate principal amount of Notes then outstanding (and prior to the Second Closing, Notes to be purchased at the Second
Closing) approved or consented to any amendment, waiver or consent given under this Agreement or the Notes, or have directed the taking of any action provided herein or therein to be taken upon the direction of the holders of a specified percentage
of the aggregate principal amount of Notes then outstanding (and prior to the Second Closing, Notes to be purchased at the Second Closing) or (iii) any other determination of the requisite percentage of the principal amount of any Notes of more than
one currency, the principal amount of any outstanding Euro Notes shall be deemed to be the Sterling Equivalent thereof. 

For the purpose of (i) allocating any partial prepayment of the Notes, or (ii) allocating any offer with respect to any
partial prepayment of the Notes, the principal amount of any outstanding Euro Notes shall be deemed to be the Sterling Equivalent thereof. 

“Sterling Equivalent” means the amount of Sterling that would be realized by converting Euros to Sterling in
the spot market at the selling rate quoted by J.P. Morgan Chase Bank N.A. in New York, New York, at approximately 10 A.M. (New York City time) two Business Days prior to the date of determination of the outstanding principal amount of the Notes, to
major banks in the interbank foreign exchange market for the purchase of Sterling with Euros or if JP. Morgan Chase Bank N.A. is not then quoting such exchange rate, then as quoted in the Currency Trading section of The Wall Street Journal under
“Exchange Rates” two Business Days prior to such date of determination. 
  

	 	22.9.	 Counterparts. 

This Agreement may be executed in any number of counterparts, each of which shall be an original but all of which together
shall constitute one instrument. Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all, of the parties hereto. 

 

	 	22.10.	 Governing Law. 

This Agreement and the Notes shall be construed and enforced in accordance with, and the rights of the parties shall be
governed by, the laws of the State of New York excluding choice-of-law principles of the law of such State that would require the application of the laws of a jurisdiction other than such State. 

[Remainder of page intentionally left blank. Next page is signature page.] 

  
 51 

 If you are in agreement with the foregoing, please sign this Agreement in the
space below provided on a counterpart of this Agreement and return it to the Company, whereupon the foregoing shall become a binding agreement between you and the Company. 
  

					
		 	Very truly yours,
		
		 	AMETEK, INC.
			
		 	By:	 	/s/ William J. Burke

					
		 	  Name:	  	William J. Burke
		 	  Title:	  	Executive Vice President, Chief Financial Officer & Treasurer

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	 AMERICAN GENERAL LIFE INSURANCE COMPANY

THE VARIABLE ANNUITY LIFE INSURANCE COMPANY

							
	By:	 	AIG Asset Management (U.S.) LLC, as Investment Adviser

							
				
		 	By:	 	/s/ Gerald F. Herman	  	

					
		 	Name:  Gerald F. Herman
		 	Title:    Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	 THE PRUDENTIAL INSURANCE COMPANY

OF AMERICA

					
			
	By:	  	/s/ ERIC SEWARD	 	

			
	Name:	 	ERIC SEWARD
	Title:	 	Vice President

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

					
	PENSIONSKASSE DES BUNDES PUBLICA

					
	By:  	 	 PGIM LIMITED, as Investment Manager

	By:  	 	 Pricoa Capital Group Limited, as Sub-Advisor

					
			
		 	 By:	 	 /s/ Tolgar Sirvanci
		 	 Name:   Tolgar Sirvanci
		 	 Title:  Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

					
	METROPOLITAN LIFE INSURANCE COMPANY
	
	METLIFE INSURANCE COMPANY USA
	By:	 	Metropolitan Life Insurance Company, its Investment Manager

							
				
		 	By:	 	/s/ John Wills	  	
		 	Name: John Wills
		 	Title:   Senior Vice President and Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

					
	METLIFE INSURANCE K.K.
	By:	 	MetLife Investment Advisors, LLC, Its Investment Manager

							
				
		 	By:	 	/s/ C. Scott Inglis	  	
		 	Name: C. Scott Inglis
		 	Title:   Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	PENSIONSKASSE DES BUNDES PUBLICA

							
	By:	 	MetLife Investment Management Limited, as Investment Manager	  	

							
				
		 	By:	 	/s/ Jason Rothenberg	  	
		 	Name: Jason Rothenberg
		 	Title:  Authorized Signatory

							
	THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
	By:	 	 Northwestern Mutual Investment Management Company, LLC,

Its investment advisor

				
		 	By:	 	/s/ Daniel J. Julka	 	

					
		 	Name:           Daniel J. Julka
		 	Title:  Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	 VOYA INSURANCE AND ANNUITY COMPANY

VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
 RELIASTAR
LIFE INSURANCE COMPANY
 RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK

	By:	 	Voya Investment Management LLC, as Agent
				
		 	By:	 	/s/ Paul Aronson	 	

					
		 	Name:  Paul Aronson
		 	Title:    Senior Vice President

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

					
	NEW YORK LIFE INSURANCE COMPANY
			
	By:	 	/s/ Jessica L. Maizel	  	

			
	Name:	 	Jessica L. Maizel
	Title:	 	Corporate Vice President

							
	
	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	By:	 	NYL Investors LLC, its Investment Manager
				
		 	By:	 	/s/ Jessica L. Maizel	  	

					
		 	Name:  Jessica L. Maizel
		 	Title:    Senior Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	PACIFIC LIFE INSURANCE COMPANY

			
		
	By:	 	/s/ Matthew A. Levene

			
	Name:	 	Matthew A. Levene
	Title:	 	Assistant Vice President

			
		
	By:	 	/s/ Cathy L. Schwartz

			
	Name:	 	Cathy L. Schwartz
	Title:	 	Assistant Secretary

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
	By:	 	Barings LLC, as Investment Adviser
				
		 	By:	 	/s/ Patrick M. Manseau	 	

					
		 	Name:        Patrick M. Manseau
		 	Title:          Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	THE LINCOLN NATIONAL LIFE INSURANCE COMPANY
	By:	 	 Delaware Investment Advisers,
 a
series of Delaware Management Business Trust,
 Attorney in Fact

				
		 	By:	 	/s/ Alex Alston	 	

					
		 	Name: Alex Alston
		 	Title:   Vice President

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	 HARTFORD LIFE INSURANCE COMPANY

HARTFORD ACCIDENT AND INDEMNITY COMPANY
 HARTFORD LIFE
AND ACCIDENT INSURANCE COMPANY
 HARTFORD FIRE INSURANCE COMPANY

SEPARATE ACCOUNT B, A SEPARATE ACCOUNT OF

  HARTFORD LIFE INSURANCE COMPANY

	By:	 	 Hartford Investment Management Company

Their Agent and Attorney-in-Fact

				
		 	By:	 	/s/ DAWN BRUNEAU	 	

					
		 	Name:          DAWN BRUNEAU
		 	Title:            VICE PRESIDENT

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA

			
		
	By:	 	/s/ Chris Miller

			
	Name:	 	Chris Miller
	Title:	 	Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	THRIVENT FINANCIAL FOR LUTHERANS

  

			
	By:	 	/s/ Christopher Patton

			
	Name:	 	Christopher Patton
	Title:	 	Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY

			
		
	By:	 	/s/ Eve Hampton

			
	Name: Eve Hampton
	Title: Vice President, Investments
		
	By:	 	/s/ Tad Anderson

			
	Name: Tad Anderson
	Title: Assistant Vice President, Investments

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA

					
			
	By:	 	/s/ CHARLES J. DUDLEY	  	

			
	Name:	 	CHARLES J. DUDLEY
	Title:	 	MANAGING DIRECTOR

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

							
	UNUM LIMITED
	By:	 	Provident Investment Management, LLC	 	
	Its:	 	Agent	 	
			
		 	By: /s/ Ben
Vance                                        
  	 	
		 	Name:	 	Ben Vance	 	
		 	Title:	 	Vice President, Senior Managing Director

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

			
	UNITED OF OMAHA LIFE INSURANCE COMPANY

			
		
	By:	 	/s/ Lee Martin
	Name: Lee Martin
	Title:   Vice President

  
 [Signature page to
Note Purchase Agreement – Ametek, Inc.] 

 SCHEDULE A 

PURCHASER INFORMATION 

 

					
	Purchaser Name	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal Amount(s)	 	 RP-1; €33,000,000

    
 RQ-1; €20,000,000

	 Payment on Account of Note(s)

    
	 	 
	 Method

    
	 	Federal Funds Wire Transfer
	 Account Information
	 	Beneficiary Bank:  Deutsche Bank, Frankfurt
	 	 	BIC:  DEUTDEFFXXX
	 	 	Beneficiary Account Name:  State Street Bank (BIC:  SBOSGB2XXXX)
	 	 	Beneficiary Account Number:  ######
	 	 	 IBAN:  ####################

    

	 	 	For RP-1:
	 	 	 FFC to:  PA40 for 031100 G*5

    

	 	 	For RQ-1:
	 	 	 FFC to:  PA40 for 031100 G@3

    

	 	 	Reference:  “Accompanying Information” below
	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.

    

	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 	     

Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

	Address / Fax # / Email for notices related to payments	 	 American General Life Insurance Company (PA40)

c/o AIG Asset Management
 2929 Allen Parkway, A36-04

Houston, Texas 77019-2155
 Attn:  PPG Investment
Portfolio Support
 Email:  PPGIPS@aig.com

	 	 	     

Duplicate payment notices (only) to:

	 	 	     

American General Life Insurance Company (PA40)

	 	 	c/o State Street Bank Corporation, Insurance Services
	 	 	Email:  kcinscustodyg@statestreet.com

 

  
 Schedule A-1 

 
			
	Purchaser Name	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	Address / Fax # / Email for all other	 	American General Life Insurance Company (PA40)
	notices	 	c/o AIG Asset Management
	 	 	2929 Allen Parkway, A36-04
	 	 	Houston, Texas 77019-2155
	 	 	Attn:  PPG Investment Portfolio Support
	 	 	Email:  PPGIPS@aig.com
	 	 	      

Compliance reporting information (financial docs, officer’s certificates, etc.) to:

     
 AIG Asset Management

2929 Allen Parkway, A36-04
 Houston, Texas 77019-2155

Attn:  Private Placements Compliance
 Email:
complianceprivateplacements@aig.com
      

Note:     Only two (2) complete sets of compliance information are required for all companies for which AIG Asset Management
Group serves as investment adviser.

	Instructions re Delivery of Note(s)	 	 DTCC

Newport Office Center
 570 Washington Blvd.

Jersey City, NJ 07310
 5th Floor / NY Window / Robert Mendez
(617-985-2074)
 SSB Participant Number:  0997
 SSB
Account Name:  AMERICAN GENERAL LIFE INS. CO.
 SSB Account Number:  PA40

     
 cc:  lavonia.kimani@aig.com
and lauren.reeves1@aig.com

	Signature Block Format	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	 	 	 By:        AIG Asset Management (U.S.) LLC,
as Investment Adviser
      

              By:           
                                         
              

              Name:

              Title:

	 Tax Identification
Number
      
	 	25-0598210

 

  
 Schedule A-2 

 
					
	Purchaser Name	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal Amount(s)	 	RS-1; £12,000,000
	Payment on Account of Note(s)	 	 
	      

Method
 
    
 Account Information
	 	      

Federal Funds Wire Transfer
      

Beneficiary Bank:  State Street Bank and Trust Company, London Branch

BIC:  SBOSGB2XXXX
 Chaps Sort
Code:  ######
 Beneficiary Account Name:  State Street Bank (BIC:  SBOSUS3FXXX)

Beneficiary Account Number:  #########
 FFC
to:  PA40 for 031100 H*4
      

Reference:  “Accompanying Information” below

	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.
 
    
	 	 
	 	 	Description of Security:	 	PPN:
	 	 	2.70% Series S Notes due November 23, 2031	 	031100 H*4
	 	 	      

Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

	Address / Fax # / Email for notices related to payments	 	 American General Life Insurance
Company (PA40)
 c/o AIG Asset Management
 2929 Allen Parkway,
A36-04
 Houston, Texas 77019-2155
 Attn:  PPG
Investment Portfolio Support
 Email:  PPGIPS@aig.com

     
 Duplicate payment notices (only)
to:
      
 American General Life
Insurance Company (PA40)
 c/o State Street Bank Corporation, Insurance Services

Email:  kcinscustodyg@statestreet.com

	Address / Fax # / Email for all other	 	American General Life Insurance Company (PA40)
	notices	 	c/o AIG Asset Management
	 	 	2929 Allen Parkway, A36-04
	 	 	Houston, Texas 77019-2155
	 	 	Attn:  PPG Investment Portfolio Support
	 	 	Email:  PPGIPS@aig.com
	 	 	      

Compliance reporting information (financial docs, officer’s certificates, etc.) to:

    

	 	 	 AIG Asset Management

2929 Allen Parkway, A36-04

	 	 	Houston, Texas 77019-2155
	 	 	Attn:  Private Placements Compliance
	 	 	 Email:  complianceprivateplacements@aig.com

     

	 	 	Note:     Only two (2) complete sets of compliance information are required for all companies for
which AIG Asset Management Group serves as investment adviser.

 

  
 Schedule A-3 

 
			
	Purchaser Name	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	Instructions re Delivery of Note(s)	 	State Street Bank and Trust Company
	 	 	525 Ferry Rd.
	 	 	Edinburgh, SCOTLAND EH5 2AW
	 	 	Attn:  Scott Davidson; Phone:  44 131 315 5940
	 	 	Account Name:  AMERICAN GENERAL LIFE INS. CO.
	 	 	 Account Number:  PA40

     

	 	 	cc:  lavonia.kimani@aig.com and lauren.reeves1@aig.com
	Signature Block Format	 	AMERICAN GENERAL LIFE INSURANCE COMPANY
	 	 	 By:        AIG Asset Management (U.S.) LLC,
as Investment Adviser
      

	 	 	              By:              
                                         
           
	 	 	              Name:
	 	 	              Title:
	 Tax Identification
Number
      
	 	25-0598210

 

  
 Schedule A-4 

 
					
	Purchaser Name	 	THE VARIABLE ANNUITY LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	HARE & CO., LLC
	 Note Registration Number(s); Principal
Amount(s)
	 	RQ-2; €25,000,000
	 Payment on Account of Note(s)

     
	 	 
	 Method

     
	 	Federal Funds Wire Transfer
	 Account Information
	 	The Bank of New York Mellon, Brussels
	 	 	BIC:  IRVTBEBBXXX
	 	 	Account Name:  Variable Annuity Insurance Company-PHYSICAL
	 	 	Account Number:  ##########
	 	 	IBAN:  ################
	 	 	 Reference:  PPN 031100 G@3

     

	 	 	Reference:  “Accompanying Information” below
	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.

     

	 	 	Description of Security:	 	PPN:
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 	      

Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

	Address / Fax # / Email for notices related	 	The Variable Annuity Life Insurance Company (2607359780)
	to payments	 	c/o AIG Asset Management
	 	 	2929 Allen Parkway, A36-04
	 	 	Houston, Texas 77019-2155
	 	 	Attn:  PPG Investment Portfolio Support
	 	 	 Email:  PPGIPS@aig.com

     

	 	 	 Duplicate payment notices (only) to:

     

	 	 	The Variable Annuity Life Insurance Company (2607359780)
	 	 	c/o The Bank of New York Mellon
	 	 	Email:     aigteam@bnymellon.com
	Address / Fax # / Email for all other	 	The Variable Annuity Life Insurance Company (2607359780)
	notices	 	c/o AIG Asset Management
	 	 	2929 Allen Parkway, A36-04
	 	 	Houston, Texas 77019-2155
	 	 	Attn:  PPG Investment Portfolio Support
	 	 	 Email:  PPGIPS@aig.com

     

	 	 	 Compliance reporting information (financial docs, officer’s
certificates, etc.) to:
      

	 	 	AIG Asset Management
	 	 	2929 Allen Parkway, A36-04
	 	 	Houston, Texas 77019-2155
	 	 	Attn:  Private Placements Compliance
	 	 	 Email: complianceprivateplacements@aig.com

     

	 	 	Note:     Only two (2) complete sets of compliance information are required for all companies for
which AIG Asset Management Group serves as investment adviser.

 

  
 Schedule A-5 

 
					
	Purchaser Name	 	THE VARIABLE ANNUITY LIFE INSURANCE COMPANY
	Instructions re Delivery of Note(s)	 	The Depository Trust Company
	 	 	570 Washington Blvd. – 5th Floor
	 	 	Jersey City, NJ 07310
	 	 	Attn: BNY Mellon / Branch Deposit Department
	 	 	Contact:  Andre Granville; Phone:  (315) 414-3068
	 	 	BNYM Participant Number:  901
	 	 	BNYM Account Name:  THE VARIABLE ANNUITY LIFE INSURANCE
	 	 	COMPANY
	 	 	 BNYM Account Number:  ######

     

	 	 	cc:  lavonia.kimani@aig.com and lauren.reeves1@aig.com
	Signature Block Format	 	THE VARIABLE ANNUITY LIFE INSURANCE COMPANY
	 	 	
By:        AIG Asset Management (U.S.) LLC, as Investment Adviser

     

              By:           
                                         
              

              Name:

              Title:

	Tax Identification Number	 	74-1625348
	 	 	13-6062916 (Hare & Co., LLC)

 

  
 Schedule A-6 

 
					
	Purchaser Name	 	THE PRUDENTIAL INSURANCE COMPANY OF AMERICA
	Name in Which to Register Note(s)	 	THE PRUDENTIAL INSURANCE COMPANY OF AMERICA
	Note Registration Number(s); Principal	 	RP-2; €25,353,676.80	 	 
	Amount(s)	 	 RP-3; €22,696,323.20
 
    
	 	 
	 	 	RQ-3; € 24,042,215.16	 	 
	 	 	RQ-4; € 10,957,784.84	 	 
	 Payment on Account of Note(s)

     
	 		 	 
	 Method

     
	 	Federal Funds Wire Transfer	 	 
	 Account Information
	 	Bank:  JPMorgan Chase Bank N.A., London	 	 
	 	 	Account Name:  PGF-INC-EUR	 	 
	 	 	Account Number:  #########	 	 
	 	 	Swift Number:  ########	 	 
	 	 	IBAN Number:  #######################	 	 
	 	 	Ref:  “Accompanying Information” below	 	 
	Accompanying Information	 	Name of Issuer:   AMETEK, INC.	 	 
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	The Prudential Insurance Company of America	 	 
	related to payments	 	c/o PGIM, Inc.	 	 
	 	 	Prudential Tower	 	 
	 	 	655 Broad Street	 	 
	 	 	14th Floor - South Tower	 	 
	 	 	Newark, NJ 07102	 	 
	 	 	Attention:  PIM Private Accounting Processing Team
	 	 	Email: Pim.Private.Accounting.Processing.Team@prudential.com
	Address / Fax # / Email for all other	 	The Prudential Insurance Company of America	 	 
	notices	 	c/o Prudential Capital Group	 	 
	 	 	1114 Avenue of the Americas, 30th Floor	 	 
	 	 	New York, NY  10036	 	 
	 	 	Attention:  Managing Director	 	 
	Instructions re Delivery of Note(s)	 	PGIM, Inc.	 	 
	 	 	655 Broad Street	 	 
	 	 	14th Floor – South Tower	 	 
	 	 	Newark, NJ  07102	 	 
	 	 	 Attention:   Michael Iacono – Trade Management
manager
      

	 	 	Send copy by email to:  thais.alexander@prudential.com
	Signature Block Format	 	 THE PRUDENTIAL INSURANCE COMPANY OF AMERICA

     

	 	 	By:                          
                                         

	 	 	Name:
	 	 	Title: Vice President
	Tax Identification Number	 	22-1211670	 	 

 

  
 Schedule A-7 

 
					
	Purchaser Name	 	PENSIONSKASSE DES BUNDES PUBLICA
	Name in Which to Register Note(s)	 	PENSIONSKASSE DES BUNDES PUBLICA
	 Note Registration Number(s); Principal
Amount(s)
	 	RP-4; €6,950,000
	 Payment on Account of Note(s)

     
	 	 
	 Method

     
	 	Federal Funds Wire Transfer
	 Account Information
	 	Correspondent Bank:  JPMorgan Chase Bank NA
	 	 	Correspondent Bank Swift Code:  CHASGB2L
	 	 	Account Name: JPMorgan Chase Bank NA
	 	 	IBAN Number:  #######################
	 	 	FFC Beneficiary Acct. Name:  Publica - Private Placement Prudential
	 	 	 FFC Beneficiary Acct. Number:  ########

     

	 	 	 Note: Remitting Bank should send a direct advice of payment and
MT103 to CHASGB2L detailing full and final beneficiary
      

	 	 	Ref:  “Accompanying Information” below
	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.

     

	 	 	Description of Security:	 	PPN:
	 	 	 1.34% Series P Notes due October 31, 2026
 
    
	 	031100 G*5
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Prudential Private Placement Investors, L.P.
	related to payments	 	c/o Prudential Capital Group
	 	 	1114 Avenue of the Americas, 30th Floor
	 	 	New York, NY 10036
	 	 	 Attention: Managing Director

     

	 	 	 and for all notices relating solely to scheduled principal and
interest payments and written confirmations of wire transfers to:
      

	 	 	ASC.GSA.Delivery.Team@jpmorgan.com
	 	 	Swiss.IFAS.Service.Team@jpmorgan.com
	Address / Fax # / Email for all other	 	Prudential Private Placement Investors, L.P.
	notices	 	c/o Prudential Capital Group
	 	 	1114 Avenue of the Americas, 30th Floor
	 	 	New York, NY  10036
	 	 	Attention:  Managing Director

 

  
 Schedule A-8 

 
			
	Purchaser Name	 	PENSIONSKASSE DES BUNDES PUBLICA
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, NY 11245-0001
	 	 	 Attention:  Physical Receive Department

     

	 	 	Please include in the cover letter accompanying the Notes a reference to the Purchaser’s account number (PUBLICA - PRIVATE PLACEMENT PRUDENTIAL; Account Number:
########).
	 	 	      

Send copy by email to:
      

	 	 	thais.alexander@prudential.com
	 	 	      

and
      

	 	 	Private.Disbursements@Prudential.com
	Signature Block Format	 	PENSIONSKASSE DES BUNDES PUBLICA
	 	 	By:        PGIM LIMITED, as Investment Manager
	 	 	 By:        Pricoa Capital Group Limited, as
Sub-Advisor
      

	 	 	              By:              
                                         
           
	 	 	              Name:
	 	 	              Title: Director
	Tax Identification Number	 	 

 

  
 Schedule A-9 

 
					
	Purchaser Name	 	METROPOLITAN LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	METROPOLITAN LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal Amount(s)	 	RP-5; €28,000,000
	 Payment on Account of Note(s)

     
	 	 
	 Method

     
	 	Federal Funds Wire Transfer
	 Account Information
	 	Bank Name:                        JP
Morgan Chase, AG Frankfurt Germany
	 	 	SWIFT BIC:                       CHASDEFX
	 	 	IBAN:                          
       ######################
	 	 	Favor:                          
       JP Morgan Chase Bank, London Branch
	 	 	Account
No.:                      ##########
	 	 	Further Credit Account:     GTI 07900 Metropolitan Life Insurance Company
	 	 	Ref:                          
           ######### – Ametek Inc, 1.34% due 10/31/2026
	 	 	      

	 	 	 with sufficient information to identify the source and application of
such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
 
    

	 	 	For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder,
and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.

     

	 	 	Description of Security:	 	PPN:
	 	 	 1.34% Series P Notes due October 31, 2026
 
    
	 	031100 G*5
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for all notices	 	Metropolitan Life Insurance Company
	and communications	 	Investments, Private Placements
	 	 	One MetLife Way
	 	 	Whippany, New Jersey 07981
	 	 	Attention:  Thomas Ho, VP Priv Placements-Corporates
	 	 	 Emails:  PPUCompliance@metlife.com and tho@metlife.com

     

	 	 	 With a copy OTHER than with respect to deliveries of financial
statements to:
      

	 	 	Metropolitan Life Insurance Company
	 	 	One MetLife Way
	 	 	Whippany, New Jersey  07981
	 	 	Attention: Chief Counsel-Investments Law (PRIV)
	 	 	 Email:  sec_invest_law@metlife.com

     

	 	 	Audit Requests:
	 	 	Soft copy to AuditConfirms.PvtPlacements@metlife.com or hard copy to:
	 	 	Metropolitan Life Insurance Company
	 	 	Attn:  Private Placements Operations (ATTN: Audit Confirmations)
	 	 	18210 Crane Nest Drive – 5th Floor
	 	 	Tampa, FL 33647

 

  
 Schedule A-10 

 
			
	Purchaser Name	 	METROPOLITAN LIFE INSURANCE COMPANY
	Instructions re Delivery of Note(s)	 	Metropolitan Life Insurance Company
	 	 	Investments Law
	 	 	One MetLife Way
	 	 	Whippany, New Jersey  07981
	 	 	Attention:  Nicolette Lopez, Esq.
	Signature Block Format	 	 METROPOLITAN LIFE INSURANCE COMPANY

     

	 	 	By:                            
                                     
	 	 	Name:
	 	 	Title:
	Tax Identification Number	 	13-5581829

 

  
 Schedule A-11 

 
					
	Purchaser Name	 	METROPOLITAN LIFE INSURANCE COMPANY	 	 
	Name in Which to Register Note(s)	 	METROPOLITAN LIFE INSURANCE COMPANY	 	 
	Note Registration Number(s); Principal Amount(s)	 	RS-2; £20,200,000	 	 
	 Payment on Account of Note(s)

     
	 		 	 
	 Method

     
	 	Federal Funds Wire Transfer	 	 
	 Account Information
	 	Bank Name:                        JP Morgan Chase Bank, London	 	 
	 	 	SWIFT:                               CHASGB2L	 	 
	 	 	Account No.:                       ########	 	 
	 	 	Sort Code:                           ######	 	 
	 	 	For Further Credit:             GTI 07900 Metropolitan Life Insurance Company
	 	 	IBAN:                                 ######################	 	 
	 	 	Ref:                          
           ######### - Ametek Inc, 2.7% due 11/23/2031
	 	 	      
	 	 
	 	 	 with sufficient information to identify the source and application of
such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
 
    

	 	 	For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder,
and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.
 
    
	 	 
	 	 	Description of Security:	 	PPN:
	 	 	 2.70% Series S Notes due November 23, 2031
 
    
	 	031100 H*4
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for all notices	 	Metropolitan Life Insurance Company	 	 
	and communications	 	Investments, Private Placements	 	 
	 	 	One MetLife Way	 	 
	 	 	Whippany, New Jersey  07981	 	 
	 	 	Attention: Thomas Ho, VP Priv Placements-Corporates	 	 
	 	 	 Emails:  PPUCompliance@metlife.com and tho@metlife.com

     

	 	 	 With a copy OTHER than with respect to deliveries of financial
statements to:
      

	 	 	Metropolitan Life Insurance Company	 	 
	 	 	One MetLife Way	 	 
	 	 	Whippany, New Jersey  07981	 	 
	 	 	Attention: Chief Counsel-Investments Law (PRIV)	 	 
	 	 	 Email:  sec_invest_law@metlife.com
 
    
	 	 
	 	 	Audit Requests:	 	 
	 	 	Soft copy to AuditConfirms.PvtPlacements@metlife.com or hard copy to:
	 	 	Metropolitan Life Insurance Company	 	 
	 	 	Attn: Private Placements Operations (ATTN: Audit Confirmations)
	 	 	18210 Crane Nest Drive – 5th Floor	 	 
	 	 	Tampa, FL 33647	 	 

 

  
 Schedule A-12 

 
			
	Purchaser Name	 	METROPOLITAN LIFE INSURANCE COMPANY
	Instructions re Delivery of Note(s)	 	Metropolitan Life Insurance Company
	 	 	Investments Law
	 	 	One MetLife Way
	 	 	Whippany, New Jersey  07981
	 	 	Attention:  Nicolette Lopez, Esq.
	Signature Block Format	 	 METROPOLITAN LIFE INSURANCE COMPANY

     

	 	 	By:                            
                                     
	 	 	Name:
	 	 	Title:
	Tax Identification Number	 	13-5581829

 

  
 Schedule A-13 

 
					
	Purchaser Name	 	METLIFE INSURANCE COMPANY USA
	Name in Which to Register Note(s)	 	METLIFE INSURANCE COMPANY USA
	Note Registration Number(s); Principal Amount(s)	 	RS-3; £4,800,000
	 Payment on Account of Note(s)

     
	 	 
	 Method

     
	 	Federal Funds Wire Transfer
	 Account Information
	 	Bank Name:        JP Morgan Chase Bank, London
	 	 	SWIFT:               CHASGB2L
	 	 	Account No.:       ########
	 	 	Sort Code:           ######
	 	 	FFC:                    ######## MetLife Insurance Company
USA
	 	 	
Ref:                     ######### - Ametek Inc, 2.7%
due 11/23/2031
      

	 	 	 with sufficient information to identify the source and application of
such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.
 
    

	 	 	For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of instructions
to the contrary, will make such payments to the account and in the manner set forth above.
	Accompanying Information	 	 Name of Issuer:   AMETEK,
INC.
      

	 	 	Description of Security:	 	PPN:
	 	 	 2.70% Series S Notes due November 23, 2031
 
    
	 	031100 H*4
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for all notices	 	MetLife Insurance Company USA
	and communications	 	c/o Metropolitan Life Insurance Company
	 	 	Investments, Private Placements
	 	 	One MetLife Way
	 	 	Whippany, New Jersey 07981
	 	 	Attention:  Thomas Ho, VP Priv Placements-Corporates
	 	 	 Emails:  PPUCompliance@metlife.com and tho@metlife.com

     

	 	 	 With a copy OTHER than with respect to deliveries of financial
statements to:
      

	 	 	MetLife Insurance Company USA
	 	 	c/o Metropolitan Life Insurance Company
	 	 	One MetLife Way
	 	 	Whippany, New Jersey  07981
	 	 	Attention: Chief Counsel-Investments Law (PRIV)
	 	 	 Email:  sec_invest_law@metlife.com

     

	 	 	Audit Requests:
	 	 	Soft copy to AuditConfirms.PvtPlacements@metlife.com or hard copy to:
	 	 	Metropolitan Life Insurance Company
	 	 	Attn:  Private Placements Operations (ATTN: Audit Confirmations)
	 	 	18210 Crane Nest Drive – 5th Floor
	 	 	Tampa, FL 33647

 

  
 Schedule A-14 

 
					
	 Purchaser Name
	 	
METLIFE INSURANCE COMPANY USA

	
Instructions re Delivery of Note(s)
	 	 MetLife Insurance Company
USA

	 	 	 c/o Metropolitan Life
Insurance Company

	 	 	 Investments
Law

	 	 	 One MetLife
Way

	 	 	 Whippany, New Jersey
07981

	 	 	
Attention:  Nicolette Lopez, Esq.

	
Signature Block Format
	 	 METLIFE INSURANCE COMPANY
USA

	 	 	 By:        
	  	 Metropolitan Life Insurance Company,
its Investment Manager

	 		 
	 	 		  	 By:
                                         
                         

	 	 		  	 Name:

	 	 	 	  	
Title:

	
Tax Identification Number
	 	
06-0566090

 

  
 Schedule A-15 

 
							
	 Purchaser Name
	 	
METLIFE INSURANCE K.K.

	
Name in Which to Register Note(s)
	 	
METLIFE INSURANCE K.K.

	Note Registration Number(s); Principal Amount(s)	 	
RP-6; €17,000,000

     

	 Payment on
Account of Note(s)
	 	 
	 		 
	 Method
	 	 Federal Funds Wire Transfer
	  	 
	 		 
	 Account Information
	 	 Beneficiary Bank:
	  	 Citibank N.A., Hong
Kong

	 	 	 Beneficiary Bank BIC:
	  	 CITIHKHX
	  	 
	 	 	 Intermediary Bank:
	  	 Citibank N.A.,
London

	 	 	 Intermediary Bank BIC
	  	 CITIGB2L

	 	 	 Beneficiary Bank Account:
	  	 ######

	 	 	 IBAN:
	  	
######################

	 	 	 Beneficiary Account No.:
	  	 ##########

	 	 	 Beneficiary Name:
	  	 MetLife Insurance
K.K.

	 	 	 Ref:
	  	 ######### - Ametek Inc,
1.34% due 10/31/2026

	 	 
	 	 	with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of
principal, interest, make whole amount or otherwise.
	 	 
	 	 	For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder,
and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
	
Accompanying Information
	 	 Name of
Issuer:   AMETEK, INC.

	 		 
	 	 	 Description of Security:
	  	PPN:
	 	 	 1.34% Series P Notes due October 31, 2026
	  	031100 G*5
	 	 
	 	 	 Due date and application
(as among principal, interest and Make-Whole

	 	 	
Amount) of the payment being made.

 

  
 Schedule A-16 

 
			
	 Purchaser Name
	 	
METLIFE INSURANCE K.K.

	Address / Fax # / Email for all notices and communications	 	 Alico Asset Management Corp.
(Japan)
 Administration Department

ARCA East 7F, 3-2-1 Kinshi

	 	 	 Sumida-ku, Tokyo 130-0013
Japan

	 	 	 Attention:  Administration
Dept. Manager

	 	 	
Email:  saura@metlife.co.jp

	 	 
	 	 	 With a copy to:

	 	 
	 	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 Investments, Private
Placements

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	 Attention:  Thomas Ho, VP
Priv Placements-Corporates

	 	 	
Emails:  PPUCompliance@metlife.com    and    
tho@metlife.com

	 	 
	 	 	 With a copy OTHER than with
respect to deliveries of financial statements to:

	 	 
	 	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	 Attention: Chief Counsel-Investments
Law (PRIV)

	 	 	
Email:  sec_invest_law@metlife.com

	 	 
	 	 	 Audit Requests:

	 	 
	 	 	 Soft copy to
AuditConfirms.PvtPlacements@metlife.com or hard copy to:

	 	 
	 	 	 Metropolitan Life Insurance
Company

	 	 	 Attn:  Private Placements
Operations (ATTN: Audit Confirmations)

	 	 	 18210 Crane Nest Drive – 5th
Floor

	 	 	
Tampa, FL 33647

	
Instructions re Delivery of Note(s)
	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 Investments Law

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	
Attention:  Nicolette Lopez, Esq.

	
Signature Block Format
	 	 METLIFE INSURANCE K.K.

	 	 	
By:         MetLife Investment Advisors, LLC, Its Investment
Manager

	 	 
	 	 	
              By:
                                         
                         

	 	 	
              Name:

	 	 	
              Title:

	
Tax Identification Number

     
	 	
98-1037269 (USA) and 00661996 (Japan)

 

  
 Schedule A-17 

 
							
	 Purchaser Name
	 	
METLIFE INSURANCE K.K.

	
Name in Which to Register Note(s)
	 	
METLIFE INSURANCE K.K.

	Note Registration Number(s); Principal Amount(s)	 	
RS-4; £4,800,000

     

	 Payment on
Account of Note(s)
	 	 
	 	 
	 Method
	 	 Federal Funds Wire
Transfer

	 		 
	 Account Information
	 	 Beneficiary Bank:
	  	 Citibank N.A., Hong
Kong

	 	 	 Beneficiary Bank BIC:
	  	 CITIHKHX

	 	 	 Intermediary Bank:
	  	 Citibank N.A.,
London

	 	 	 Intermediary Bank BIC
	  	 CITIGB2L

	 	 	 Beneficiary Bank Account:
	  	 ######

	 	 	 Beneficiary Account No.:
	  	 ##########

	 	 	 Beneficiary Name:
	  	 MetLife Insurance
K.K.

	 	 	 Additional Information:
	  	 Sort Code
######

	 	 	 Ref:
	  	 ######### - Ametek Inc,
2.7% due 11/23/2031

	 	 
	 	 	with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of
principal, interest, make whole amount or otherwise.
	 	 
	 	 	For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder,
and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.
	
Accompanying Information
	 	 Name of
Issuer:   AMETEK, INC.

	 		 
	 	 	 Description of Security:
	  	PPN:
	 	 	
2.70% Series S Notes due November 23, 2031
	  	031100 H*4
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

 

  
 Schedule A-18 

 
			
	 Purchaser Name
	 	
METLIFE INSURANCE K.K.

	Address / Fax # / Email for all notices and communications	 	 Alico Asset Management Corp.
(Japan)
 Administration Department

	 	 	 ARCA East 7F, 3-2-1
Kinshi

	 	 	 Sumida-ku, Tokyo 130-0013
Japan

	 	 	 Attention:  Administration
Dept. Manager

	 	 	
Email:  saura@metlife.co.jp

	 	 
	 	 	 With a copy to:

	 	 
	 	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 Investments, Private
Placements

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	 Attention:  Thomas Ho, VP
Priv Placements-Corporates

	 	 	
Emails:  PPUCompliance@metlife.com    and    
tho@metlife.com

	 	 
	 	 	 With a copy OTHER than with
respect to deliveries of financial statements to:

	 	 
	 	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	 Attention: Chief Counsel-Investments
Law (PRIV)

	 	 	
Email:  sec_invest_law@metlife.com

	 	 
	 	 	 Audit Requests:

	 	 
	 	 	 Soft copy to
AuditConfirms.PvtPlacements@metlife.com or hard copy to:

	 	 
	 	 	 Metropolitan Life Insurance
Company

	 	 	 Attn: Private Placements Operations
(ATTN: Audit Confirmations)

	 	 	 18210 Crane Nest Drive – 5th
Floor

	 	 	
Tampa, FL 33647

	
Instructions re Delivery of Note(s)
	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 Investments Law

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	
Attention:  Nicolette Lopez, Esq.

	
Signature Block Format
	 	 METLIFE INSURANCE K.K.

	 	 	
By:        MetLife Investment Advisors, LLC, Its Investment
Manager

	 	 	
              By:        
                                         
                 

	 	 	
              Name:

	 	 	
              Title:

	
Tax Identification Number
	 	
98-1037269 (USA) and 00661996 (Japan)

 

  
 Schedule A-19 

 
							
	 Purchaser Name
	 	
METLIFE INSURANCE K.K.

	
Name in Which to Register Note(s)
	 	
METLIFE INSURANCE K.K.

	Note Registration Number(s); Principal Amount(s)	 	
RS-5; £4,800,000

     

	 Payment on
Account of Note(s)
	 	 
	 	 
	 Method
	 	 Federal Funds Wire
Transfer

	 		 
	 Account Information
	 	 Beneficiary Bank:
	 	 Citibank N.A., Hong
Kong

	 	 	 Beneficiary Bank BIC:
	 	 CITIHKHX

	 	 	 Intermediary Bank:
	 	 Citibank N.A.,
London

	 	 	 Intermediary Bank BIC
	 	 CITIGB2L

	 	 	 Beneficiary Bank Account:
	 	 ######

	 	 	 Beneficiary Account No.:
	 	 ##########

	 	 	 Beneficiary Name:
	 	 MetLife Insurance
K.K.

	 	 	 Additional Information:
	 	 Sort Code
######

	 	 	 Ref:
	 	 ######### - Ametek Inc,
2.7% due 11/23/2031

	 	 
	 	 	with sufficient information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of
principal, interest, make whole amount or otherwise.
	 	 
	 	 	For all payments other than scheduled payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of
instructions to the contrary, will make such payments to the account and in the manner set forth above.
	
Accompanying Information
	 	
Name of Issuer: AMETEK, INC.

	 		 
	 	 	 Description of Security:
	  	 PPN:

	 	 	2.70% Series S Notes due November 23, 2031	  	031100 H*4
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

 

  
 Schedule A-20 

 
			
	 Purchaser Name
	 	
METLIFE INSURANCE K.K.

	Address / Fax # / Email for all notices and communications	 	 Alico Asset Management Corp.
(Japan)
 Administration Department

	 	 	 ARCA East 7F, 3-2-1
Kinshi

	 	 	 Sumida-ku, Tokyo 130-0013
Japan

	 	 	 Attention:  Administration
Dept. Manager

	 	 	
Email:  saura@metlife.co.jp

	 	 
	 	 	 With a copy to:

	 	 
	 	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 Investments, Private
Placements

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	 Attention:  Thomas Ho, VP
Priv Placements-Corporates

	 	 	
Emails:  PPUCompliance@metlife.com    and    
tho@metlife.com

	 	 
	 	 	 With a copy OTHER than with
respect to deliveries of financial statements to:

	 	 
	 	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	 Attention: Chief Counsel-Investments
Law (PRIV)

	 	 	
Email:  sec_invest_law@metlife.com

	 	 
	 	 	 Audit Requests:

	 	 
	 	 	 Soft copy to
AuditConfirms.PvtPlacements@metlife.com or hard copy to:

	 	 
	 	 	 Metropolitan Life Insurance
Company

	 	 	 Attn: Private Placements Operations
(ATTN: Audit Confirmations)

	 	 	 18210 Crane Nest Drive – 5th
Floor

	 	 	
Tampa, FL 33647

	
Instructions re Delivery of Note(s)
	 	 MetLife Insurance K.K.

	 	 	 c/o MetLife Investment Advisors,
LLC

	 	 	 Investments Law

	 	 	 One MetLife Way

	 	 	 Whippany, New Jersey
07981

	 	 	
Attention:  Nicolette Lopez, Esq.

	
Signature Block Format
	 	 METLIFE INSURANCE K.K.

	 	 	
By:        MetLife Investment Advisors, LLC, Its Investment
Manager

	 	 
	 	 	
              By:
                                         
                         

	 	 	
              Name:

	 	 	
              Title:

	
Tax Identification Number
	 	
98-1037269 (USA) and 00661996 (Japan)

 

  
 Schedule A-21 

 
					
	Purchaser Name	 	PENSIONSKASSE DES BUNDES PUBLICA
	Name in Which to Register Note(s)	 	PENSIONSKASSE DES BUNDES PUBLICA
	Note Registration Number(s); Principal Amount(s)	 	RS-6; £5,400,000
	 Payment on Account of Note(s)

     
	 	 
	 Method

     
	 	Federal Funds Wire Transfer
	 Account Information
	 	
Currency:            GBP

Bank Name:        JPMORGAN CHASE BANK, N.A.

SWIFT:               ########

Account No.:      ########################

Name:                 PUBLICA - PRIVATE PLACEMENT METLIFE

Sort Code:          ######

Ref:                    Ametek Inc, 2.70% due
11/23/2031
      
 with sufficient
information to identify the source and application of such funds, including issuer, PPN#, interest rate, maturity and whether payment is of principal, interest, make whole amount or otherwise.

     
 For all payments other than scheduled
payments of principal and interest, the Company shall seek instructions from the holder, and in the absence of instructions to the contrary, will make such payments to the account and in the manner set forth above.

	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.
 
    
	 	 
	 	 	 Description of Security:
 2.70% Series S
Notes due November 23, 2031
      
	 	 PPN:

031100 H*4

	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

 

  
 Schedule A-22 

 
					
	Purchaser Name	 	PENSIONSKASSE DES BUNDES PUBLICA
	Address / Fax # / Email for all notices	 	Publica
	and communications	 	c/o MetLife Investment Management Limited
	 	 	Investments, Private Placements
	 	 	One MetLife Way
	 	 	Whippany, NJ 07981
	 	 	Attention:  Thomas Ho, VP Priv Placements-Corporates
	 	 	Emails:  PPUCompliance@metlife.com     and     tho@metlife.com
	 	 
	 	 	With a copy OTHER than with respect to deliveries of financial statements to:
	 	 
	 	 	Swiss Federal Pension Fund PUBLICA
	 	 	Attn. Asset Management
	 	 	Eigerstrasse 57
	 	 	P.O. Box, 3000 Berne 23, Switzerland
	 	 	Facsimile: +41 31 378 81 15
	 	 
	 	 	and
	 	 
	 	 	Publica
	 	 	c/o MetLife Investment Management Limited
	 	 	One MetLife Way
	 	 	Whippany, NJ 07981
	 	 	Attention: Chief Counsel-Investments Law (PRIV)
	 	 	Email: sec_invest_law@metlife.com
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, New York 11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Reference Account: ########
	 	 	Reference:  Account Name - PUBLICA - PRIVATE PLACEMENT METLIFE
	 	 
	 	 	With COPIES OF THE NOTES emailed to nlopez3@metlife.com
	Signature Block Format	 	PENSIONSKASSE DES BUNDES PUBLICA
	 	 	By:        	 	MetLife Investment Management Limited, as Investment Manager
	 	 	 
	 	 		 	 By:
                                         
                         

	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	ZPV 230’763’575

 

  
 Schedule A-23 

 
							
	Purchaser Name	 	THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal	 	RP-7; €67,000,000
	Amount(s)	 	 
	 	 	RQ-5; €20,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	Please contact our Treasury & Investment Operations Department to securely obtain wire transfer instructions.
	 	 	E-mail: payments@northwesternmutual.com
	 	 	Phone: (414) 665-1679
	 	 
	 	 	Re:  “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	The Northwestern Mutual Life Insurance Company
	related to payments	 	720 East Wisconsin Avenue
	 	 	Milwaukee, WI  53202
	 	 	Attention:  Investment Operations
	 	 	Email:  payments@northwesternmutual.com 
	 	 	Phone: (414) 665-1679
	Address / Fax # / Email for all other	 	The Northwestern Mutual Life Insurance Company
	notices	 	720 East Wisconsin Avenue
	 	 	Milwaukee, WI  53202
	 	 	Attention:  Securities Department
	 	 	Email:  privateinvest@northwesternmutual.com
	Instructions re Delivery of Note(s)	 	The Northwestern Mutual Life Insurance Company
	 	 	720 East Wisconsin Avenue
	 	 	Milwaukee, WI 53202
	 	 	Attention:  Matthew E. Gabrys
	Signature Block Format	 	THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
	 	 	By:      	  	Northwestern Mutual Investment Management Company, LLC,
	 	 		  	Its investment adviser
	 	 		 
	 	 		  	By:                                     
                            	 	 
	 	 		  	Name:	 	 
	 	 	 	  	Title:  Managing Director	 	 
	Tax Identification Number	 	39-0509570	 	 

 

  
 Schedule A-24 

 
					
	Purchaser Name	  	VOYA INSURANCE AND ANNUITY COMPANY
	Name in Which to Register Note(s)	  	VOYA INSURANCE AND ANNUITY COMPANY
	Note Registration Number(s); Principal	  	RR-1; £24,000,000
	Amount(s)	  	 
	Payment on Account of Note(s)	  	 
	 	 
	 Method
	  	Federal Funds Wire Transfer
	 	 
	 Account Information
	  	Bank of New York, London
	 	  	BIC Code:  IRVTGB2X
	 	  	A/C:  Bank of New York Brussels
	 	  	A/C:  ##########
	 	  	Sort Code:  ######
	 	  	F/O:  Voya Insurance & Annuity Company – ##########
	 	  	Reference:  “Accompanying Information” below
	Accompanying Information	  	Name of Issuer:   AMETEK, INC.
	 	 	 
	 	  	Description of Security:	 	PPN:
	 	  	2.59% Series R Notes due November 23, 2028	 	031100 G#1
	 	 
	 	  	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	  	Voya Investment Management LLC
	related to payments	  	5780 Powers Ferry Road NW, Suite 300
	 	  	Atlanta, GA  30327-4347
	 	  	Attn:  Operations/Settlements
	 	  	Email:  VoyaIMCashOperations@Voya.com
	Address / Fax # / Email for all other	  	Voya Investment Management LLC
	notices	  	5780 Powers Ferry Road NW, Suite 300
	 	  	Atlanta, GA  30327-4347
	 	  	Attn:  Private Placements
	 	  	Fax:  (770) 690-5342
	 	  	Email:  Private.Placements@Voya.com
	Instructions re Delivery of Note(s)	  	The Depository Trust Company
	 	  	570 Washington Blvd - 5th floor
	 	  	Jersey City, NJ 07310
	 	  	Attn:  BNY Mellon/Branch Deposit Department
	 	 
	 	  	with a copy to:
	 	 
	 	  	Patti.Boss@voya.com and opssettlements@voya.com
	 	 
	 	  	Each cover letter accompanying the above Notes should set forth the name of the issuer, a description of the Notes (including the interest rate, maturity date and
private placement number), and the name of each purchaser and its account number at The Bank of New York Mellon (Voya Insurance and Annuity Co /Acct. ##########) and the following:
	 	 
	 	  	The contact person at the Issuer of the Notes related to payments on the Notes is:
	 	  	Name:
                                         
 	 	 
	 	  	Telephone #:                                	 	 
	 	  	E-Mail:
                                        
	 	 

 

  
 Schedule A-25 

 
					
	Purchaser Name	 	VOYA INSURANCE AND ANNUITY COMPANY
	Signature Block Format	 	VOYA INSURANCE AND ANNUITY COMPANY
	 	 	By:      	 	Voya Investment Management LLC, as Agent
	 		 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	41-0991508

 

  
 Schedule A-26 

 
					
	Purchaser Name	 	VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
	Name in Which to Register Note(s)	 	VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
	Note Registration Number(s); Principal	 	RR-2; £41,000,000
	Amount(s)	 	 
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	Bank of New York, London
	 	 	BIC Code:  IRVTGB2X
	 	 	A/C:  Bank of New York Brussels
	 	 	A/C:  ##########
	 	 	Sort Code:  ######
	 	 	F/O:  Voya Retirement Insurance & Annuity – ##########
	 	 	Reference:  “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	2.59% Series R Notes due November 23, 2028	 	031100 G#1
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Voya Investment Management LLC
	related to payments	 	5780 Powers Ferry Road NW, Suite 300
	 	 	Atlanta, GA  30327-4347
	 	 	Attn:  Operations/Settlements
	 	 	Email:  VoyaIMCashOperations@Voya.com
	Address / Fax # / Email for all other	 	Voya Investment Management LLC
	notices	 	5780 Powers Ferry Road NW, Suite 300
	 	 	Atlanta, GA  30327-4347
	 	 	Attn:  Private Placements
	 	 	Fax:  (770) 690-5342
	 	 	Email:  Private.Placements@Voya.com
	Instructions re Delivery of Note(s)	 	The Depository Trust Company
	 	 	570 Washington Blvd - 5th floor
	 	 	Jersey City, NJ  07310
	 	 	Attn:  BNY Mellon/Branch Deposit Department
	 	 
	 	 	with a copy to:
	 	 
	 	 	Patti.Boss@voya.com and opssettlements@voya.com
	 	 
	 	 	Each cover letter accompanying the above Notes should set forth the name of the issuer, a description of the Notes (including the interest rate, maturity date and
private placement number), and the name of each purchaser and its account number at The Bank of New York Mellon (Voya Retirement Insurance and Annuity Co/Acct. ##########) and the following:
	 	 
	 	 	The contact person at the Issuer of the Notes related to payments on the Notes is:
	 	 	Name:
                                         
 	 	 
	 	 	Telephone #:                                	 	 
	 	 	E-Mail:
                                        
	 	 

 

  
 Schedule A-27 

 
					
	Purchaser Name	 	VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
	Signature Block Format	 	VOYA RETIREMENT INSURANCE AND ANNUITY COMPANY
	 	 	By:      	 	Voya Investment Management LLC, as Agent
	 		 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	71-0294708

 

  
 Schedule A-28 

 
					
	Purchaser Name	 	RELIASTAR LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	RELIASTAR LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal	 	RR-3; £4,500,000
	Amount(s)	 	 
	Payment on Account of Note	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	Bank of New York, London
	 	 	BIC Code:  IRVTGB2X
	 	 	A/C:  Bank of New York Brussels
	 	 	A/C:  ##########
	 	 	Sort Code:  ######
	 	 	F/O:  ReliaStar Life Insurance Company – ##########
	 	 	Reference:  “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.	 	 
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	2.59% Series R Notes due November 23, 2028	 	031100 G#1
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Voya Investment Management LLC
	related to payments	 	5780 Powers Ferry Road NW, Suite 300
	 	 	Atlanta, GA  30327-4347
	 	 	Attn:  Operations/Settlements
	 	 	Email:  VoyaIMCashOperations@Voya.com
	Address / Fax # / Email for all other	 	Voya Investment Management LLC
	notices	 	5780 Powers Ferry Road NW, Suite 300
	 	 	Atlanta, GA  30327-4347
	 	 	Attn:  Private Placements
	 	 	Fax:  (770) 690-5342
	 	 	Email:  Private.Placements@Voya.com
	Instructions re Delivery of Notes	 	The Depository Trust Company
	 	 	570 Washington Blvd - 5th floor
	 	 	Jersey City, NJ  07310
	 	 	Attn:  BNY Mellon/Branch Deposit Department
	 	 
	 	 	with a copy to:
	 	 
	 	 	Patti.Boss@voya.com and opssettlements@voya.com
	 	 
	 	 	Each cover letter accompanying the above Notes should set forth the name of the issuer, a description of the Notes (including the interest rate, maturity date and
private placement number), and the name of each purchaser and its account number at The Bank of New York Mellon (RLIC/Acct. ##########) and the following:
	 	 
	 	 	The contact person at the Issuer of the Notes related to payments on the Notes is:
	 	 	Name:
                                        
	 	 
	 	 	Telephone #:                               	 	 
	 	 	E-Mail:
                                       	 	 

 

  
 Schedule A-29 

 
					
	Purchaser Name	 	RELIASTAR LIFE INSURANCE COMPANY
	Signature Block Format	 	RELIASTAR LIFE INSURANCE COMPANY
	 	 	By:      	 	Voya Investment Management LLC, as Agent
	 		 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	41-0451140

 

  
 Schedule A-30 

 
					
	Purchaser Name	 	RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK
	Name in Which to Register Note(s)	 	RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK
	Note Registration Number(s); Principal	 	RR-4; £500,000
	Amount(s)	 	 
	Payment on Account of Note	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	Bank of New York, London
	 	 	BIC Code: IRVTGB2X
	 	 	A/C: Bank of New York Brussels
	 	 	A/C:  ##########
	 	 	Sort Code: ######
	 	 	F/O: ReliaStar Life Insurance Company, New York – ##########
	 	 	Reference:  “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	2.59% Series R Notes due November 23, 2028	 	031100 G#1
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Voya Investment Management LLC
	related to payments	 	5780 Powers Ferry Road NW, Suite 300
	 	 	Atlanta, GA  30327-4347
	 	 	Attn:  Operations/Settlements
	 	 	Email:  VoyaIMCashOperations@Voya.com
	Address / Fax # / Email for all other	 	Voya Investment Management LLC
	notices	 	5780 Powers Ferry Road NW, Suite 300
	 	 	Atlanta, GA  30327-4347
	 	 	Attn:  Private Placements
	 	 	Fax:  (770) 690-5342
	 	 	Email:  Private.Placements@Voya.com
	Instructions re Delivery of Notes	 	The Depository Trust Company
	 	 	570 Washington Blvd - 5th floor
	 	 	Jersey City, NJ  07310
	 	 	Attn:  BNY Mellon/Branch Deposit Department
	 	 
	 	 	with a copy to:
	 	 
	 	 	Patti.Boss@voya.com and opssettlements@voya.com
	 	 
	 	 	Each cover letter accompanying the above Notes should set forth the name of the issuer, a description of the Notes (including the interest rate, maturity date and
private placement number), and the name of each purchaser and its account number at The Bank of New York Mellon (RLNY/Acct. ##########) and the following:
	 	 
	 	 	The contact person at the Issuer of the Notes related to payments on the Notes is:
	 	 	Name:
                                         
 	 	 
	 	 	Telephone #:                                	 	 
	 	 	E-Mail:
                                        
	 	 

 

  
 Schedule A-31 

 
					
	Purchaser Name	 	RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK
	Signature Block Format	 	RELIASTAR LIFE INSURANCE COMPANY OF NEW YORK
	 	 	By:      	 	Voya Investment Management LLC, as Agent
	 		 
	 	 		 	By:
                                         
                         
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	53-0242530

 

  
 Schedule A-32 

 
							
	Purchaser Name	 	NEW YORK LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	NEW YORK LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal	 	RQ-6; €17,500,000
	Amount(s)	 	 
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase Bank AG, Frankfurt
	 	 	SWIFT BIC:  CHASDEFX
	 	 	Favor:  JPMorgan Chase Bank, London Branch, Swift ########
	 	 	A/C#:  ######################
	 	 
	 	 	For Further Credit:  GTI14371 New York Life Insurance Company
	 	 
	 	 	with sufficient information (including issuer, PPN number, interest rate, maturity and whether payment is of principal, premium, or interest) to identify the
source and application of such funds. MT102 PMT message should be provided if available in order to expedite the process.
	 	 
	 	 	Any changes in the foregoing payment instructions shall be confirmed by e-mail to NYLIMWireConfirmation@nylim.com prior to
becoming effective.
	Accompanying Information	 	Name of Issuer:   AMETEK, INC.
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	New York Life Insurance Company
	related to payments	 	c/o NYL Investors LLC
	 	 	51 Madison Avenue
	 	 	2nd Floor Room 208
	 	 	New York, New York 10010-1603
	 			 
	 	 	Attention:        	 	Investment Services	 	 
	 	 		 	Private Group	 	 
	 	 		 	2nd Floor	 	 
	 	 		 	Fax #:  908-840-3385	 	 
	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com

 

  
 Schedule A-33 

 
					
	Purchaser Name	 	NEW YORK LIFE INSURANCE COMPANY
	Address / Fax # / Email for all other	 	New York Life Insurance Company
	notices	 	c/o NYL Investors LLC
	 	 	51 Madison Avenue
	 	 	New York, New York 10010
	 		 
	 	 	Attention:	 	Private Capital Investors
	 	 		 	2nd Floor
	 	 		 	Fax #: 908-840-3385
	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com
	 	 
	 	 	and with a copy of any notices regarding defaults or Events of Default under the operative documents to:
	 		 
	 	 	Attention:        	 	Office of General Counsel
	 	 		 	Investment Section, Room 1016
	 	 	 	 	Fax #: (212) 576-8340
	Instructions re Delivery of Note(s)	 	New York Life Insurance Company
	 	 	51 Madison Avenue, Room 1016
	 	 	New York, NY  10010
	 	 	Attn: Dean Morini
	Signature Block Format	 	NEW YORK LIFE INSURANCE COMPANY
	 	 
	 	 	By:
                                         
                       
	 	 	Name:	 	 
	 	 	Title:	 	 
	Tax Identification Number	 	13-5582869

 

  
 Schedule A-34 

 
							
	Purchaser Name	 	NEW YORK LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	NEW YORK LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal	 	RR-5; £28,000,000
	Amount(s)	 	 
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 			 
	 Account Information
	 	GBP:	 		 	 
	 	 	Beneficiary Bank:	 	 JP Morgan Chase, London

	 	 	Swift:	 	 ########
	 	 
	 	 	Account Name:	 	 NYLIC Investments 1193

	 	 	IBAN:	 	 ######################

	 	 
	 	 	with sufficient information (including issuer, PPN number, interest rate, maturity and whether payment is of principal, premium, or interest) to identify the
source and application of such funds.
	 	 
	 	 	Any changes in the foregoing payment instructions shall be confirmed by e-mail to NYLIMWireConfirmation@nylim.com prior to
becoming effective.
	Accompanying Information	 	Name of Issuer:   AMETEK, INC.
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	2.59% Series R Notes due November 23, 2028	 	031100 G#1
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	New York Life Insurance Company
	related to payments	 	c/o NYL Investors LLC
	 	 	51 Madison Avenue
	 	 	2nd Floor Room 208
	 	 	New York, New York 10010-1603	 	 
	 			 
	 	 	Attention:	 	Investment Services	 	 
	 	 		 	Private Group, 2nd Floor	 	 
	 	 		 	Fax #:  908-840-3385	 	 
	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com

 

  
 Schedule A-35 

 
					
	Purchaser Name	 	NEW YORK LIFE INSURANCE COMPANY
	Address / Fax # / Email for all other	 	New York Life Insurance Company
	notices	 	c/o NYL Investors LLC
	 	 	51 Madison Avenue
	 	 	2nd Floor, Room 208
	 	 	New York, New York 10010
	 		 
	 	 	Attention:          	 	Private Capital Investors
	 	 		 	2nd Floor
	 	 		 	Fax #: 908-840-3385
	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com
	 	 
	 	 	and with a copy of any notices regarding defaults or Events of Default under the operative documents to:
	 		 
	 	 	Attention:	 	Office of General Counsel
	 	 		 	Investment Section, Room 1016
	 	 	 	 	Fax #: (212) 576-8340
	Instructions re Delivery of Note(s)	 	New York Life Insurance Company
	 	 	51 Madison Avenue, Room 1016
	 	 	New York, NY  10010
	 	 	Attn: Dean Morini
	Signature Block Format	 	NEW YORK LIFE INSURANCE COMPANY
	 	 
	 	 	By:
                                         
                       
	 	 	Name:	 	 
	 	 	Title:	 	 
	Tax Identification Number	 	13-5582869	 	 

 

  
 Schedule A-36 

 
							
	Purchaser Name	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	Name in Which to Register Note(s)	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	Note Registration Number(s); Principal	 	RQ-7; €7,500,000
	Amount(s)	 	 
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase Bank AG, Frankfurt
	 	 	SWIFT BIC:  ########
	 	 	Favor:  JPMorgan Chase Bank, London Branch, Swift CHASGB2L
	 	 	A/C#:  ######################
	 	 
	 	 	For Further Credit:  ######## New York Life Insurance and Annuity Corporation
	 	 
	 	 	with sufficient information (including issuer, PPN number, interest rate, maturity and whether payment is of principal, premium, or interest) to identify the
source and application of such funds. MT102 PMT message should be provided if available in order to expedite the process. 
	 	 
	 	 	Any changes in the foregoing payment instructions shall be confirmed by e-mail to NYLIMWireConfirmation@nylim.com prior to
becoming effective.
	Accompanying Information	 	Name of Issuer:   AMETEK, INC.	 	 
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	New York Life Insurance Company	 	 
	related to payments	 	c/o NYL Investors LLC	 	 
	 	 	51 Madison Avenue	 	 
	 	 	2nd Floor Room 208	 	 
	 	 	New York, New York 10010-1603	 	 
	 			 
	 	 	Attention:          	 	Investment Services	 	 
	 	 		 	Private Group	 	 
	 	 		 	2nd Floor	 	 
	 	 		 	Fax #:  908-840-3385	 	 
	 		 
	 	 	with a copy sent electronically to:	 	 
	 		 
	 	 	FIIGLibrary@nylim.com	 	 
	 	 	TraditionalPVtOps@nylim.com	 	 

 

  
 Schedule A-37 

 
					
	Purchaser Name	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	Address / Fax # / Email for all other notices	 	 New York Life Insurance Company

c/o NYL Investors LLC

	 	 	51 Madison Avenue
	 	 	New York, New York 10010
	 		 
	 	 	Attention:	 	 Private Capital Investors

	 	 		 	 2nd Floor

	 	 		 	 Fax #: 908-840-3385

	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com
	 	 
	 	 	and with a copy of any notices regarding defaults or Events of Default under the operative documents to:
	 		 
	 	 	Attention:	 	 Office of General Counsel

	 	 		 	 Investment Section, Room 1016

	 	 	 	 	 Fax #: (212)
576-8340

	Instructions re Delivery of Note(s)	 	New York Life Insurance Company
	 	 	51 Madison Avenue, Room 1016
	 	 	New York, NY  10010
	 	 	Attn: Dean Morini
	Signature Block Format	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	 	 	By:          NYL Investors LLC, its Investment Manager
	 	 
	 	 	                By:
                                         
                        
	 	 	                Name:
	 	 	                Title:
	Tax Identification Number	 	13-3044743

 

  
 Schedule A-38 

 
					
	Purchaser Name	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	Name in Which to Register Note(s)	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	Note Registration Number(s); Principal Amount(s)	 	RR-6; £12,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	GBP:
	 	 	Beneficiary Bank:	 	 JP Morgan Chase, London

	 	 	Swift:	 	 ########

	 	 	Account Name:	 	 NYLIAC Investments 1182

	 	 	IBAN:	 	 ######################

	 	 
	 	 	with sufficient information (including issuer, PPN number, interest rate, maturity and whether payment is of principal, premium, or interest) to identify the
source and application of such funds.
	 	 
	 	 	Any changes in the foregoing payment instructions shall be confirmed by e-mail to NYLIMWireConfirmation@nylim.com prior to
becoming effective.
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 
	 	 	Description of Security:                    
                                        
PPN:
	 	 	2.59% Series R Notes due November 23,
2028                        031100 G#1
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	New York Life Insurance and Annuity Corporation
	related to payments	 	c/o NYL Investors LLC
	 	 	51 Madison Avenue
	 	 	2nd Floor, Room 208
	 	 	New York, New York 10010-1603
	 		 
	 	 	Attention:	 	Investment Services
	 	 		 	Private Group, 2nd Floor
	 	 		 	Fax #:  908-840-3385
	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com

 

  
 Schedule A-39 

 
					
	Purchaser Name	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	Address / Fax # / Email for all other notices	 	 New York Life Insurance and Annuity Corporation

c/o NYL Investors LLC

	 	 	51 Madison Avenue
	 	 	2nd Floor, Room 208
	 	 	New York, New York 10010-1603
	 		 
	 	 	Attention:	 	 Private Capital Services

	 	 		 	 2nd Floor

	 	 		 	 Fax #: 908-840-3385

	 	 
	 	 	with a copy sent electronically to:
	 	 
	 	 	FIIGLibrary@nylim.com
	 	 	TraditionalPVtOps@nylim.com
	 	 
	 	 	and with a copy of any notices regarding defaults or Events of Default under the operative documents to:
	 		 
	 	 	Attention:	 	 Office of General Counsel

	 	 		 	 Investment Section, Room 1016

	 	 	 	 	 Fax #: (212)
576-8340

	Instructions re Delivery of Note(s)	 	New York Life Insurance Company
	 	 	51 Madison Avenue, Room 1016
	 	 	New York, NY  10010
	 	 	Attn: Dean Morini
	Signature Block Format	 	NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION
	 	 	By:          NYL Investors LLC, its Investment Manager
	 	 
	 	 	                By:
                                         
                        
	 	 	                Name:
	 	 	                Title:
	Tax Identification Number	 	13-3044743

 

  
 Schedule A-40 

 
					
	Purchaser Name	 	PACIFIC LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	MAC & CO., AS NOMINEE FOR PACIFIC LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal Amount(s)	 	 RP-8; €5,000,000

RP-9; €5,000,000

	 	 	RP-10; €5,000,000
	 	 	RP-11; €5,000,000
	 	 	RP-12; €5,000,000
	 	 	RP-13; €5,000,000
	 	 
	 	 	RQ-8; €5,000,000
	 	 	RQ-9; €5,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	Cash Correspondent Name:              Bank of New York Mellon, Frankfurt
	 	 	Cash Correspondent SWIFT/BIC:    ########
	 	 
	 	 	Global Custodian Name:                   The Bank of New York
Mellon, NY
	 	 	Global Custodian SWIFT/BIC:         ###########
	 	 	Global Custodian Account:               ##########
	 	 
	 	 	FFC:  Pacific Life Ins Co – General Acct - Account ##########
	 	 
	 	 	Include “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:   AMETEK, INC.
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	The Bank of New York Mellon
	 	Attn:  Pacific Life Accounting Team
	 	 	One Mellon Bank Center
	 	 	Room 0930
	 	 	Pittsburgh, PA    15258-0001
	 	 
	 	 	And
	 	 
	 	 	Pacific Life Insurance Company
	 	 	Attn:  IM – Cash Team
	 	 	700 Newport Center Drive
	 	 	Newport Beach, CA  92660
	 	 	Fax:  949-718-5845
	Address / Fax # / Email for all other notices	 	Pacific Life Insurance Company
	 	Attn:  IM – Credit Analysis
	 	 	700 Newport Center Drive
	 	 	Newport Beach, CA  92660-6397
	 	 	PrivatePlacementCompliance@PacificLife.com

 

  
 Schedule A-41 

 
					
	Purchaser Name	 	PACIFIC LIFE INSURANCE COMPANY
	Instructions re Delivery of Note(s)	 	The Depository Trust Company
	 	 	Attn: BNY Mellon/Branch Deposit Department
	 	 	570 Washington Blvd - 5th Floor
	 	 	Jersey City, NJ 07310	 	 
	 		 
	 	 	Account Name:	 	Pacific Life Ins Co - General Acct
	 	 	EUR Account Number:      	 	##########
	Signature Block Format	 	PACIFIC LIFE INSURANCE COMPANY
	 	 
	 	 	By:
                                         
                         
	 	 	Name:	 	 
	 	 	Title:	 	 
	 	 
	 	 	By:
                                         
                         
	 	 	Name:	 	 
	 	 	Title:	 	 
	Tax Identification Number	 	95-1079000	 	 

 

  
 Schedule A-42 

 
							
	Purchaser Name	 	MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal	 	RP-14; €40,000,000	 	 
	Amount(s)	 	 	 	 
	Payment on Account of Note(s)	 		 	 
	 		 
	 Method
	 	Federal Funds Wire Transfer	 	 
	 		 
	 Account Information
	 	Account Name:    	 	Massachusetts Mutual Life Insurance Company
	 	 	Account #:	 	 ########
	 	 
	 	 	IBAN #:	 	 ######################
	 	 
	 	 	Bank:	 	Citibank London	 	 
	 	 	SWIFT:	 	 ########
	 	 
	 	 	Ref:	 	Payment with cover under MT103	 	 
	 	 	 	 	Description of security, cusip, principal and interest split
	Accompanying Information	 	Name of Issuer:	 	AMETEK, INC.	 	 
	 		 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Massachusetts Mutual Life Insurance Company	 	 
	related to payments	 	Treasury Operations Liquidity Management	 	 
	 	 	1295 State Street	 	 
	 	 	Springfield, MA 01111	 	 
	 	 	Attn: Janelle Tarantino	 	 
	 		 
	 	 	With a copy to:	 	 
	 		 
	 	 	Massachusetts Mutual Life Insurance Company	 	 
	 	 	c/o Barings LLC	 	 
	 	 	1500 Main Street – Suite 2200	 	 
	 	 	PO Box 15189	 	 
	 	 	Springfield, MA  01115	 	 
	 	 
	 	 	With advice of payment to the Treasury Operations Liquidity Management Department at Massachusetts Mutual Life Insurance Company
at mmincometeam@massmutual.com or (413) 226-4295 (facsimile).

 

  
 Schedule A-43 

 
					
	Purchaser Name	 	MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
	Address / Fax # / Email for all other notices	 	Massachusetts Mutual Life Insurance Company
	 	c/o Barings LLC
	 	 	1500 Main Street – Suite 2200
	 	 	PO Box 15189
	 	 	Springfield, MA 01115-5189
	 	 
	 	 	Electronic Delivery of Financials and other information to:
	 	 
	 	 	Massachusetts Mutual Life Insurance Company
	 	 	c/o Barings LLC
	 	 	1500 Main Street – Suite 2200
	 	 	PO Box 15189
	 	 	Springfield, MA 01115-5189
	 	 
	 	 	With notification to:
	 	 
	 	 	privateplacements@barings.com
	 	 	ben.jones@barings.com
	Instructions re Delivery of Note(s)	 	Lori King, Sr. Legal Analyst
	 	 	Barings LLC
	 	 	1500 Main Street, Suite 2800
	 	 	Springfield, MA 01115-5189
	 	 	Telephone: 413-226-1055
	 	 	Facsimile: 413-226-2055
	 	 	E-mail: lori.king@barings.com and steve.katz@barings.com
	Signature Block Format	 	MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY
	 	 	By:        	 	Barings LLC, as Investment Adviser
	 	 	 
	 	 		 	By:
                                         
                         
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	04-1590850

 

  
 Schedule A-44 

 
					
	Purchaser Name	 	THE LINCOLN NATIONAL LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	THE LINCOLN NATIONAL LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal	 	RQ-10;  €20,000,000
	Amount(s)	 	RQ-11;  €10,000,000
	Payment on Account of Note(s)	 		 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 	 
	 Account Information
	 	Beneficiary Bank Name:	 	The Bank of New York Mellon SA/NV
	 	 	SWIFT/BIC:	 	 ########

	 	 	Account #:	 	 ##########

	 	 	Ultimate Beneficiary:	 	The Lincoln National Life Insurance Company
	 	 	Account #:	 	##########
	 	 	IBAN:	 	################
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	                             
               PPN:
	 	 	1.53% Series Q Notes due October 31,
2028                031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	The Bank of New York Mellon
	related to payments	 	P.O. Box 392003
	 	 	Pittsburgh, PA  15251-9003
	 	 	Attn:  Private Placement P & I Dept
	 	 	Ref:  Registered Holder / Sec Desc/PPN#
	 	 	Email:  ppservicing@bnymellon.com
	 	 
	 	 	Lincoln Financial Group
	 	 	1300 South Clinton Street, Mail Stop 1H-15
	 	 	Fort Wayne, IN  46802
	 	 	Attn E-Mail:  IADERIVOPERATIONS@LFG.COM
	 	 	Attn:  Rhoda Anderson (E-Mail:  Rhoda.Anderson@lfg.com)
	 	 	Telephone:  260-455-4405
	 	 
	 	 	Delaware Investment Advisers
	 	 	2005 Market Street, Mail Stop 41-104
	 	 	Philadelphia, PA  19103
	 	 	Attn:  Fixed Income Private Placements
	 	 	Email:  Delawareprivateplacements@delinvest.com
	Address / Fax # / Email for all other	 	Delaware Investment Advisers
	notices	 	2005 Market Street, Mail Stop 41-104
	 	 	Philadelphia, PA  19103
	 	 	Attn:  Fixed Income Private Placements
	 	 	Email:  Delawareprivateplacements@delinvest.com

 

  
 Schedule A-45 

 
							
	Purchaser Name	  	THE LINCOLN NATIONAL LIFE INSURANCE COMPANY
	Instructions re Delivery of Note(s)	  	The Depository Trust Company
	 	  	570 Washington Blvd – 5th Floor
	 	  	Jersey City, New Jersey 07310
	 	  	Attention: BNY Mellon/Branch Deposit Department
	 	  	Ref:  (in cover letter reference note amount, account name and bank custody account #) 
	 			 
	 	  	Note Amount	  	Account Name	  	Bank Custody
	 	  		  		  	Account #
	 			 
	 	  	€20,000,000	  	The Lincoln Natl Life	  	######
	 	  		  	Ins Co (Seg 66)	  	 
	 			 
	 	  	€10,000,000	  	The Lincoln Natl Life	  	######
	 	  		  	Ins Co (Seg 76)	  	 
	 	 
	 	  	Please fax copy of cover letter to:
	 	  	Karen Costa – The Bank of New York Mellon
	 	  	Fax #:  844-601-7769 and to andrea.fox@lfg.com
	Signature Block Format	  	THE LINCOLN NATIONAL LIFE INSURANCE COMPANY
	 	  	By:        Delaware Investment Advisers,
	 	  	 a series of Delaware Management Business
Trust,

	 	  	 Attorney in Fact

	 	 
	 	  	 By:
                                         
                       

	 	  	 Name:

	 	  	
Title:

	Tax Identification Number	  	35-0472300

 

  
 Schedule A-46 

 
					
	Purchaser Name	 	HARTFORD LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	HARTFORD LIFE INSURANCE COMPANY
	 Note Registration Number(s); Principal Amount(s)

 
	 	RP-15; €3,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase, A.G. Frankfurt, Germany
	 	 	Swift Bic Code: ########
	 	 	Favor: JP Morgan Chase Bank, London Branch
	 	 	Account No. ##########
	 	 	Further Credit: Hartford Life Ins Co Fixed Ann – LFA
	 	 	Account No. ######## - IBAN ######################
	 	 	Attn: Bond Interest /Principal – AMETEK, Inc. 1.34% Series P Notes due
	 	 	October 31, 2026
	 	 
	 	 	Ref: “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.	 	 
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Hartford Investment Management Company
	related to payments	 	c/o Investment Operations
	 	 	Mailing Address:
	 	 	One Hartford Plaza - NP5
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8875/8876
	Address / Fax # / Email for all other	 	Hartford Investment Management Company
	notices	 	c/o Investment Department-Private Placements
	 	 	E-mail Address:
	 	 	kristin.kapur@himco.com and PrivatePlacements.Himco@Himco.com, subject to confirming copy of notice being sent same day by recognized international
commercial delivery service (charges prepaid) to the following addresses:
	 	 	Mailing Address:
	 	 	One Hartford Plaza, NP5-B
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8884
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, New York 11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Custody Account Number: ########### must appear on outside of envelope

 

  
 Schedule A-47 

 
					
	Purchaser Name	 	HARTFORD LIFE INSURANCE COMPANY
	Signature Block Format	 	HARTFORD LIFE INSURANCE COMPANY
	 	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	 	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	 	 	HARTFORD FIRE INSURANCE COMPANY
	 	 	 SEPARATE ACCOUNT B, A
SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY

	 	 	By:        	 	Hartford Investment Management Company
	 	 		 	Their Agent and Attorney-in-Fact
	 	 	 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	06-0974148

 

  
 Schedule A-48 

 
					
	Purchaser Name	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	Name in Which to Register Note(s)	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	 Note Registration Number(s); Principal Amount(s)

 
	 	 RP-16; €5,000,000

RP-17; €5,000,000
  

	 
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase, A.G. Frankfurt, Germany
	 	 	Swift Bic Code: ########
	 	 	Favor: JP Morgan Chase Bank, London Branch
	 	 	Account No. ##########
	 	 	Further Credit: Hartford Accident and Indemnity Company – HAI
	 	 	Account No. ######## - IBAN ######################
	 	 	Attn: Bond Interest /Principal – AMETEK, Inc. 1.34% Series P Notes due
	 	 	October 31, 2026
	 	 
	 	 	Ref: “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	Hartford Investment Management Company
	 	c/o Investment Operations
	 	 	Mailing Address:
	 	 	One Hartford Plaza - NP5
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8875/8876
	Address / Fax # / Email for all other notices	 	Hartford Investment Management Company
	 	c/o Investment Department-Private Placements
	 	 	E-mail Address:
	 	 	kristin.kapur@himco.com and PrivatePlacements.Himco@Himco.com, subject to confirming copy of notice being sent same day by recognized international
commercial delivery service (charges prepaid) to the following addresses:
	 	 	Mailing Address:
	 	 	One Hartford Plaza, NP5-B
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8884
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, New York 11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Custody Account Number: ########### must appear on outside of envelope

 

  
 Schedule A-49 

 
					
	Purchaser Name	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	Signature Block Format	 	HARTFORD LIFE INSURANCE COMPANY
	 	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	 	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	 	 	HARTFORD FIRE INSURANCE COMPANY
	 	 	 SEPARATE ACCOUNT B, A
SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY

	 	 	By:        	 	Hartford Investment Management Company
	 	 		 	Their Agent and Attorney-in-Fact
	 	 	 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	06-0383030

 

  
 Schedule A-50 

 
					
	Purchaser Name	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	Name in Which to Register Note(s)	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	 Note Registration Number(s); Principal Amount(s)

 
	 	RP-18; €5,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase, A.G. Frankfurt, Germany
	 	 	Swift Bic Code: ########
	 	 	Favor: JP Morgan Chase Bank, London Branch
	 	 	Account No. ##########
	 	 	Further Credit: Hartford L & A Ins – EBD
	 	 	Account No. ######## - IBAN ######################
	 	 	Attn: Bond Interest /Principal – AMETEK, Inc. 1.34% Series P Notes due
	 	 	October 31, 2026
	 	 
	 	 	Ref: “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	Hartford Investment Management Company
	 	c/o Investment Operations
	 	 	Mailing Address:
	 	 	One Hartford Plaza - NP5
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8875/8876
	Address / Fax # / Email for all other notices	 	Hartford Investment Management Company
	 	c/o Investment Department-Private Placements
	 	 	E-mail Address:
	 	 	kristin.kapur@himco.com and PrivatePlacements.Himco@Himco.com, subject to confirming copy of notice being sent same day by recognized
international commercial delivery service (charges prepaid) to the following addresses:
	 	 	Mailing Address:
	 	 	One Hartford Plaza, NP5-B
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8884
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, New York 11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Custody Account Number: ########### must appear on outside of envelope

 

  
 Schedule A-51 

 
					
	Purchaser Name	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	Signature Block Format	 	HARTFORD LIFE INSURANCE COMPANY
	 	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	 	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	 	 	HARTFORD FIRE INSURANCE COMPANY
	 	 	 SEPARATE ACCOUNT B, A
SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY

	 	 	By:        	 	Hartford Investment Management Company
	 	 		 	Their Agent and Attorney-in-Fact
	 	 	 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	06-0838648

 

  
 Schedule A-52 

 
					
	Purchaser Name	 	HARTFORD FIRE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	HARTFORD FIRE INSURANCE COMPANY
	 Note Registration Number(s); Principal Amount(s)

 
	 	RP-19; €5,000,000
	 	 RP-20; €5,000,000

 

	Payment on Account of Note(s)	 	 	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase, A.G. Frankfurt, Germany
	 	 	Swift Bic Code: ########
	 	 	Favor: JP Morgan Chase Bank, London Branch
	 	 	Account No. ##########
	 	 	Further Credit: Hartford Fire Insurance Co – FIR
	 	 	Account No. ######## - IBAN ######################
	 	 	Attn: Bond Interest /Principal – AMETEK, Inc. 1.34% Series P Notes due
	 	 	October 31, 2026
	 	 
	 	 	Ref: “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Hartford Investment Management Company
	related to payments	 	c/o Investment Operations
	 	 	Mailing Address:
	 	 	One Hartford Plaza - NP5
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8875/8876
	Address / Fax # / Email for all other	 	Hartford Investment Management Company
	notices	 	c/o Investment Department-Private Placements
	 	 	E-mail Address:
	 	 	kristin.kapur@himco.com and PrivatePlacements.Himco@Himco.com, subject to confirming copy of notice being sent same day by recognized
international commercial delivery service (charges prepaid) to the following addresses:
	 	 	Mailing Address:
	 	 	One Hartford Plaza, NP5-B
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8884
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, New York 11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Custody Account Number: ########### must appear on outside of envelope

 

  
 Schedule A-53 

 
					
	Purchaser Name	 	HARTFORD FIRE INSURANCE COMPANY
	Signature Block Format	 	HARTFORD LIFE INSURANCE COMPANY
	 	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	 	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	 	 	HARTFORD FIRE INSURANCE COMPANY
	 	 	 SEPARATE ACCOUNT B, A
SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY

	 	 	By:        	 	Hartford Investment Management Company
	 	 		 	Their Agent and Attorney-in-Fact
	 	 	 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	06-0383750

 

  
 Schedule A-54 

 
					
	Purchaser Name	 	SEPARATE ACCOUNT B, A SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	SEPARATE ACCOUNT B, A SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY
	 Note Registration Number(s); Principal Amount(s)

 
	 	RP-21; €2,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	JP Morgan Chase, A.G. Frankfurt, Germany
	 	 	Swift Bic Code: ########
	 	 	Favor: JP Morgan Chase Bank, London Branch
	 	 	Account No. ##########
	 	 	Further Credit: Hartford Pension Separate Account B – BPP
	 	 	Account No. ######## - IBAN ######################
	 	 	Attn: Bond Interest /Principal – AMETEK, Inc. 1.34% Series P Notes due
	 	 	October 31, 2026
	 	 
	 	 	Ref:  “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.34% Series P Notes due October 31, 2026	 	031100 G*5
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	Hartford Investment Management Company
	 	c/o Investment Operations
	 	 	Mailing Address:
	 	 	One Hartford Plaza - NP5
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8875/8876
	Address / Fax # / Email for all other notices	 	Hartford Investment Management Company
	 	c/o Investment Department-Private Placements
	 	 	E-mail Address:
	 	 	kristin.kapur@himco.com and PrivatePlacements.Himco@Himco.com, subject to confirming copy of notice being sent same day by recognized
international commercial delivery service (charges prepaid) to the following addresses:
	 	 	Mailing Address:
	 	 	One Hartford Plaza, NP5-B
	 	 	Hartford, Connecticut 06155
	 	 	Telefacsimile: (860)297-8884
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, New York 11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Custody Account Number: ########### must appear on outside of envelope

 

  
 Schedule A-55 

 
					
	Purchaser Name	 	SEPARATE ACCOUNT B, A SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY
	Signature Block Format	 	HARTFORD LIFE INSURANCE COMPANY
	 	 	HARTFORD ACCIDENT AND INDEMNITY COMPANY
	 	 	HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY
	 	 	HARTFORD FIRE INSURANCE COMPANY
	 	 	 SEPARATE ACCOUNT B, A
SEPARATE ACCOUNT OF HARTFORD LIFE INSURANCE COMPANY

	 	 	By:        	 	Hartford Investment Management Company
	 	 		 	Their Agent and Attorney-in-Fact
	 	 	 
	 	 		 	By:
                                         
                       
	 	 		 	Name:
	 	 	 	 	Title:
	Tax Identification Number	 	06-0974148

 

  
 Schedule A-56 

 
					
	Purchaser Name	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	Name in Which to Register Note(s)	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	Note Registration Number(s); Principal Amount(s)	 	RQ-12;  €20,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Electronic Funds Transfer
	 	 
	 Account Information
	 	All payments in Euros on or in respect of the Series Q Notes shall be made in immediately available funds on the due date by electronic funds transfer
to:
	 	 
	 	 	Citibank N.A., London
	 	 	SWIFT Code: ########
	 	 	IBAN Number: ######################
	 	 	Account Number: #######
	 	 	Account Name:  Teachers Ins & Ann College Retirement
	 	 	Reference:  PPN: 031100 G@3/AMETEK, Inc.
	 	 	Maturity Date: October 31, 2028/Interest Rate: 1.53%/P&I Breakdown
	 	 
	 	 	All payments in Dollars on or in respect of the Series Q Notes shall be made in immediately available funds on the due date by electronic funds transfer
to:
	 	 
	 	 	JPMorgan Chase Bank, N.A.
	 	 	ABA # 021-000-021
	 	 	Account Number: 900-9-000200
	 	 	Account Name:  TIAA
	 	 	For Further Credit to the Account Number: G07040
	 	 	Reference: AMETEK, Inc.
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	1.53% Series Q Notes due October 31, 2028	 	031100 G@3
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

 

  
 Schedule A-57 

 
					
	Purchaser Name	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	Address / Fax # / Email for notices related to payments	 	Teachers Insurance and Annuity Association of America
	 	730 Third Avenue
	 	 	New York, New York 10017
	 	 	Attention: Securities Accounting Division
	 	 	Phone: (212) 916-5504
	 	 	Email: jpiperato@tiaa.org or mwolfe@tiaa.org
	 	 
	 	 	With a copy to:
	 	 
	 	 	JPMorgan Chase Bank, N.A.
	 	 	P.O. Box 35308
	 	 	Newark, New Jersey 07101
	 	 
	 	 	And to:
	 	 
	 	 	Teachers Insurance and Annuity Association of America
	 	 	8500 Andrew Carnegie Boulevard
	 	 	Charlotte, North Carolina 28262
	 	 	Attention: Global Private Markets
	 	 	Telephone:                    	 	(704) 988-4349 (Ho Young Lee)
	 	 		 	(704) 988-1000 (General Number)
	 	 	Facsimile:	 	(704) 988-4916
	 	 	Email:	 	hlee@tiaa.org
	Address / Fax # / Email for all other notices	 	Teachers Insurance and Annuity Association of America
	 	8500 Andrew Carnegie Boulevard
	 	 	Charlotte, North Carolina 28262
	 	 	Attention: Global Private Markets
	 	 	Telephone:          (704) 988-4349 (Ho Young Lee)
	 	 	 (704) 988-1000 (General Number)

	 	 	Facsimile:            (704) 988-4916
	 	 	Email:                 
hlee@tiaa.org
	Instructions re Delivery of Note(s)	 	Teachers Insurance and Annuity Association of America
	 	 	730 Third Avenue
	 	 	New York, New York 10017
	 	 	Attention:  Timothy F. Hodgdon
	 	 	
  Asset Management Law, 12th Floor

	Signature Block Format	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	 	 
	 	 	By:
                                         
                       
	 	 	Name:
	 	 	Title:
	Tax Identification Number	 	13-1624203

 

  
 Schedule A-58 

 
					
	Purchaser Name	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	Name in Which to Register Note(s)	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	Note Registration Number(s); Principal Amount(s)	 	RS-7; £7,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Electronic Funds Transfer
	 	 
	 Account Information
	 	All payments in Sterling on or in respect of the Series S Notes shall be made in immediately available funds on the due date by electronic funds transfer
to:
	 	 
	 	 	Citibank N.A., London
	 	 	SWIFT Code: ########
	 	 	IBAN Number: ######################
	 	 	Account Number: #######
	 	 	Account Name: Teachers Ins & Ann College Retirement
	 	 	Reference:  PPN: 031100 H*4/AMETEK, Inc.
	 	 	Maturity Date: November 23, 2031/Interest Rate: 2.70%/P&I Breakdown
	 	 
	 	 	All payments in Dollars on or in respect of the Series S Notes shall be made in immediately available funds on the due date by electronic funds transfer
to:
	 	 
	 	 	JPMorgan Chase Bank, N.A.
	 	 	ABA # #########
	 	 	Account Number: ##########
	 	 	Account Name: TIAA
	 	 	For Further Credit to the Account Number: ######
	 	 	Reference:  AMETEK, Inc.
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.	 	 
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	2.70% Series S Notes due November 23, 2031	 	031100 H*4
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.

 

  
 Schedule A-59 

 
					
	Purchaser Name	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	Address / Fax # / Email for notices related to payments	 	Teachers Insurance and Annuity Association of America
	 	730 Third Avenue
	 	 	New York, New York 10017
	 	 	Attention: Securities Accounting Division
	 	 	Phone: (212) 916-5504
	 	 	Email: jpiperato@tiaa.org or mwolfe@tiaa.org
	 	 
	 	 	With a copy to:
	 	 
	 	 	JPMorgan Chase Bank, N.A.
	 	 	P.O. Box 35308
	 	 	Newark, New Jersey 07101
	 	 
	 	 	And to:
	 	 
	 	 	Teachers Insurance and Annuity Association of America
	 	 	8500 Andrew Carnegie Boulevard
	 	 	Charlotte, North Carolina 28262
	 	 	Attention: Global Private Markets
	 	 	Telephone:                    	 	(704) 988-4349 (Ho Young Lee)
	 	 		 	(704) 988-1000 (General Number)
	 	 	Facsimile:	 	(704) 988-4916
	 	 	Email:	 	hlee@tiaa.org
	Address / Fax # / Email for all other notices	 	Teachers Insurance and Annuity Association of America
	 	8500 Andrew Carnegie Boulevard
	 	 	Charlotte, North Carolina 28262
	 	 	Attention: Global Private Markets
	 	 	Telephone:          (704) 988-4349 (Ho Young Lee)
	 	 	 (704) 988-1000 (General Number)

	 	 	Facsimile:            (704) 988-4916
	 	 	Email:                 
hlee@tiaa.org
	Instructions re Delivery of Note(s)	 	Teachers Insurance and Annuity Association of America
	 	 	730 Third Avenue
	 	 	New York, New York 10017
	 	 	Attention:  Timothy F. Hodgdon
	 	 	
  Asset Management Law, 12th Floor

	Signature Block Format	 	TEACHERS INSURANCE AND ANNUITY ASSOCIATION OF AMERICA
	 	 
	 	 	By:
                                         
                       
	 	 	Name:
	 	 	Title:
	Tax Identification Number	 	13-1624203

 

  
 Schedule A-60 

 
					
	Purchaser Name	 	THRIVENT FINANCIAL FOR LUTHERANS
	Name in Which to Register Note(s)	 	THRIVENT FINANCIAL FOR LUTHERANS
	Note Registration Number(s); Principal Amount(s)	 	RR-7; £25,000,000
	Payment on Account of Note(s)	 	 
	 	 
	 Method
	 	Federal Funds Wire Transfer
	 	 
	 Account Information
	 	State Street Bank and Trust Company, London Branch
	 	 	20 Churchill Place,
	 	 	Canary Wharf,
	 	 	London E14 5HJ
	 	 	United Kingdom
	 	 	BIC: SBOSGB2XXXX
	 	 	Account Name: SBOSUS3FXXX
	 	 	Cash Account: #########
	 	 	Chaps Sort Code: ######
	 	 	Reference Fund NCE1 – Thrivent Financial General Account
	 	 	Ref: “Accompanying Information” below
	Accompanying Information	 	Name of Issuer:    AMETEK, INC.	 	 
	 	 	 
	 	 	Description of Security:	 	PPN:
	 	 	2.59% Series R Notes due November 23, 2028	 	031100 G#1
	 	 
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices	 	Investment Division-Private Placements	 	 
	related to payments	 	Attn:  Chris Patton	 	 
	 	 	Thrivent Financial for Lutherans	 	 
	 	 	625 Fourth Avenue South	 	 
	 	 	Minneapolis, MN 55415	 	 
	 	 	Fax:  (612) 844-4027	 	 
	 	 	Email:  privateinvestments@thrivent.com	 	 
	 	 	 
	 	 	With a copy to:	 	 
	 	 	 
	 	 	Attn:  Jeremy Anderson or Harmon Bergenheir	 	 
	 	 	Thrivent Financial for Lutherans	 	 
	 	 	625 Fourth Avenue South	 	 
	 	 	Minneapolis, MN 55415	 	 
	 	 	Email: boxprivateplacement@thrivent.com	 	 
	Address / Fax # / Email for all other	 	Thrivent Financial for Lutherans	 	 
	notices	 	Attn:  Investment Division-Private Placements	 	 
	 	 	625 Fourth Avenue South	 	 
	 	 	Minneapolis, MN 55415	 	 
	 	 	Fax:  (612) 844-4027	 	 
	 	 	Email: privateinvestments@thrivent.com	 	 

 

  
 Schedule A-61 

 
							
	Purchaser Name	 	THRIVENT FINANCIAL FOR LUTHERANS
	Instructions re Delivery of Note(s)	 	DTCC
	 	 	Newport Office Center
	 	 	570 Washington Blvd
	 	 	Jersey City, NJ  07310
	 	 	Attn:  5th Floor / NY Window / Robert Mendez
	 	 	Ref:	 	State Street Account	 	 
	 	 		 	 Fund Name:  Thrivent Financial for Lutherans 

	 	 		 	 Fund Number:  NCE1
  
	 	 
	 	 	With a copy to:  lisa.corbin@thrivent.com
	Signature Block Format	 	 THRIVENT FINANCIAL FOR LUTHERANS

 

	 	 	By:
                                         
                       	 	 
	 	 	Name:  Christopher Patton	 	 
	 	 	Title:  Managing Director
	Tax Identification Number	 	39-0123480

 

  
 Schedule A-62 

 
							
	Purchaser Name	 	GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY
	Name in Which to Register Note(s)	 	GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY
	Note Registration Number(s); Principal Amount(s)	 	 RR-8; £15,000,000

 

	 Payment on Account of Note(s)

 
	 	 
	 Method
	 	 Federal Funds Wire Transfer

 

	 Account Information
	 	The Bank of New York Mellon
	 	 	Bank BIC:  IRVTBEBBXXX
	 	 	IBAN No.:  ################
	 	 	Account No.:    ##########
	 	 	Cash BIC:  ########
	 	 	Sort Code:  ######
	 	 	FBO:  Great-West Life & Annuity Insurance Company
	 	 	FFC:  ##########
	 	 	Reference:  “Accompanying Information” below
	Accompanying Information	 	 Name of Issuer:    AMETEK, INC.

 

	 	 	Description of Security:	 	PPN:
	 	 	 2.59% Series R Notes due November 23, 2028
  
	 	031100 G#1
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for all notices and communications	 	 Great-West Life & Annuity Insurance Company

8515 East Orchard Road, 3T2

	 	 	Greenwood Village, CO 80111
	 	 	Attn:  Investments Division
	 	 	Email:  bond_compliance@greatwest.com
	 	 	Fax:  (303) 737-6193
	Instructions re Delivery of Note(s)	 	The Depository Trust Company
	 	 	570 Washington Boulevard, 5th Floor
	 	 	Jersey City, NJ 07310
	 	 	Attn:  BNY Mellon/Branch Deposit Department
	 	 	Reference:  Great-West Life & Annuity Insurance Company/Acct No. 640935
	Signature Block Format	 	 GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY

 

	 	 	By:
                                         
                       	 	 
	 	 	Name:	 	 
	 	 	 Title:
  
	 	 
	 	 	By:
                                         
                       	 	 
	 	 	Name:	 	 
	 	 	Title:
	Tax Identification Number	 	84-0467907	 	 

 

  
 Schedule A-63 

 
							
	Purchaser Name	 	ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
	Name in Which to Register Note(s)	 	MAC & CO., LLC
	Note Registration Number(s); Principal Amount(s)	 	 RQ-13; €15,000,000

 

	 Payment on Account of Note(s)

 
	 	 
	 Method
	 	 Federal Funds Wire Transfer

 

	 Account Information
	 	Bank Name:  Deutsche Bank AG, Frankfurt Germany
	 	 	Swift Code:  DEUTDEFF
	 	 	Beneficiary Name:  Bank of NY Mellon Global Custody BSDTUS33GBL
	 	 	Beneficiary DDA:  ###########
	 	 	Wire Reference:  Account # ########## – Allianz Life Insurance
	 	 	Company of NA Further Credit to DDA ##########
	 	 	Re: “Accompanying Information” below
	 	 	For Credit to Portfolio Account:  AZL Special Investments ###########
	Accompanying Information	 	 Name of Issuer:    AMETEK, INC.

 

	 	 	Description of Security:	 	PPN:
	 	 	 1.53% Series Q Notes due October 31, 2028
  
	 	031100 G@3
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	 Allianz Life Insurance Company of North America

c/o Allianz Investment Management

	 	 	Attn: Private Placements
	 	 	55 Greens Farms Road
	 	 	Westport, Connecticut  06880
	 	 	Phone:   203-293-1900
	 	 	 Email:   ppt@allianzlife.com

 

	 	 	With a copy to:
	 	 	Kathy Muhl
	 	 	Supervisor – Income Group
	 	 	The Bank of New York Mellon
	 	 	Three Mellon Center – Room 153-1818
	 	 	Pittsburgh, Pennsylvania  15259
	 	 	Phone:   412-234-5192
	 	 	Email:   kathy.muhl@bnymellon.com
	Address / Fax # / Email for all other notices	 	 Allianz Life Insurance Company of North America

c/o Allianz Investment Management

	 	 	Attn:  Private Placements
	 	 	55 Greens Farms Road
	 	 	Westport, Connecticut 06880
	 	 	Phone:   203-293-1900
	 	 	Email:   ppt@allianzlife.com
	Instructions re Delivery of Note(s)	 	The Depository Trust Company
	 	 	570 Washington Blvd - 5th floor
	 	 	Jersey City, NJ 07310
	 	 	 Attn:  BNY Mellon / Branch Deposit Department

 

	 	 	For Credit to:  Allianz Life Insurance Company of North America, AZL Special Investments ###########

 

  
 Schedule A-64 

 
			
	Purchaser Name	 	ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
	Signature Block Format	 	ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
	 	 	 
	 	 	By:
                                         
                       
	 	 	Name:
	 	 	Title:
	Tax Identification Number	 	41-1366075

 

  
 Schedule A-65 

 
							
	Purchaser Name	 	UNUM LIMITED
	Name in Which to Register Note(s)	 	UNUM LIMITED
	Note Registration Number(s); Principal Amount(s)	 	 RS-8; £10,000,000

    

	 Payment on Account of Note(s)

    
	 	 
	 Method

    
	 	Federal Funds Wire Transfer
	 Account Information
	 	JPMorgan Chase Bank, N. A. London
	 	 	BIC:  CHASGB2L
	 	 	Further Credit Acct #####
	 	 	Sort Code: ######
	 	 	IBAN:  ######################
	 	 	F/O Account ########
	 	 	Re: (See “Accompanying Information” below)
	Accompanying Information	 	 Name of Issuer:   AMETEK, INC.

 

	 	 	Description of Security:	 	PPN:
	 	 	 2.70% Series S Notes due November 23, 2031

    
	 	031100 H*4
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	 Provident Investment Management, LLC

Private Placements

	 	 	1 Fountain Square
	 	 	Chattanooga, Tennessee 37402 USA	 	 
	 	 	Telephone:	 	(423) 294-1172	 	 
	 	 	Fax:	 	(423) 209-3781	 	 
	 	 	E-mail:	 	snbrown@unum.com and a copy to PrivateCompliance@unum.com	 	 
	Address / Fax # / Email for all other notices	 	 Provident Investment Management, LLC

Private Placements

	 	 	1 Fountain Square
	 	 	Chattanooga, Tennessee 37402 USA	 	 
	 	 	Telephone:	 	(423) 294-1172	 	 
	 	 	Fax:	 	(423) 209-3781	 	 
	 	 	E-mail:	 	snbrown@unum.com and a copy to PrivateCompliance@unum.com	 	 
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank, N.A.
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Physical Receive Dept.
	 	 	Brooklyn, NY 11245-0001
	 	 	Attention:  Brian Cavanaugh
	 	 	Telephone:  (718) 242-0264
	 	 	Account Name:	 	 Unum Limited [Policyholders]	 	 
	 	 	Account No.:	 	 #####	 	 
	Signature Block Format	 	UNUM LIMITED
	 	 	By:    Provident Investment Management, LLC
	 	 	
Its:     Agent

    

	 	 	By:
                                         
                       	 	 
	 	 	Name:  Ben Vance	 	 
	 	 	Title:  Vice President, Senior Managing Director
	Tax Identification Number	 	854 / 53530 / 04181 (Unum Limited)	 	 

 

  
 Schedule A-66 

 
							
	Purchaser Name	 	UNITED OF OMAHA LIFE INSURANCE COMPANY
	Name in Which to Register Note(s)	 	UNITED OF OMAHA LIFE INSURANCE COMPANY
	Note Registration Number(s); Principal Amount(s)	 	 RS-9; £6,000,000

    

	 Payment on Account of Note(s)

    
	 	 
	 Method
	 	 Federal Funds Wire Transfer

    

	 Account Information
	 	GBP:
	 	 	Favor:  JPMorgan Chase Bank NA London
	 	 	Account Number:  ######################
	 	 	Sort Code:  ######
	 	 	For further credit:  7786 United of Omaha Life Insurance Company
	 	 	Ref: “Accompanying Information” below
	Accompanying Information	 	 Name of Issuer:    AMETEK, INC.

    

	 	 	Description of Security:	 	PPN:
	 	 	 2.70% Series S Notes due November 23, 2031

    
	 	031100 H*4
	 	 	Due date and application (as among principal, interest and Make-Whole Amount) of the payment being made.
	Address / Fax # / Email for notices related to payments	 	 JPMorgan Chase Bank

4 Chase Metrotech Center

	 	 	Brooklyn, NY  11245-0001
	 	 	Attn:  Income Processing
	 	 	a/c:  ######
	Address / Fax # / Email for all other notices	 	 4 - Investment Management

United of Omaha Life Insurance Company

	 	 	Mutual of Omaha Plaza
	 	 	Omaha, NE  68175-1011
	Instructions re Delivery of Note(s)	 	JPMorgan Chase Bank
	 	 	4 Chase Metrotech Center, 3rd Floor
	 	 	Brooklyn, NY  11245-0001
	 	 	Attention:  Physical Receive Department
	 	 	Account ######
	Signature Block Format	 	 UNITED OF OMAHA LIFE INSURANCE COMPANY

 

	 	 	By:
                                         
               
	 	 	Name:	 	 
	 	 	Title:
	Tax Identification Number	 	47-0322111	 	 

 

  
 Schedule A-67 

 SCHEDULE B 

DEFINED TERMS 

As used herein, the following terms have the respective meanings set forth below or set forth in the Section hereof following
such term: 
 “Accountants’ Certificate” is defined in Section 7.1(b). 

“Affiliate” means, at any time, and with respect to any Person, any other Person that at such time directly
or indirectly through one or more intermediaries Controls, or is Controlled by, or is under common Control with, such first Person, and, with respect to the Company, shall include any Person beneficially owning or holding, directly or indirectly,
10% or more of any class of Voting Stock of the Company or any Subsidiary or any Person of which the Company and its Subsidiaries beneficially own or hold, in the aggregate, directly or indirectly, 10% or more of any class of Voting Stock. As
used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by
contract or otherwise. Unless the context otherwise clearly requires, any reference to an “Affiliate” is a reference to an Affiliate of the Company. 

“this Agreement” is defined in Section 17.3. 

“Anti-Corruption Laws” means any law or regulation in a U.S. or any non-U.S. jurisdiction regarding bribery
or any other corrupt activity, including the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act 2010. 

“Anti-Money Laundering Laws” means any law or regulation in a U.S. or any non-U.S. jurisdiction regarding
money laundering, drug trafficking, terrorist-related activities or other money laundering predicate crimes, including the Currency and Foreign Transactions Reporting Act of 1970 (otherwise known as the Bank Secrecy Act) and the USA PATRIOT Act.

 “Bank Credit Agreement” means the Credit Agreement, dated as of September 22, 2011, among the
Company, the Foreign Subsidiary Borrowers (as defined therein) from time to time party thereto, the lenders from time to time party thereto, Bank of America, N.A., PNC Bank National Association, SunTrust Bank and Wells Fargo Bank, National
Association, as Co-Syndication Agents and JPMorgan Chase Bank, N.A., as Administrative Agent, as amended and restated as of March 10, 2016, and as may be further supplemented, amended, restated, refinanced or replaced from time to time, and any
other credit agreement which may from time to time constitute the Company’s principal bank facility. 

“Blocked Person” means (a) a Person whose name appears on the list of Specially Designated Nationals and
Blocked Persons published by OFAC, (b) a Person, entity, organization, country or regime that is blocked or a target of sanctions that have been imposed under U.S. Economic Sanctions Laws or (c) a Person that is an agent, department or
instrumentality of, or is otherwise beneficially owned by, controlled by or acting on behalf of, directly or indirectly, any Person, entity, organization, country or regime described in clause (a) or (b). 

  
 Schedule B-1 

 “Business Day” means any day other than a Saturday, a Sunday or
a day on which commercial banks in New York City, London, England or Frankfurt, Germany are required or authorized to be closed. 

“Capital Lease” means, at any time, a lease which is accounted for as a capital lease in accordance with
GAAP. 
 “Change of Control” is defined in Section 8.7. 

“Change of Control Notice” is defined in Section 8.7. 

“Change of Control Prepayment Date” is defined in Section 8.7. 

“CISADA” means the United States Comprehensive Iran Sanctions, Accountability, and Divestment Act of 2010.

 “Closing” is defined in Section 3.2. 

“Closing Date” is defined in Section 3.2. 

“Code” means the Internal Revenue Code of 1986, as amended from time to time, and the rules and regulations
promulgated thereunder from time to time. 
 “Company” is defined in the introductory paragraph to this
Agreement. 
 “Confidential Information” is defined in Section 20. 

“Consolidated Debt” means, at any time, all Indebtedness of the Company and its Subsidiaries (excluding
intercompany items) determined on a consolidated basis in accordance with GAAP, including Indebtedness under securitization transactions. 

“Consolidated Tangible Assets” means, at any time, Consolidated Total Assets minus all amounts that would be
shown on a consolidated balance sheet of the Company prepared as of such date as goodwill or other intangible assets. 

“Consolidated Total Assets” means, at any time, all assets of the Company and its Subsidiaries as determined
on a consolidated basis in accordance with GAAP. 
 “Controlled Affiliate” means, at any time, and with
respect to any Person, any Affiliate of such Person that at such time is Controlled by such first Person. As used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

  
 Schedule B-2 

 “Controlled Entity” means (a) any of the Subsidiaries of the
Company and any of their or the Company’s respective Controlled Affiliates and (b) if the Company has a parent company, such parent company and its Controlled Affiliates.

“Debt Prepayment Transfer” is defined in Section 8.8. 

“Default” means an event or condition the occurrence or existence of which would, with the giving of notice
or the lapse of time, or both, become an Event of Default. 
 “Default Rate” means, with respect to any
Note, that rate per annum of interest that is the greater of (a) 2% per annum above the rate of interest stated in clause (a) of the first paragraph of such Note and (b) 2% above the rate of interest publicly announced by JPMorgan Chase Bank, N.A.
from time to time at its principal office in New York, New York as its “base rate” for loans denominated in Euros or Sterling, as applicable. 

“Disclosure Documents” is defined in Section 5.3. 

“Disposition” is defined in Section 10.3. 

“Dollar” or “$” means the lawful money of the United States. 

“Domestic Subsidiary” means any Subsidiary of the Company incorporated or organized in the United States or
any state or territory thereof. 
 “EBITDA” means, for any period, income before income taxes and
extraordinary or nonrecurring gains or losses and any other non-recurring income or other charges of the Company and its Subsidiaries plus to the extent deducted in calculating such income (a) Interest Expense, (b) depreciation and
amortization expense and (c) the amount of any increase in the Company’s LIFO reserve (exclusive of any portion thereof attributable to sales of assets) during such period (minus any decrease in the Company’s LIFO reserve (exclusive of any
portion thereof attributable to sales of assets) during such period), all as the same are or would be set forth in a consolidated statement of income of the Company and its Subsidiaries for such period in accordance with GAAP or if any such item is
not defined by GAAP, then as determined in the Company’s judgment. 
 “Electronic Delivery” is defined
in Section 7.1(a). 
 “EMU Legislation” means the legislative measures of the European Council for the
introduction of, changeover to and operation of a single or unified European currency (whether known as the Euro or otherwise). 

“Environmental Laws” means any and all federal, state, local, and foreign statutes, laws, regulations,
ordinances, rules, judgments, orders, decrees, permits, concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution and the protection of the environment or the release of any materials into the
environment, including but not limited to those related to Hazardous Material. 

  
 Schedule B-3 

 “ERISA” means the Employee Retirement Income Security Act of
1974, as amended from time to time, and the rules and regulations promulgated thereunder from time to time in effect. 

“ERISA Affiliate” means any trade or business (whether or not incorporated) that is treated as a single
employer together with the Company under section 414 of the Code. 
 “Euro” or “€”
means the single currency of Participating Member States of the European Union. 
 “Event of Default” is
defined in Section 11. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to
time, and the rules and regulations promulgated thereunder from time to time in effect.
 “First Closing”
is defined in Section 3.1. 
 “First Closing Date” is defined in Section 3.1. 

“First Closing Purchasers” is defined in Section 3.1. 

“Foreign Subsidiary” means any Subsidiary of the Company that is not a Domestic Subsidiary. 

“Form 10-K” is defined in Section 7.1(b). 

“Form 10-Q” is defined in Section 7.1(a). 

“GAAP” means generally accepted accounting principles as in effect from time to time in the United States of
America. 
 “Governmental Authority” means 

(a)        the government of 

(i)        the United States of America or any State or other political subdivision
thereof, or 
 (ii)       any jurisdiction in which the Company or any Subsidiary
conducts all or any part of its business, or which asserts jurisdiction over any properties of the Company or any Subsidiary, or 

(b)        any entity exercising executive, legislative, judicial, regulatory or
administrative functions of, or pertaining to, any such government. 
 “Governmental Official” means any
governmental official or employee, employee of any government-owned or government-controlled entity, political party, any official of a political party, candidate for political office, official of any public international organization or anyone else
acting in an official capacity. 

  
 Schedule B-4 

 “Guaranty” means, with respect to any Person, any obligation
(except the endorsement in the ordinary course of business of negotiable instruments for deposit or collection) of such Person guaranteeing or in effect guaranteeing any indebtedness, dividend or other obligation of any other Person in any manner,
whether directly or indirectly, including (without limitation) obligations incurred through an agreement, contingent or otherwise, by such Person: 

(a)        to purchase such indebtedness or obligation or any property constituting
security therefor; 
 (b)        to advance or supply funds (i) for the purchase or
payment of such indebtedness or obligation, or (ii) to maintain any working capital or other balance sheet condition or any income statement condition of any other Person or otherwise to advance or make available funds for the purchase or payment of
such indebtedness or obligation; 
 (c)        to lease properties or to purchase
properties or services primarily for the purpose of assuring the owner of such indebtedness or obligation of the ability of any other Person to make payment of the indebtedness or obligation; or 

(d)        otherwise to assure the owner of such indebtedness or obligation against
loss in respect thereof. 
 In any computation of the indebtedness or other liabilities of the obligor under any Guaranty,
the indebtedness or other obligations that are the subject of such Guaranty shall be assumed to be direct obligations of such obligor. 

“Hazardous Material” means any and all pollutants, toxic or hazardous wastes or any other substances that
might pose a hazard to health or safety, the removal of which may be required or the generation, manufacture, refining, production, processing, treatment, storage, handling, transportation, transfer, use, disposal, release, discharge, spillage,
seepage, or filtration of which is or shall be restricted, prohibited or penalized by any applicable law (including without limitation asbestos, urea formaldehyde foam insulation and polychlorinated biphenyls). 

“holder” means, with respect to any Note, the Person in whose name such Note is registered in the register
maintained by the Company pursuant to Section 13.1, provided, however, that if such Person is a nominee, then for the purposes of Sections 7, 12, 17.2 and 18 and any related definitions in this Schedule B, “holder” shall
mean the beneficial owner of such Note whose name and address appears in such register. 
 “Indebtedness”
means, as to any Person, at a particular time without duplication, 
 (a)        its
liabilities for borrowed money and its redemption obligations in respect of mandatorily redeemable Preferred Stock; 

(b)        its liabilities for the deferred purchase price of property acquired by
such Person (excluding trade payables and accrued expenses arising in the ordinary course of business but including all liabilities created or arising under any conditional sale or other title retention agreement with respect to any such property);

  
 Schedule B-5 

 (c)        all liabilities appearing on
its balance sheet in accordance with GAAP in respect of Capital Leases; 

(d)        all liabilities for borrowed money secured by any Lien with respect to any
property owned by such Person (whether or not it has assumed or otherwise become liable for such liabilities); 

(e)        all its reimbursement obligations in respect of letters of credit or
instruments serving a similar function issued or accepted for its account by banks and other financial institutions (whether or not representing obligations for borrowed money) solely to the extent drawn and limited to the drawn amounts; 

(f)        Swaps of such Person; 

(g)        all obligations in respect of securitization transactions entered into by
such Person, including any obligations in respect of any Permitted Receivables Securitization Program; and 

(h)        any Guaranty of such Person with respect to liabilities of a type described
in any of clauses (a) through (g) above. 
 Indebtedness of any Person shall include all obligations of such Person of the
character described in clauses (a) through (h) to the extent such Person remains legally liable in respect thereof notwithstanding that any such obligation is deemed to be extinguished under GAAP. 

“INHAM Exemption” is defined in Section 6.2(e). 

“Institutional Investor” means (a) any original purchaser of a Note, (b) any holder of a Note holding
(together with one or more of its Affiliates) more than 10% of the aggregate principal amount of the Notes then outstanding, (c) any bank, trust company, savings and loan association or other financial institution, any pension plan, any investment
company, any mutual fund, any insurance company, any broker or dealer, or any other similar financial institution or entity, regardless of legal form and (d) any Related Fund of any holder of any Note. 

“Interest Expense” means, for any period, total interest expense (including that attributable to Capital
Leases in accordance with GAAP) of the Company and its Subsidiaries with respect to all outstanding Indebtedness of the Company and its Subsidiaries, including without limitation all commissions, discounts and other fees and charges owed with
respect to letters of credit and bankers’ acceptance financing and net costs (i.e., costs minus benefits) under interest rate hedging agreements, but excluding amortization of deferred financing costs to the extent included in total
interest expense, in each case net of the total interest income (excluding non-cash interest income on investments issued with original issue discount) of the Company and its Subsidiaries for such period, all determined on a consolidated basis. 

“Lien” means, with respect to any Person, any mortgage, lien, pledge, charge, security interest or other
encumbrance, or any interest or title of any vendor, lessor, lender or other secured party to or of such Person under any conditional sale or other title retention agreement or Capital Lease, upon or with respect to any property or asset of such
Person (including in the case of stock, stockholder agreements, voting trust agreements and all similar arrangements). 

  
 Schedule B-6 

 “Majority Holders” means at any time (a) prior to the earlier of
(i) the Second Closing Date and (ii) the date all Purchasers have no further obligation to purchase Notes hereunder, a majority of (x) the Purchasers (by principal amount of their intended purchase hereunder) in respect of any Notes which have not
been issued at such time and (y) the holders of the unpaid principal amount of the Notes at the time outstanding exclusive of Notes then owned by the Company or any of its Affiliates and (b) on or after the Second Closing Date, the holders of a
majority of the unpaid principal amount of the Notes at the time outstanding exclusive of Notes then owned by the Company or any of its Affiliates. 

“Make-Whole Amount” is defined in Section 8.6. 

“Material” means material in relation to the business, operations, affairs, financial condition, assets or
properties of the Company and its Subsidiaries taken as a whole. 
 “Material Adverse Effect” means a
material adverse effect on (a) the business, operations, financial condition, assets or properties of the Company and its Subsidiaries taken as a whole, (b) the ability of the Company to perform its obligations under this Agreement and the Notes or
(c) the validity or enforceability of this Agreement or the Notes. 
 “Memorandum” is defined in Section
5.3. 
 “Multiemployer Plan” means any Plan that is a “multiemployer plan” (as such term is
defined in section 4001(a)(3) of ERISA). 
 “NAIC” means the National Association of Insurance
Commissioners or any successor thereto. 
 “NAIC Annual Statement” is defined in Section 6.2(a). 

“Net Gain” is defined in Section 8.6. 

“Notes” is defined in Section 1. 

“OFAC” means the Office of Foreign Assets Control of the United States Department of the Treasury. 

“OFAC Sanctions Program” means any economic or trade sanction that OFAC is responsible for administering and
enforcing. A list of OFAC Sanctions Programs may be found at
http://www.treasury.gov/resource-center/sanctions/Pages/default.aspx.

“Officer’s Certificate” means a certificate of a Senior Financial Officer or of any other officer of the
Company whose responsibilities extend to the subject matter of such certificate. 
 “Participating Member
States” means each state so described in any EMU Legislation. 

  
 Schedule B-7 

 “PBGC” means the Pension Benefit Guaranty Corporation referred
to and defined in ERISA or any successor thereto. 
 “Permitted Receivables Securitization Program” means a
receivables securitization program pursuant to which the Company or any Subsidiary sells or grants a security interest in its accounts receivable or an undivided interest therein, provided that the recourse of the purchaser or lender thereunder, as
the case may be, for losses resulting from an obligor’s failure to pay a receivable due to credit problems is limited to such accounts receivable or an interest therein, and the collections thereof (it being understood that recourse to the
Company and its Subsidiaries pursuant to provisions that are customary in an off-balance sheet accounts receivable transaction shall be permitted). 

“Person” or “person” means an individual, partnership, corporation, limited liability
company, joint venture, association, joint-stock company, trust, unincorporated organization, business entity or Governmental Authority. 

“Plan” means an “employee benefit plan” (as defined in section 3(3) of ERISA) that is or, within
the preceding five years, has been established or maintained, or to which contributions are or, within the preceding five years, have been made or required to be made, by the Company or any ERISA Affiliate or with respect to which the Company or any
ERISA Affiliate may have any liability. 
 “Preferred Stock” means any class of capital stock of a Person
that is preferred over any other class of capital stock (or similar equity interests) of such Person as to the payment of dividends or the payment of any amount upon liquidation or dissolution of such Person. 

“Priority Debt” means, at any time, the sum (without duplication) of (a) all Indebtedness of the Company and
its Subsidiaries secured by Liens other than the Liens described in clauses (a) through (i) of Section 10.2 and (b) all Indebtedness of Subsidiaries excluding (i) Indebtedness of any Subsidiary owing to the Company or a Wholly-Owned Subsidiary and
(ii) Indebtedness of any Subsidiary Obligor. 
 “property” or “properties” means, unless
otherwise specifically limited, real or personal property of any kind, tangible or intangible, inchoate or otherwise. 

“PTE” is defined in Section 6.2(a). 

“Purchasers” means each of the purchasers that has executed and delivered this Agreement to the Company and
such Purchaser’s successors and assigns (so long as any such assignment complies with Section 13.2), provided, however, that any Purchaser of a Note that ceases to be the registered holder or a beneficial owner (through a nominee)
of such Note as the result of a transfer thereof pursuant to Section 13.2 shall cease to be included within the meaning of “Purchaser” of such Note for purposes of this Agreement upon such transfer. 

“QPAM” is defined in Section 6.2(d). 

“QPAM Exemption” is defined in Section 6.2(d). 

  
 Schedule B-8 

 “Qualified Institutional Buyer” means any Person who is a
“qualified institutional buyer” within the meaning of such term as set forth in Rule 144A(a)(1) under the Securities Act. 

“Ratable Portion” means, in respect of any holder of any Note and any Disposition, an amount equal to the
product of 
 (a)        the net proceeds arising from such Disposition being
offered to be applied to the payment of the Notes pursuant to Section 10.3(d)(ii), multiplied by 

(b)        a fraction, the numerator of which is the outstanding principal amount of
such Note, and the denominator of which is the outstanding principal amount of all Notes. 
 “Related Fund”
means, with respect to any holder of any Note, any fund or entity that (a) invests in Securities or bank loans, and (b) is advised or managed by such holder, the same investment advisor as such holder or by an affiliate of such holder or such
investment advisor. 
 “Response Date” is defined in Section 8.7. 

“Responsible Officer” means any Senior Financial Officer and any other officer of the Company with
responsibility for the administration of the subject matter of the relevant portion of this Agreement. 

“SEC” means the Securities and Exchange Commission of the United States, or any successor thereto. 

“Second Closing” is defined in Section 3.2. 

“Second Closing Date” is defined in Section 3.2. 

“Second Closing Purchasers” is defined in Section 3.2. 

“Securities” or “Security” shall have the meaning specified in Section 2(a)(1) of the
Securities Act. 
 “Securities Act” means the Securities Act of 1933, as amended from time to time, and the
rules and regulations promulgated thereunder from time to time in effect. 
 “Senior Financial Officer”
means the chief financial officer, principal accounting officer, treasurer or comptroller of the Company. 
 “Series
P Notes” is defined in Section 1(a). 
 “Series P Purchaser” is defined in Section 3.1. 

“Series Q Notes” is defined in Section 1(b). 

“Series Q Purchaser” is defined in Section 3.1. 

“Series R Notes” is defined in Section 1(c). 

  
 Schedule B-9 

 “Series R Purchaser” is defined in Section 3.2. 

“Series S Notes” is defined in Section 1(d). 

“Series S Purchaser” is defined in Section 3.2. 

“Significant Subsidiary” means, at any time, each Subsidiary the total assets of which account for at least
10% of Consolidated Total Assets (determined as of the end of the Company’s then most recently ended fiscal quarter) and any two or more Subsidiaries the total assets of which, taken together, represent, on an aggregate basis, not less than 10%
of Consolidated Total Assets (determined as of the end of the Company’s then most recently ended fiscal quarter). 

“Source” is defined in Section 6.2. 

“State Sanctions List” means a list that is adopted by any state Governmental Authority within the United
States of America pertaining to Persons that engage in investment or other commercial activities in Iran or any other country that is a target of economic sanctions imposed under U.S. Economic Sanctions Laws. 

“Sterling” or “£” means the lawful currency of the United Kingdom. 

“Sterling Equivalent” is defined in Section 22.8. 

“Subsidiary” means, as to any Person, any corporation or other business entity a majority of the combined
voting power of all Voting Stock of which is owned by such Person or one or more of its Subsidiaries or such Person and one or more of its Subsidiaries. Unless the context otherwise clearly requires, any reference to a “Subsidiary” is
a reference to a Subsidiary of the Company. 
 “Subsidiary Obligor” means a Subsidiary that has guarantied
or otherwise become obligated in respect of the Notes in accordance with the terms of Section 10.1(c). 
 “Surviving
Person” is defined in Section 10.4(a). 
 “SVO” means the Securities Valuation Office of the NAIC
or any successor to such Office. 
 “Swap Reimbursement Amount” is defined in Section 8.6(c). 

“Swaps” means, with respect to any Person, payment obligations with respect to interest rate swaps, currency
swaps and similar obligations obligating such Person to make payments, whether periodically or upon the happening of a contingency. For the purposes of this Agreement, the amount of the obligation under any Swap shall be the amount determined
in respect thereof as of the end of the then most recently ended fiscal quarter of such Person, based on the assumption that such Swap had terminated at the end of such fiscal quarter, and in making such determination, if any agreement relating to
such Swap provides for the netting of amounts payable by and to such Person thereunder or if any such agreement provides for the simultaneous payment of amounts by and to such Person, then in each such case, the amount of such obligation shall be
the net amount so determined. 

  
 Schedule B-10 

 “Transfer Prepayment Date” is defined in Section 8.8. 

“Transfer Prepayment Offer” is defined in Section 8.8. 

“U.S. Economic Sanctions Laws” means those laws, executive orders, enabling legislation or regulations
administered and enforced by the United States pursuant to which economic sanctions have been imposed on any Person, entity, organization, country, or regime, including the Trading with the Enemy Act, the International Emergency Economic Powers Act,
the Iran Sanctions Act, the Sudan Accountability and Divestment Act and any other OFAC Sanctions Program. 
 “USA
PATRIOT Act” means United States Public Law 107-56, Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, as amended from time to time, and the rules and
regulations promulgated thereunder from time to time in effect. 
 “Voting Stock” means, with respect to
any Person, any shares of stock or other equity interests of any class or classes of such Person whose holders are entitled under ordinary circumstances (irrespective of whether at the time stock or other equity interests of any other class or
classes shall have or might have voting power by reason of the happening of any contingency) to vote for the election of a majority of the directors, managers, trustees or other governing body of such Person. 

“Wholly-Owned Subsidiary” means, at any time, any Subsidiary all of the equity interests (except
directors’ qualifying shares) and voting interests of which are owned by any one or more of the Company and the Company’s other Wholly-Owned Subsidiaries at such time. 

  
 Schedule B-11 

 SCHEDULE 4.9 

CHANGES IN CORPORATE STRUCTURE 

NONE 

  
 Schedule 4.9-1 

 SCHEDULE 5.4 

SUBSIDIARIES OF THE COMPANY, OWNERSHIP 

OF SUBSIDIARY STOCK, ETC. 

SUBSIDIARIES OF AMETEK, INC. 
  

							
	 Advanced Measurement Technology, Inc.
	  	Delaware	  	 	100	% 
	 Sunpower, Inc.
	  	Delaware	  	 	100	% 
	 AIP/MPM Funding, Inc.
	  	Delaware	  	 	100	% 
	 AIP/MPM Holdings, Inc.
	  	Delaware	  	 	100	% 
	 Micro-Poise Measurement Systems, LLC
	  	Delaware	  	 	100	% 
	 Akron Standard Bestry (Guangzhou) Measurement
	  		  			
	 Equipment Co., Ltd.
	  	China	  	 	50	% 
	 Micro-Poise Measurement Systems Europe GmbH
	  	Germany	  	 	100	% 
	 QM China Holding Inc.
	  	Delaware	  	 	100	% 
	 Micro-Poise Industrial Equipment (Beijing) Ltd.
	  	China	  	 	100	% 
	 AMETEK (Bermuda), Ltd.
	  	Bermuda	  	 	100	% 
	 AMETEK Canada, LLC
	  	Delaware	  	 	100	% 
	 AMETEK Canada 1 ULC
	  	Canada	  	 	100	% 
	 AMETEK Canada 2 ULC
	  	Canada	  	 	100	% 
	 AMETEK Creaform Financing, L.P.
	  	Delaware	  	 	99.90	% 
	 AMETEK Financing Canada Limited Partnership
	  	Canada	  	 	99.90	% 
	 AMETEK Creaform Inc.
	  	Canada	  	 	100	% 
	 AMETEK Canada 3 ULC
	  	Canada	  	 	100	% 
	 AMETEK Canada Limited Partnership
	  	Canada	  	 	99.90	% 
	 Creaform Inc.
	  	Canada	  	 	100	% 
	 Creaform Shanghai Ltd.
	  	China	  	 	100	% 
	 Creaform Japan K.K.
	  	Japan	  	 	100	% 
	 Creaform France S.A.S.
	  	France	  	 	100	% 
	 AMETEK Receivables Corp.
	  	Delaware	  	 	100	% 
	 AMETEK Thermal Systems, Inc.
	  	Delaware	  	 	100	% 
	 Chandler Instruments Company, L.L.C.
	  	Texas	  	 	100	% 
	 Grabner Instruments Messtechnik GmbH
	  	Austria	  	 	56	% 
	 Petrolab, L.L.C.
	  	Delaware	  	 	100	% 
	 CS Holdings Co., Inc.
	  	Delaware	  	 	100	% 
	 CS Intermediate Holdings Co., Inc.
	  	Delaware	  	 	100	% 
	 Controls Southeast, Inc.
	  	North Carolina	  	 	100	% 
	 EDAX, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK B.V.
	  	Netherlands	  	 	100	% 
	 EMA Corp.
	  	Delaware	  	 	100	% 
	 Amekai (BVI), Ltd.
	  	British Virgin Islands	  	 	50	% 
	 AMETEK Aerospace & Power Holdings, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK Advanced Industries, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK Aircraft Parts & Accessories, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK Ameron, LLC
	  	Delaware	  	 	100	% 
	 AMETEK HSA, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK MRO Florida, Inc.
	  	Delaware	  	 	100	% 
	 Drake Air, Inc.
	  	Oklahoma	  	 	100	% 
	 Elgar Holdings, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK Programmable Power, Inc.
	  	Delaware	  	 	100	% 
	 ESP Holdco, Inc.
	  	Delaware	  	 	100	% 
	 Electronic Systems Protection, Inc.
	  	Delaware	  	 	100	% 
	 Powervar, Inc.
	  	Illinois	  	 	100	% 
	 Powervar Canada Inc.
	  	Canada	  	 	100	% 

  
 Schedule 5.4-1 

							
	 Powervar Limited
	  	United Kingdom	  	 	100	% 
	 Powervar Deutschland GmbH
	  	Germany	  	 	100	% 
	 Powervar Mexico S.A. de C.V.
	  	Mexico	  	 	99.9	% 
	 Southern Aero Partners, Inc.
	  	Oklahoma	  	 	100	% 
	 AMETEK EMG Holdings, Inc.
	  	Delaware	  	 	100	% 
	 Avicenna Technology, Inc.
	  	Minnesota	  	 	100	% 
	 Coining, Inc.
	  	Delaware	  	 	100	% 
	 Dunkermotoren USA Inc.
	  	Delaware	  	 	100	% 
	 Hamilton Precision Metals, Inc.
	  	Delaware	  	 	100	% 
	 Hamilton Precision Metals of Delaware, Inc.
	  	Delaware	  	 	100	% 
	 HCC Industries, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK Ceramics, Inc.
	  	Delaware	  	 	100	% 
	 Glasseal Products, Inc.
	  	New Jersey	  	 	100	% 
	 Sealtron, Inc.
	  	Delaware	  	 	100	% 
	 HCC Aegis, Inc.
	  	Delaware	  	 	100	% 
	 HCC Industries International
	  	California	  	 	100	% 
	 HCC Machining Company, Inc.
	  	Delaware	  	 	100	% 
	 Hermetic Seal Corporation
	  	Delaware	  	 	100	% 
	 KBA Enterprises, Inc.
	  	Delaware	  	 	100	% 
	 Reading Alloys, Inc.
	  	Pennsylvania	  	 	100	% 
	 RAI Enterprises, Inc.
	  	Delaware	  	 	100	% 
	 SCPH Holdings, Inc.
	  	Delaware	  	 	100	% 
	 AMETEK SCP, Inc.
	  	Rhode Island	  	 	100	% 
	 AMETEK SCP (Barrow) Limited
	  	United Kingdom	  	 	100	% 
	 Technical Services for Electronics, Inc.
	  	Minnesota	  	 	100	% 
	 AMETEK Grundbesitz GmbH
	  	Germany	  	 	100	% 
	 AMETEK Haydon Kerk, Inc.
	  	Delaware	  	 	100	% 
	 Tritex Corporation
	  	Delaware	  	 	100	% 
	 Haydon Kerk Motion Solutions, Inc.
	  	Massachusetts	  	 	100	% 
	 AMETEK International C.V.
	  	Netherlands	  	 	89	% 
	 AMETEK Holdings B.V.
	  	Netherlands	  	 	100	% 
	 AMETEK Denmark A/S
	  	Denmark	  	 	100	% 
	 AMETEK European Holdings GmbH
	  	Germany	  	 	100	% 
	 AMETEK Italia S.r.l.
	  	Italy	  	 	100	% 
	 AMETEK Holdings de Mexico, S. de R.L.
	  	Mexico	  	 	50	% 
	 AMETEK Latin America Holding Company S.à r.l.
	  	Luxembourg	  	 	100	% 
	 AMETEK Mexico Holding Company, LLC
	  	Delaware	  	 	100	% 
	 AMETEK Lamb Motores de Mexico, S. de R.L. de C.V.
	  	Mexico	  	 	99.99	% 
	 AMETEK Do Brasil Ltda.
	  	Brazil	  	 	99	% 
	 AMETEK Europe L.L.C.
	  	Delaware	  	 	100	% 
	 AMETEK UK Limited Partnership
	  	United Kingdom	  	 	96.9	% 
	 AMETEK (Barbados) SRL
	  	Barbados	  	 	100	% 
	 AMETEK European Holdings Limited
	  	United Kingdom	  	 	100	% 
	 AMETEK Elektromotory, s.r.o
	  	Czech Republic	  	 	99.97	% 
	 AMETEK Singapore Private Ltd.
	  	Singapore	  	 	100	% 
	 Amekai Singapore Private Ltd.
	  	Singapore	  	 	50	% 
	 Amekai Meter (Xiamen) Co., Ltd.
	  	China	  	 	100	% 
	 Amekai Taiwan Co., Ltd.
	  	Taiwan	  	 	50	% 
	 AMETEK Commercial Enterprise Shanghai
	  	China	  	 	100	% 
	 AMETEK Engineered Materials Sdn. Bhd.
	  	Malaysia	  	 	100	% 
	 AMETEK Instruments India Private Ltd.
	  	India	  	 	100	% 
	 AMETEK Motors Asia Pte., Ltd.
	  	Singapore	  	 	100	% 
	 AMETEK Industrial Technology (Shanghai) Co., Ltd.
	  	China	  	 	100	% 

  
 Schedule 5.4-2 

									
	 Haydon Linear Motors (Changzhou) Co., Ltd.
	  	 	China	  	  	 	100	% 
	 AMETEK Global Tubes, LLC
	  	 	Delaware	  	  	 	100	% 
	 Tubes Holdco Limited
	  	 	United Kingdom	  	  	 	100	% 
	 Fine Tubes Limited
	  	 	United Kingdom	  	  	 	100	% 
	 Superior Tube Company, Inc.
	  	 	Pennsylvania	  	  	 	100	% 
	 EMA Holdings UK Limited
	  	 	United Kingdom	  	  	 	100	% 
	 AMETEK Aerospace & Defense Grp UK Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 AEM Limited
	  	 	United Kingdom	  	  	 	100	% 
	 AMETEK Airtechnology Group Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 Airtechnology Pension Trustees Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 Muirhead Aerospace Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 AMETEK Instruments Group UK Limited
	  	 	United Kingdom	  	  	 	100	% 
	 AMETEK (GB) Limited
	  	 	United Kingdom	  	  	 	100	% 
	 Atlas Material Testing Technology Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 Vision Research Limited
	  	 	United Kingdom	  	  	 	100	% 
	 AMETEK Precision Instruments (UK) Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 Taylor Hobson Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 Taylor Hobson Trustees Limited
	  	 	United Kingdom	  	  	 	100	% 
	 Solartron Metrology Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 AMETEK Kabushiki Kaisha
	  	 	Japan	  	  	 	100	% 
	 AMETEK Material Analysis Holdings GmbH
	  	 	Germany	  	  	 	100	% 
	 AMETEK Holdings SARL
	  	 	France	  	  	 	74	% 
	 Antavia SAS
	  	 	France	  	  	 	100	% 
	 CAMECA SAS
	  	 	France	  	  	 	100	% 
	 AMETEK GmbH
	  	 	Germany	  	  	 	35.9	% 
	 AMETEK Nordic AB
	  	 	Sweden	  	  	 	100	% 
	 Zygo Germany GmbH
	  	 	Germany	  	  	 	64.2	% 
	 AMETEK Germany GmbH
	  	 	Germany	  	  	 	100	% 
	 AMETEK Korea Co., Ltd.
	  	 	Korea	  	  	 	100	% 
	 CAMECA Instruments, Inc.
	  	 	New York	  	  	 	100	% 
	 Direl Holding GmbH
	  	 	Germany	  	  	 	100	% 
	 Direl GmbH
	  	 	Germany	  	  	 	100	% 
	 Dunkermotoren GmbH
	  	 	Germany	  	  	 	100	% 
	 Dunkermotoren Linear Systems Ltd.
	  	 	United Kingdom	  	  	 	100	% 
	 Dunkermotoren Subotica d.o.o.
	  	 	Serbia	  	  	 	100	% 
	 Dunkermotoren Taicang Co., Ltd.
	  	 	China	  	  	 	100	% 
	 RETE Holding GmbH
	  	 	Switzerland	  	  	 	100	% 
	 EM Test (Switzerland) GmbH
	  	 	Switzerland	  	  	 	100	% 
	 AMETEK CTS Germany GmbH
	  	 	Germany	  	  	 	100	% 
	 Teseq Holding AG
	  	 	Switzerland	  	  	 	100	% 
	 AMETEK CTS US, Inc.
	  	 	New York	  	  	 	100	% 
	 Frameflair Limited
	  	 	United Kingdom	  	  	 	100	% 
	 Milmega Limited
	  	 	United Kingdom	  	  	 	100	% 
	 Teseq AG
	  	 	Switzerland	  	  	 	100	% 
	 Teseq GmbH
	  	 	Germany	  	  	 	100	% 
	 Teseq Company Ltd.
	  	 	China	  	  	 	100	% 
	 Teseq Limited
	  	 	United Kingdom	  	  	 	100	% 
	 SPECTRO Analytical Instruments GmbH
	  	 	Germany	  	  	 	100	% 
	 OBCORP LLC
	  	 	Missouri	  	  	 	100	% 
	 OBCORP International LLC
	  	 	Missouri	  	  	 	100	% 
	 O’Brien BVBA
	  	 	Belgium	  	  	 	99.9	% 

  
 Schedule 5.4-3 

							
	 CARDINALUHP LLC
	  	Missouri	  	 	100	% 
	 Universal Analyzers Inc.
	  	Nevada	  	 	100	% 
	 Barben Analyzer Technology, LLC
	  	Nevada	  	 	100	% 
	 Rotron Incorporated
	  	New York	  	 	100	% 
	 AMETEK Technical & Industrial Products, Inc.
	  	Minnesota	  	 	51.9	% 
	 Seiko EG&G Co. Ltd.
	  	Japan	  	 	49	% 
	 Solidstate Controls, LLC
	  	Delaware	  	 	100	% 
	 HDR Power Systems, LLC
	  	Delaware	  	 	100	% 
	 Solidstate Controls, Inc. de Argentina S.R.L.
	  	Argentina	  	 	90	% 
	 Solidstate Controls Mexico, S.A. de C.V.
	  	Mexico	  	 	99.9	% 
	 Vision Research, Inc.
	  	Delaware	  	 	100	% 
	 Vision Research Europe B.V.
	  	Netherlands	  	 	100	% 
	 Vision Research Limited
	  	United Kingdom	  	 	100	% 
	 Vision Research srl
	  	Romania	  	 	100	% 

  
  

*    Exclusive of directors’ qualifying shares and shares held by nominees as
required by the laws of the jurisdiction of incorporation. 
 Schedule 5.4 – (ii) Affiliates 

None 

Schedule 5.4 – (iii) Directors and Senior Officers 
  

			
	Chief Executive Officer	 	-            David A. Zapico
	Executive Chairman	 	-            Frank S. Hermance
	Director	 	-            Ruby R. Chandy
	Director	 	-            Anthony J. Conti
	Director	 	-            Steven W. Kohlhagen
	Director	 	-            James R. Malone
	Director	 	-            Elizabeth R. Varet
	Director	 	-            Dennis K. Williams
	Director	 	-            Gretchen W. McClain
	Executive Vice President - Chief Financial Officer & Treasurer	 	-            William J. Burke
	Chief Administrative Officer	 	-            Ronald J. Oscher
	President - Electronic Instruments	 	-            John Wesley Hardin
	President - Electronic Instruments	 	-            Thomas C. Marecic
	President - Electromechanical Group	 	-            Timothy N. Jones
	Senior Vice President - Comptroller	 	-            Thomas M. Montgomery
	Senior Vice President - Corporate Development	 	-            William D. Eginton
	Senior Vice President & General Counsel	 	-            Robert S. Feit
	Senior Vice President - Human Resources	 	-            Gregory J. Kelble

  
 Schedule 5.4-4 

 SCHEDULE 5.5 

FINANCIAL STATEMENTS 
 The consolidated
financial statements of AMETEK, Inc. and its subsidiaries included in: 
 AMETEK, Inc. Form 10-K for the year ended December
31, 2015 
 AMETEK, Inc. Form 10-Q for the period ended March 31, 2016 

AMETEK, Inc. Form 10-Q for the period ended June 30, 2016 

  
 Schedule 5.5-1 

 SCHEDULE 5.8 

LITIGATION 

The Company is, from time to time, subject to a variety of litigation and similar proceedings incidental to its business.
These lawsuits may involve claims for damages arising out of the use of the Company’s products and services, personal injury, employment matters, tax matters, commercial disputes and intellectual property matters. The Company may also become
subject to lawsuits as a result of past or future acquisitions. Based upon the Company’s experience, the Company does not believe that these proceedings and claims will have a material adverse effect on its results of operations, financial
position or cash flows. 
 Asbestos Litigation 

The Company (including its subsidiaries) has been named as a defendant, along with many other companies, in a number of asbestos-related
lawsuits. Many of these lawsuits either relate to businesses which were acquired by the Company and do not involve products which were manufactured or sold by the Company or relate to previously owned businesses of the Company which are under new
ownership. In connection with many of these lawsuits, the sellers or new owners of such businesses, as the case may be, have agreed to indemnify the Company against these claims (the “Indemnified Claims”). The Indemnified Claims have been
tendered to, and are being defended by, such sellers and new owners. These sellers and new owners have met their obligations, in all respects, and the Company does not have any reason to believe such parties would fail to fulfill their obligations
in the future; however, one of these companies filed for bankruptcy liquidation in 2007. To date, no judgments have been rendered against the Company as a result of any asbestos-related lawsuit. The Company believes it has strong defenses to the
claims being asserted and intends to continue to vigorously defend itself in these matters. 
 Environmental Matters 

Certain historic processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal
and state laws and regulations. At June 30, 2016, the Company is named a Potentially Responsible Party (“PRP”) at 14 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned” sites). The Company is identified as
a “de minimis” party in 13 of these sites based on the low volume of waste attributed to the Company relative to the amounts attributed to other named PRPs. In nine of these sites, the Company has reached a tentative agreement on the cost
of the de minimis settlement to satisfy its obligation and is awaiting executed agreements. The tentatively agreed-to settlement amounts are fully reserved. In the other four sites, the Company is continuing to investigate the accuracy of the
alleged volume attributed to the Company as estimated by the parties primarily responsible for remedial activity at the sites to establish an appropriate settlement amount. At the remaining site where the Company is a non-de minimis PRP, the Company
is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been established sufficient to satisfy the Company’s expected obligations. The Company historically has resolved these issues
within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites, the 

  
 Schedule 5.8-1 

 
Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For
claims and proceedings against the Company with respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the
various stages of investigation, risk assessment, feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the low end of the range.
It is reasonably possible that the actual cost of remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to
result in a material change to the consolidated financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the
other PRPs to fulfill their obligations. 
 Total environmental reserves at June 30, 2016 and December 31, 2015 were $28.1 million and $30.5
million, respectively, for both non-owned and owned sites. For the six months ended June 30, 2016, the Company recorded $1.4 million in reserves. Additionally, the Company spent $3.4 million on environmental matters and had $0.4 million due to
foreign currency translation losses for the six months ended June 30, 2016. The Company’s reserves for environmental liabilities at June 30, 2016 and December 31, 2015 include reserves of $12.7 million and $11.5 million, respectively, for an
owned site acquired in connection with the 2005 acquisition of HCC Industries (“HCC”). The Company is the designated performing party for the performance of remedial activities for one of several operating units making up a Superfund site
in the San Gabriel Valley of California. The Company has obtained indemnifications and other financial assurances from the former owners of HCC related to the costs of the required remedial activities. At June 30, 2016, the Company had $11.8 million
in receivables related to HCC for probable recoveries from third-party escrow funds and other committed third-party funds to support the required remediation. Also, the Company is indemnified by HCC’s former owners for approximately $19 million
of additional costs. 
 The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of
previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of
these other parties also carry insurance coverage for some environmental matters. To date, these parties have met their obligations in all material respects. 

The Company believes it has established reserves which are sufficient to perform all known responsibilities under existing
claims and consent orders. The Company has no reason to believe that other third parties would fail to perform their obligations in the future. In the opinion of management, based upon presently available information and past experience related to
such matters, an adequate provision for probable costs has been made and the ultimate cost resulting from these actions is not expected to materially affect the consolidated results of operations, financial position or cash flows of the Company.

  
 Schedule 5.8-2 

 SCHEDULE 5.12 

COMPLIANCE WITH ERISA 

Retirement Plans and Other Postretirement Benefits 

Retirement and Pension Plans 
 The
Company sponsors several retirement and pension plans covering eligible salaried and hourly employees. The plans generally provide benefits based on participants’ years of service and/or compensation. The following is a brief description of the
Company’s retirement and pension plans. 
 The Company maintains contributory and noncontributory defined benefit pension plans.
Benefits for eligible salaried and hourly employees under all defined benefit plans are funded through trusts established in conjunction with the plans. The Company’s funding policy with respect to its defined benefit plans is to contribute
amounts that provide for benefits based on actuarial calculations and the applicable requirements of U.S. federal and local foreign laws. The Company estimates that it will make both required and discretionary cash contributions of approximately $4
million to $7 million to its worldwide defined benefit pension plans in 2016. 
 The Company uses a measurement date of December 31
(its fiscal year end) for its U.S. and foreign defined benefit pension plans. 
 The Company sponsors a 401(k) retirement and savings plan
for eligible U.S. employees. Participants in the retirement and savings plan may contribute a specified portion of their compensation on a pre-tax basis, which varies by location. The Company matches employee contributions ranging from 20% to 100%,
up to a maximum percentage ranging from 1% to 8% of eligible compensation or up to a maximum of $1,200 per participant in some locations. 

The Company’s retirement and savings plan has a defined contribution retirement feature principally to cover U.S. salaried employees
joining the Company after December 31, 1996. Under the retirement feature, the Company makes contributions for eligible employees based on a pre-established percentage of the covered employee’s salary subject to pre-established vesting.
Employees of certain of the Company’s foreign operations participate in various local defined contribution plans. 
 The Company has
nonqualified unfunded retirement plans for its Directors and certain retired employees. It also provides supplemental retirement benefits, through contractual arrangements and/or a SERP covering certain current and former executives of the Company.
These supplemental benefits are designed to compensate the executive for retirement benefits that would have been provided under the Company’s primary retirement plan, except for statutory limitations on compensation that must be taken into
account under those plans. The projected benefit obligations of the SERP and the contracts will primarily be funded by a grant of shares of the Company’s common stock upon retirement or termination of the executive. The Company is providing for
these obligations by charges to earnings over the applicable periods. 

  
 Schedule 5.12-1 

 The following tables set forth the changes in net projected benefit obligation and the fair value
of plan assets for the funded and unfunded defined benefit plans for the years ended December 31: 
 U.S. Defined Benefit Pension Plans: 

 

									
	 	  	2015	 	 	2014	 
	 	  	(In thousands)	 
	 Change in projected benefit obligation:
	  				 			
	 Net projected benefit obligation at the beginning of the year
	  	$	491,373	  	 	$	428,675	  
	 Service cost
	  	 	3,924	  	 	 	3,208	  
	 Interest cost
	  	 	20,761	  	 	 	21,000	  
	 Actuarial (gains) losses
	  	 	(27,605	) 	 	 	65,417	  
	 Gross benefits paid
	  	 	(27,930	) 	 	 	(26,927	) 
	 Acquisition
	  	 	11,954	  	 	 	—	  
		  	  
	  
	 	 	  
	  
	 
	 Net projected benefit obligation at the end of the year
	  	$	472,477	  	 	$	491,373	  
		  	  
	  
	 	 	  
	  
	 
			
	 Change in plan assets:
	  				 			
	 Fair value of plan assets at the beginning of the year
	  	$	498,923	  	 	$	518,388	  
	 Actual return on plan assets
	  	 	(21,020	) 	 	 	7,094	  
	 Employer contributions
	  	 	50,726	  	 	 	368	  
	 Gross benefits paid
	  	 	(27,930	) 	 	 	(26,927	) 
	 Acquisition
	  	 	8,076	  	 	 	—	  
		  	  
	  
	 	 	  
	  
	 
	 Fair value of plan assets at the end of the year
	  	$	508,775	  	 	$	498,923	  
		  	  
	  
	 	 	  
	  
	 
			
	 Foreign Defined Benefit Pension Plans:
  
	  				 			
	 	  	2015	 	 	2014	 
	 	  	(In thousands)	 
	 Change in projected benefit obligation:
	  				 			
	 Net projected benefit obligation at the beginning of the year
	  	$	197,671	  	 	$	185,178	  
	 Service cost
	  	 	3,076	  	 	 	2,945	  
	 Interest cost
	  	 	7,910	  	 	 	7,931	  
	 Foreign currency translation adjustment
	  	 	(14,337	) 	 	 	(15,961	) 
	 Employee contributions
	  	 	303	  	 	 	339	  
	 Actuarial (gains) losses
	  	 	(6,892	) 	 	 	23,903	  
	 Expenses paid from assets
	  	 	(610	) 	 	 	—	  
	 Gross benefits paid
	  	 	(8,064	) 	 	 	(6,664	) 
	 Acquisition
	  	 	64,867	  	 	 	—	  
		  	  
	  
	 	 	  
	  
	 
	 Net projected benefit obligation at the end of the year
	  	$	243,924	  	 	$	197,671	  
		  	  
	  
	 	 	  
	  
	 
			
	 Change in plan assets:
	  				 			
	 Fair value of plan assets at the beginning of the year
	  	$	159,907	  	 	$	165,420	  
	 Actual return on plan assets
	  	 	7,471	  	 	 	6,628	  
	 Employer contributions
	  	 	4,490	  	 	 	5,361	  
	 Employee contributions
	  	 	303	  	 	 	339	  
	 Foreign currency translation adjustment
	  	 	(10,584	) 	 	 	(11,177	) 
	 Expenses paid from assets
	  	 	(610	) 	 	 	—	  
	 Gross benefits paid
	  	 	(8,064	) 	 	 	(6,664	) 
	 Acquisition
	  	 	60,383	  	 	 	—	  
		  	  
	  
	 	 	  
	  
	 
	 Fair value of plan assets at the end of the year
	  	$	  213,296	  	 	$	  159,907	  
		  	  
	  
	 	 	  
	  
	 

  
 Schedule 5.12-2 

 The accumulated benefit obligation consisted of the following at December 31: 

U.S. Defined Benefit Pension Plans: 
  

									
	 	  	2015	 	  	2014	 
	 	  	(In thousands)	 
	 Funded plans
	  	$	454,498	  	  	$	471,960	  
	 Unfunded plans
	  	 	5,481	  	  	 	5,915	  
		  	  
	  
	 	  	  
	  
	 
	 Total
	  	$	  459,979	  	  	$	  477,875	  
		  	  
	  
	 	  	  
	  
	 
	  
 Foreign Defined Benefit Pension Plans:

 
	  				  			
	 	  	2015	 	  	2014	 
	 	  	(In thousands)	 
	 Funded plans
	  	$	203,229	  	  	$	154,200	  
	 Unfunded plans
	  	 	30,327	  	  	 	32,845	  
		  	  
	  
	 	  	  
	  
	 
	 Total
	  	$	  233,556	  	  	$	  187,045	  
		  	  
	  
	 	  	  
	  
	 

 Weighted average assumptions used to determine benefit obligations at December 31: 

 

									
	 	  	  2015  	 	 	  2014  	 
	 U.S. Defined Benefit Pension Plans:
	  				 			
	 Discount rate
	  	 	4.80	% 	 	 	4.20	% 
	 Rate of compensation increase (where applicable)
	  	 	3.75	% 	 	 	3.75	% 
			
	 Foreign Defined Benefit Pension Plans:
	  				 			
	 Discount rate
	  	 	3.62	% 	 	 	3.44	% 
	 Rate of compensation increase (where applicable)
	  	 	2.88	% 	 	 	2.88	% 

 The following is a summary of the fair value of plan assets for U.S. plans at December 31, 2015 and 2014. 

 

																									
	 	  	December 31, 2015	 	  	December 31, 2014	 
	 Asset Class
	  	Total	 	  	Level 1	 	  	Level 2	 	  	Total	 	  	Level 1	 	  	Level 2	 
	 	  	(In thousands)	 
	 Cash and temporary investments
	  	$	3,542	  	  	$	—	  	  	$	3,542	  	  	$	2,413	  	  	$	—	  	  	$	2,413	  
	 Equity securities:
	  				  				  				  				  				  			
	 AMETEK common stock
	  	 	27,515	  	  	 	27,515	  	  	 	—	  	  	 	26,979	  	  	 	26,979	  	  	 	—	  
	 U.S. Small cap common stocks
	  	 	31,780	  	  	 	31,780	  	  	 	—	  	  	 	31,629	  	  	 	31,629	  	  	 	—	  
	 U.S. Large cap common stocks
	  	 	101,709	  	  	 	61,331	  	  	 	40,378	  	  	 	105,288	  	  	 	67,484	  	  	 	37,804	  
	 Diversified common stocks – Global
	  	 	91,590	  	  	 	—	  	  	 	91,590	  	  	 	93,558	  	  	 	—	  	  	 	93,558	  
	 Fixed-income securities and other:
	  				  				  				  				  				  			
	 U.S. Corporate
	  	 	23,470	  	  	 	8,660	  	  	 	14,810	  	  	 	24,162	  	  	 	7,290	  	  	 	16,872	  
	 U.S. Government
	  	 	7,327	  	  	 	5,308	  	  	 	2,019	  	  	 	4,917	  	  	 	3,840	  	  	 	1,077	  
	 Global asset allocation(1)
	  	 	221,842	  	  	 	170,495	  	  	 	51,347	  	  	 	187,202	  	  	 	111,860	  	  	 	75,342	  
	 Inflation related funds
	  	 	—	  	  	 	—	  	  	 	—	  	  	 	13,729	  	  	 	—	  	  	 	13,729	  
	 Alternative investments:
	  				  				  				  				  				  			
	 Inflation related pooled investment fund
	  	 	—	  	  	 	—	  	  	 	—	  	  	 	9,046	  	  	 	—	  	  	 	—	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total investments
	  	$	508,775	  	  	$	  305,089	  	  	$	  203,686	  	  	$	  498,923	  	  	$	 249,082	  	  	$	  240,795	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

  
  

(1)  This asset class was invested in diversified companies in all geographical regions. 

U.S. equity securities and global equity securities categorized as level 1 are traded on national and international exchanges and are valued
at their closing prices on the last trading day of the year. For U.S. equity securities and global equity securities not traded on an active exchange, or if the closing price is not available, the trustee obtains indicative quotes from a pricing
vendor, broker or investment manager. These securities are categorized as level 2 if the custodian obtains corroborated quotes from a pricing vendor. 

  
 Schedule 5.12-3 

 Additionally, some U.S. equity securities and global equity securities are public investment
vehicles valued using the Net Asset Value (“NAV”) provided by the fund manager. The NAV is the total value of the fund divided by the number of shares outstanding. U.S. equity securities and global equity securities are categorized as
level 1 if traded at their NAV on a nationally recognized securities exchange or categorized as level 2 if the NAV is corroborated by observable market data. 

Fixed income securities categorized as level 1 are traded on national and international exchanges and are valued at their closing prices on
the last trading day of the year and categorized as level 2 if valued by the trustee using pricing models that use verifiable observable market data, bids provided by brokers or dealers or quoted prices of securities with similar characteristics.

 Alternative investments categorized as level 3 are valued based on unobservable inputs and cannot be corroborated using verifiable
observable market data. Investments in level 3 funds are redeemable, however, cash reimbursement may be delayed or a portion held back until asset finalization. 

The following is a summary of the changes in the fair value of the U.S. plans’ level 3 investments (fair value using significant
unobservable inputs): 
  

					
	 	  	Alternative	 
	 	  	 Investments 	 
	 	  	(In	 
	 	  	thousands)	 
	 Balance, December 31, 2013
	  	$	12,163	  
	 Actual return on assets:
	  			
	 Unrealized losses relating to instruments still held at the end of the year
	  	 	(3,117	) 
	 Realized gains (losses) relating to assets sold during the year
	  	 	—	  
	 Purchases, sales, issuances and settlements, net
	  	 	—	  
		  	  
	  
	 
	 Balance, December 31, 2014
	  	 	9,046	  
		  	  
	  
	 
	 Actual return on assets:
	  			
	 Unrealized (losses) relating to instruments still held at the end of the year
	  	 	(600	) 
	 Realized gains (losses) relating to assets sold during the year
	  	 	—	  
	 Purchases, sales, issuances and settlements, net
	  	 	(8,446 	) 
		  	  
	  
	 
	 Balance, December 31, 2015
	  	$	  —	  
		  	  
	  
	 

 The expected long-term rate of return on these plan assets was 7.75% in 2015 and 7.75% in 2014. Equity
securities included 512,565 shares of AMETEK, Inc. common stock with a market value of $27.5 million (5.4% of total plan investment assets) at December 31, 2015 and 512,565 shares of AMETEK, Inc. common stock with a market value of $27.0 million
(5.4% of total plan investment assets) at December 31, 2014. 
 The objectives of the AMETEK, Inc. U.S. defined benefit plans’
investment strategy are to maximize the plans’ funded status and minimize Company contributions and plan expense. Because the goal is to optimize returns over the long term, an investment policy that favors equity holdings has been established.
Since there may be periods of time where both equity and fixed-income markets provide poor returns, an allocation to alternative assets may be made to improve the overall portfolio’s diversification and return potential. The Company
periodically reviews its asset allocation, taking into consideration plan liabilities, plan benefit payment streams and the investment strategy of the pension plans. The actual asset allocation is monitored frequently relative to the established
targets and ranges and is rebalanced when necessary. The target allocations for the U.S. defined benefits plans are approximately 50% equity securities, 20% fixed-income securities and 30% other securities and/or cash. 

  
 Schedule 5.12-4 

 The equity portfolio is diversified by market capitalization and style. The equity portfolio also
includes international components. 
 The objective of the fixed-income portion of the pension assets is to provide interest rate
sensitivity for a portion of the assets and to provide diversification. The fixed-income portfolio is diversified within certain quality and maturity guidelines in an attempt to minimize the adverse effects of interest rate fluctuations. 

Other than for investments in alternative assets, certain investments are prohibited. Prohibited investments include venture capital, private
placements, unregistered or restricted stock, margin trading, commodities, short selling and rights and warrants. Foreign currency futures, options and forward contracts may be used to manage foreign currency exposure. 

The following is a summary of the fair value of plan assets for foreign defined benefit pension plans at December 31, 2015 and 2014. 

 

																	
	 	  	December 31, 2015	 	  	December 31, 2014	 
	 Asset Class
	  	Total	 	  	Level 2	 	  	Total	 	  	Level 2	 
	 	  	(In thousands)	 
	 Cash
	  	$	5,270	  	  	$	5,270	  	  	$	5,153	  	  	$	5,153	  
	 U.S. Mutual equity funds
	  	 	8,927	  	  	 	8,927	  	  	 	15,400	  	  	 	15,400	  
	 Foreign mutual equity funds
	  	 	36,463	  	  	 	36,463	  	  	 	94,444	  	  	 	94,444	  
	 Global mixed asset funds
	  	 	96,284	  	  	 	96,284	  	  	 	—	  	  	 	—	  
	 Real estate
	  	 	7,266	  	  	 	7,266	  	  	 	4,032	  	  	 	4,032	  
	 Mutual bond funds – Global
	  	 	38,600	  	  	 	38,600	  	  	 	31,990	  	  	 	31,990	  
	 Life insurance
	  	 	20,486	  	  	 	—	  	  	 	8,888	  	  	 	—	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total investments
	  	$	  213,296	  	  	$	  192,810	  	  	$	  159,907	  	  	$	  151,019	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

 Equity funds, real estate funds and fixed income funds that are valued by the vendor using observable market
inputs are considered level 2 investments. Life insurance assets are considered level 3 investments as their values are determined by the sponsor using unobservable market data. 

The following is a summary of the changes in the fair value of the foreign plans’ level 3 investments (fair value determined using
significant unobservable inputs): 
  

					
	 	  	Life Insurance	 
	 	  	(In thousands)	 
	 Balance, December 31, 2013
	  	$	13,971	  
	 Actual return on assets:
	  			
	 Unrealized (losses) relating to instruments still held at the end of the year
	  	 	(5,083	) 
	 Realized gains (losses) relating to assets sold during the year
	  	 	—	  
	 Purchases, sales, issuances and settlements, net
	  	 	—	  
		  	  
	  
	 
	 Balance, December 31, 2014
	  	 	8,888	  
		  	  
	  
	 
	 Actual return on assets:
	  			
	 Unrealized (losses) relating to instruments still held at the end of the year
	  	 	(980	) 
	 Realized gains (losses) relating to assets sold during the year
	  	 	—	  
	 Purchases, sales, issuances and settlements, net
	  	 	12,578	  
		  	  
	  
	 
	 Balance, December 31, 2015
	  	$	      20,486	  
		  	  
	  
	 

  
 Schedule 5.12-5 

 The objective of AMETEK, Inc.’s foreign defined benefit plans’ investment strategy is
to maximize the long-term rate of return on plan investments, subject to a reasonable level of risk. Liability studies are also performed on a regular basis to provide guidance in setting investment goals with an objective to balance risks against
the current and future needs of the plans. The trustees consider the risk associated with the different asset classes, relative to the plans’ liabilities and how this can be affected by diversification, and the relative returns available on
equities, fixed-income investments, real estate and cash. Also, the likely volatility of those returns and the cash flow requirements of the plans are considered. It is expected that equities will outperform fixed-income investments over the long
term. However, the trustees recognize the fact that fixed-income investments may better match the liabilities for pensioners. Because of the relatively young active employee group covered by the plans and the immature nature of the plans, the
trustees have chosen to adopt an asset allocation strategy more heavily weighted toward equity investments. This asset allocation strategy will be reviewed, from time to time, in view of changes in market conditions and in the plans’ liability
profile. The target allocations for the foreign defined benefit plans are approximately 70% equity securities, 15% fixed-income securities and 15% other securities, insurance or cash. 

The assumption for the expected return on plan assets was developed based on a review of historical investment returns for the investment
categories for the defined benefit pension assets. This review also considered current capital market conditions and projected future investment returns. The estimates of future capital market returns by asset class are lower than the actual
long-term historical returns. The current low interest rate environment influences this outlook. Therefore, the assumed rate of return for U.S. plans is 7.75% and 6.95% for foreign plans in 2016. 

The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with a projected benefit
obligation in excess of plan assets and pension plans with an accumulated benefit obligation in excess of plan assets were as follows at December 31: 

U.S. Defined Benefit Pension Plans: 
  

																	
	 	  	Projected Benefit
Obligation Exceeds
Fair Value of Assets	 	  	Accumulated Benefit
Obligation Exceeds
Fair Value of Assets	 
	 	  	2015	 	  	2014	 	  	2015	 	  	2014	 
	 	  	(In thousands)	 
	 Benefit obligation
	  	$	  5,481	  	  	$	  25,790	  	  	$	  5,481	  	  	$	  25,790	  
	 Fair value of plan assets
	  	 	—	  	  	 	17,182	  	  	 	—	  	  	 	17,182	  
	  
 Foreign Defined Benefit Pension Plans:

 
	  				  				  				  			
	 	  	Projected Benefit
Obligation Exceeds
Fair Value of Assets	 	  	Accumulated Benefit
Obligation Exceeds
Fair Value of Assets	 
	 	  	2015	 	  	2014	 	  	2015	 	  	2014	 
	 	  	(In thousands)	 
	 Benefit obligation
	  	$	  161,711	  	  	$	  111,095	  	  	$	  155,169	  	  	$	  104,196	  
	 Fair value of plan assets
	  	 	119,045	  	  	 	63,496	  	  	 	119,045	  	  	 	63,496	  

  
 Schedule 5.12-6 

 The following table provides the amounts recognized in the consolidated balance sheet at December
31: 
  

									
	 	  	2015	 	 	2014	 
	 	  	(In thousands)	 
	 Funded status asset (liability):
	  				 			
	 Fair value of plan assets
	  	$	722,071	  	 	$	  658,830	  
	 Projected benefit obligation
	  	 	(716,401	) 	 	 	(689,044	) 
		  	  
	  
	 	 	  
	  
	 
	 Funded status at the end of the year
	  	$	5,670	  	 	$	(30,214	) 
		  	  
	  
	 	 	  
	  
	 
			
	 Amounts recognized in the consolidated balance sheet consisted of:
	  				 			
	 Noncurrent asset for pension benefits (other assets)
	  	$	53,817	  	 	$	25,993	  
	 Current liabilities for pension benefits
	  	 	(1,001	) 	 	 	(1,139	) 
	 Noncurrent liability for pension benefits
	  	 	(47,146	) 	 	 	(55,068	) 
		  	  
	  
	 	 	  
	  
	 
	 Net amount recognized at the end of the year
	  	$	5,670	  	 	$	(30,214	) 
		  	  
	  
	 	 	  
	  
	 

 The following table provides the amounts recognized in accumulated other comprehensive income, net of taxes,
at December 31: 
  

									
	 Net amounts recognized:
	  	2015	 	 	2014	 
	 	  	(In thousands)	 
	 Net actuarial loss
	  	$	  156,351	  	 	$	  143,380	  
	 Prior service costs
	  	 	(1,321	) 	 	 	(1,407	) 
	 Transition asset
	  	 	8	  	 	 	9	  
		  	  
	  
	 	 	  
	  
	 
	 Total recognized
	  	$	155,038	  	 	$	141,982	  
		  	  
	  
	 	 	  
	  
	 

 The following table provides the components of net periodic pension benefit expense (income) for the years
ended December 31: 
  

													
	 	  	2015	 	 	2014	 	 	2013	 
	 	  	(In thousands)	 
	 Defined benefit plans:
	  				 				 			
	 Service cost
	  	$	7,000	  	 	$	6,153	  	 	$	6,323	  
	 Interest cost
	  	 	28,670	  	 	 	28,931	  	 	 	26,000	  
	 Expected return on plan assets
	  	 	(54,819	) 	 	 	(50,196	) 	 	 	(45,008	) 
	 Amortization of:
	  				 				 			
	 Net actuarial loss
	  	 	9,383	  	 	 	4,483	  	 	 	13,484	  
	 Prior service costs
	  	 	(55	) 	 	 	(51	) 	 	 	(35	) 
	 Transition asset
	  	 	1	  	 	 	1	  	 	 	(1	) 
		  	  
	  
	 	 	  
	  
	 	 	  
	  
	 
	 Total net periodic benefit (income) expense
	  	 	(9,820	) 	 	 	(10,679	) 	 	 	763	  
		  	  
	  
	 	 	  
	  
	 	 	  
	  
	 
	 Other plans:
	  				 				 			
	 Defined contribution plans
	  	 	22,750	  	 	 	20,714	  	 	 	18,195	  
	 Foreign plans and other
	  	 	4,800	  	 	 	5,325	  	 	 	5,151	  
		  	  
	  
	 	 	  
	  
	 	 	  
	  
	 
	 Total other plans
	  	 	27,550	  	 	 	26,039	  	 	 	23,346	  
		  	  
	  
	 	 	  
	  
	 	 	  
	  
	 
	 Total net pension expense
	  	$	17,730	  	 	$	15,360	  	 	$	24,109	  
		  	  
	  
	 	 	  
	  
	 	 	  
	  
	 

 The total net periodic benefit expense (income) is included in Cost of sales, excluding depreciation in the
consolidated statement of income. The estimated amount that will be amortized from accumulated other comprehensive income into net periodic pension benefit expense in 2016 for the net actuarial losses and prior service costs is expected to be $9.9
million. 

  
 Schedule 5.12-7 

 The following weighted average assumptions were used to determine the above net periodic pension
benefit expense for the years ended December 31: 
  

													
	 	  	 2015 	 	 	 2014 	 	 	 2013 	 
	 U.S. Defined Benefit Pension Plans:
	  				 				 			
	 Discount rate
	  	 	4.20	% 	 	 	5.00	% 	 	 	4.10	% 
	 Expected return on plan assets
	  	 	7.75	% 	 	 	7.75	% 	 	 	7.75	% 
	 Rate of compensation increase (where applicable)
	  	 	3.75	% 	 	 	3.75	% 	 	 	3.75	% 
				
	 Foreign Defined Benefit Pension Plans:
	  				 				 			
	 Discount rate
	  	 	3.44	% 	 	 	4.38	% 	 	 	4.44	% 
	 Expected return on plan assets
	  	 	6.92	% 	 	 	6.93	% 	 	 	6.91	% 
	 Rate of compensation increase (where applicable)
	  	 	2.88	% 	 	 	2.92	% 	 	 	2.89	% 

 Estimated Future Benefit Payments 

The estimated future benefit payments for U.S. and foreign plans are as follows: 2016 - $36.4 million; 2017 - $37.9 million; 2018 - $39.2
million; 2019 - $40.2 million; 2020 - $40.9 million; 2021 to 2025 - $224.9 million. Future benefit payments primarily represent amounts to be paid from pension trust assets. Amounts included that are to be paid from the Company’s assets are not
significant in any individual year. 
 Postretirement Plans and Postemployment Benefits 

The Company provides limited postretirement benefits other than pensions for certain retirees and a small number of former employees. Benefits
under these arrangements are not funded and are not significant. 
 The Company also provides limited postemployment benefits for certain
former or inactive employees after employment but before retirement. Those benefits are not significant in amount. 
 The Company has a
deferred compensation plan, which allows employees whose compensation exceeds the statutory IRS limit for retirement benefits to defer a portion of earned bonus compensation. The plan permits deferred amounts to be deemed invested in either, or a
combination of, (a) an interest-bearing account, benefits from which are payable out of the general assets of the Company, or (b) the equivalent of a fund which invests in shares of the Company’s common stock on behalf of the employee. The
amount deferred under the plan, including income earned, was $23.4 million and $21.2 million at December 31, 2015 and 2014, respectively. Administrative expense for the deferred compensation plan is borne by the Company and is not significant. 

  
 Schedule 5.12-8 

 SCHEDULE 5.15 

EXISTING INDEBTEDNESS; FUTURE LIENS, ETC. 

AMETEK, Inc. 
  

													
	 	 	  	 	  	Aggregate Principal	 	 	 	 	  	 
	 	 	  	 	  	Amount as of	 	 	 	 	  	 
	 	 	  	Obligor	  	June 30, 2016	 	    (1)    	 	Description	  	Guarantor
						
	 	1.	  	  	 AMETEK, Inc.
	  	270,000,000	 		 	 6.20% Senior Notes due December 2017
	  	
	 	2.	  	  	 AMETEK, Inc.
	  	80,000,000	 		 	 6.35% Senior Notes due July 2018
	  	
	 	3.	  	  	 AMETEK, Inc.
	  	160,000,000	 		 	 7.08% Senior Notes due September 2018
	  	
	 	4.	  	  	 AMETEK, Inc.
	  	65,000,000	 		 	 7.18% Senior Notes due December 2018
	  	
	 	5.	  	  	 AMETEK, Inc.
	  	100,000,000	 		 	 6.30% Senior Notes due December 2019
	  	
	 	6.	  	  	 AMETEK, Inc.
	  	300,000,000	 		 	 3.73% Senior Notes due September 2024
	  	
	 	7.	  	  	 AMETEK, Inc.
	  	50,000,000	 		 	 3.91% Senior Notes due June 2025
	  	
	 	8.	  	  	 AMETEK, Inc.
	  	100,000,000	 		 	 3.96% Senior Notes due August 2025
	  	
	 	9.	  	  	 AMETEK, Inc.
	  	100,000,000	 		 	 3.83% Senior Notes due September 2026
	  	
	 	10.	  	  	 AMETEK, Inc.
	  	100,000,000	 		 	 3.98% Senior Notes due September 2029
	  	
	 	11.	  	  	 AMETEK, Inc.
	  	50,000,000	 		 	 4.45% Senior Notes due August 2035
	  	
	 	12.	  	  	 AMETEK, Inc.
	  	106,029,000	 		 	 4.68% 80 million British pound Senior Note
	  	
	 	13.	  	  	 AMETEK, Inc.
	  	53,015,000	 		 	 5.993% 40 million British pound Senior Note
	  	
	 	14.	  	  	 AMETEK, Inc.
	  	545,100,000	 		 	 Revolving credit loans
	  	
	 	15.	  	  	 AMETEK, Inc.
	  	56,289,000	 		 	 2.44% 55 million Swiss Franc Senior Note
	  	
	 	16.	  	  	 Cameca SAS
	  	9,189,000	 		 	 Capital Lease
	  	
	 	17.	  	  	 AMETEK do Brasil Ltda.
	  	952,000	 		 	 Short-Term
	  	 AMETEK, Inc.

	 	18.	  	  	 AMETEK Co. LTD
	  	1,460,000	 		 	 Short-Term
	  	 AMETEK, Inc.

				  	 LESS: Prepaid deferred financing costs
	  	(4,882,000)	 		 		  	
				  	  Total	  	$2,142,152,000	 		 		  	

 (1)      Foreign indebtedness includes foreign exchange adjustments. 

  
 Schedule 5.15-1 

 SCHEDULE 5.18 

ENVIRONMENTAL MATTERS 

2016 Second Quarter 10-Q Excerpt

Environmental Matters 
 Certain historic
processes in the manufacture of products have resulted in environmentally hazardous waste by-products as defined by federal and state laws and regulations. At June 30, 2016, the Company is named a Potentially Responsible Party (“PRP”) at
14 non-AMETEK-owned former waste disposal or treatment sites (the “non-owned” sites). The Company is identified as a “de minimis” party in 13 of these sites based on the low volume of waste attributed to the Company relative to
the amounts attributed to other named PRPs. In nine of these sites, the Company has reached a tentative agreement on the cost of the de minimis settlement to satisfy its obligation and is awaiting executed agreements. The tentatively agreed-to
settlement amounts are fully reserved. In the other four sites, the Company is continuing to investigate the accuracy of the alleged volume attributed to the Company as estimated by the parties primarily responsible for remedial activity at the
sites to establish an appropriate settlement amount. At the remaining site where the Company is a non-de minimis PRP, the Company is participating in the investigation and/or related required remediation as part of a PRP Group and reserves have been
established sufficient to satisfy the Company’s expected obligations. The Company historically has resolved these issues within established reserve levels and reasonably expects this result will continue. In addition to these non-owned sites,
the Company has an ongoing practice of providing reserves for probable remediation activities at certain of its current or previously owned manufacturing locations (the “owned” sites). For claims and proceedings against the Company with
respect to other environmental matters, reserves are established once the Company has determined that a loss is probable and estimable. This estimate is refined as the Company moves through the various stages of investigation, risk assessment,
feasibility study and corrective action processes. In certain instances, the Company has developed a range of estimates for such costs and has recorded a liability based on the low end of the range. It is reasonably possible that the actual cost of
remediation of the individual sites could vary from the current estimates and the amounts accrued in the consolidated financial statements; however, the amounts of such variances are not expected to result in a material change to the consolidated
financial statements. In estimating the Company’s liability for remediation, the Company also considers the likely proportionate share of the anticipated remediation expense and the ability of the other PRPs to fulfill their obligations. 

Total environmental reserves at June 30, 2016 and December 31, 2015 were $28.1 million and $30.5 million, respectively, for both non-owned and
owned sites. For the six months ended June 30, 2016, the Company recorded $1.4 million in reserves. Additionally, the Company spent $3.4 million on environmental matters and had $0.4 million due to foreign currency translation losses for the six
months ended June 30, 2016. The Company’s reserves for environmental liabilities at June 30, 2016 and December 31, 2015 include reserves of $12.7 million and $11.5 million, respectively, for an owned site acquired in connection with the 2005
acquisition of 

  
 Schedule 5.18-1 

 
HCC Industries (“HCC”). The Company is the designated performing party for the performance of remedial activities for one of several operating units making up a Superfund site in the
San Gabriel Valley of California. The Company has obtained indemnifications and other financial assurances from the former owners of HCC related to the costs of the required remedial activities. At June 30, 2016, the Company had $11.8 million in
receivables related to HCC for probable recoveries from third-party escrow funds and other committed third-party funds to support the required remediation. Also, the Company is indemnified by HCC’s former owners for approximately $19 million of
additional costs. 
 The Company has agreements with other former owners of certain of its acquired businesses, as well as new owners of
previously owned businesses. Under certain of the agreements, the former or new owners retained, or assumed and agreed to indemnify the Company against, certain environmental and other liabilities under certain circumstances. The Company and some of
these other parties also carry insurance coverage for some environmental matters. To date, these parties have met their obligations in all material respects. 

The Company believes it has established reserves which are sufficient to perform all known responsibilities under existing
claims and consent orders. The Company has no reason to believe that other third parties would fail to perform their obligations in the future. In the opinion of management, based upon presently available information and past experience related to
such matters, an adequate provision for probable costs has been made and the ultimate cost resulting from these actions is not expected to materially affect the consolidated results of operations, financial position or cash flows of the Company.

  
 Schedule 5.18-2 

 SCHEDULE 8.6 

SWAP CERTIFICATE 

[LETTERHEAD OF INVESTOR] 
 October
[    ], 2016 
 AMETEK, Inc. 

1100 Cassatt Road 
 Berwyn,
Pennsylvania 19312-1177 
  

	 	Re:	Principal Swap Terms relating to Notes issued under AMETEK, Inc. 

	 	  	Note Purchase Agreement 

 Ladies and Gentlemen: 

This letter is being delivered pursuant to Section 8.6 of the Note Purchase Agreement dated as of October 31, 2016 among AMETEK, Inc. and
the purchasers party thereto (the “Note Purchase Agreement”). Capitalized terms used but not otherwise defined herein have the respective meanings set forth in the Note Purchase Agreement. 

Set forth below are the principal terms of the [Initial][Replacement] Swap Agreement[s] with respect to the Notes: 

 

	1.	Purchaser Name:
[                                         
           ] 

 Description of Notes:
[      ]% Series [    ] Notes, due [              ] 

Trade Date:
[                     ], 2016 

Effective Date:
[                          ], 2016 

Termination Date:
[                      , 20    ] 

[Investor Name] pays Euros/Pounds Sterling fixed [        ]% semi 30/360 [un]adjusted 

[Investor Name] receives Dollars fixed [        ]% semi 30/360 [un]adjusted 

Size:
€[                          ]
/£[                        ] v.
$[                      ] initial and final exchange 
  

	[2.	Purchaser Name:
[                                         
           ] 

 Description of Notes:
[      ]% Series [    ] Notes, due [              ] 

Trade Date:
[                     ], 2016 

Effective Date:
[                          ], 2016 

Termination Date:
[                      , 20    ] 

[Investor Name] pays Euros/Pounds Sterling fixed [        ]% semi 30/360 [un]adjusted 

[Investor Name] receives Dollars fixed [        ]% semi 30/360 [un]adjusted 

Size:
€[                          ]/£[           
             ] v. $[                      ] initial and final
exchange]1 
  

					
	[INVESTOR NAME]
			
	By:	 	  
	 	

 
							
	Name:	 	  
	 		 	

 
					
	Title:	 	  
	 	

  
  

1 If institution has multiple purchasers

  
 Schedule 8.6-1 

 EXHIBIT 1 

[FORM OF SERIES P NOTE] 

AMETEK, INC. 
 1.34%
SERIES P SENIOR NOTE DUE OCTOBER 31, 2026 
  

			
	No. RP-[    ]	 	[Date]
	€[                ]	 	PPN: 031100 G*5

 For Value Received, the undersigned, AMETEK, INC. (herein called the
“Company”), a corporation organized and existing under the laws of the State of Delaware, hereby promises to pay to
[                        ], or registered assigns, the principal sum of
[                                         
  ] Euros (€[                        ]) (or so much thereof as shall not have been prepaid) on October
31, 2026, with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 1.34% per annum from the date hereof, payable semiannually, on the 30th day of April and the 31st day of
October in each year, commencing with the April 30 or October 31 next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, on any overdue payment of interest and,
during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the Default Rate, payable semiannually as aforesaid (or, at the option of the
registered holder hereof, on demand). 
 Payments of principal of, interest on and any Make-Whole Amount with respect to
this Note are to be made in Euros or Dollars, as applicable, at the principal office of JPMorgan Chase Bank, N.A. in New York, New York or at such other place as the Company shall have designated by written notice to the holder of this Note as
provided in the Note Purchase Agreement referred to below. 
 This Note is one of a series of 1.34% Series P Senior Notes
(herein called the “Notes”) issued pursuant to the Note Purchase Agreement, dated as of October 31, 2016 (as from time to time amended, the “Note Purchase Agreement”), between the Company and the respective
Purchasers named therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and
(ii) made the representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement. 

This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration
of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the
name of, the transferee. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the
Company will not be affected by any notice to the contrary. 

  
 Exhibit 1-1 

 This Note is subject to optional prepayment, in whole or from time to time in
part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 
 If an Event of Default
occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall
be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State. 

 

					
	AMETEK, INC.	 	
			
	By:	 	  
	 	
		 	Name:	 	
		 	Title:	 	

  
 Exhibit 1-2 

 EXHIBIT 2 

[FORM OF SERIES Q NOTE] 

AMETEK, INC. 
 1.53%
SERIES Q SENIOR NOTE DUE OCTOBER 31, 2028 
  

			
	No. RQ-[    ]	 	[Date]
	€[                ]	 	PPN: 031100 G@3

 For Value Received, the undersigned, AMETEK, INC. (herein called the
“Company”), a corporation organized and existing under the laws of the State of Delaware, hereby promises to pay to
[                        ], or registered assigns, the principal sum of
[                                         
  ] Euros (€[                        ]) (or so much thereof as shall not have been prepaid) on October
31, 2028, with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 1.53% per annum from the date hereof, payable semiannually, on the 30th day of April and the 31st day of
October in each year, commencing with the April 30 or October 31 next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, on any overdue payment of interest and,
during the continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the Default Rate, payable semiannually as aforesaid (or, at the option of the
registered holder hereof, on demand). 
 Payments of principal of, interest on and any Make-Whole Amount with respect to
this Note are to be made in Euros or Dollars, as applicable, at the principal office of JPMorgan Chase Bank, N.A. in New York, New York or at such other place as the Company shall have designated by written notice to the holder of this Note as
provided in the Note Purchase Agreement referred to below. 
 This Note is one of a series of 1.53% Series Q Senior Notes
(herein called the “Notes”) issued pursuant to the Note Purchase Agreement, dated as of October 31, 2016 (as from time to time amended, the “Note Purchase Agreement”), between the Company and the respective
Purchasers named therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and
(ii) made the representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement. 

This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration
of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the
name of, the transferee. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the
Company will not be affected by any notice to the contrary. 

  
 Exhibit 2-1 

 This Note is subject to optional prepayment, in whole or from time to time in
part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 
 If an Event of Default
occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall
be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State. 

 

					
	AMETEK, INC.
			
	By:	 	  
	 	
		 	Name:	 	
		 	Title:	 	

  
 Exhibit 2-2 

 EXHIBIT 3 

[FORM OF SERIES R NOTE] 

AMETEK, INC. 
 2.59%
SERIES R SENIOR NOTE DUE NOVEMBER 23, 2028 
  

			
	No. RR-[    ]	 	[Date]
	£[                ]	 	PPN: 031100 G#1

 For Value Received, the undersigned, AMETEK, INC. (herein called the
“Company”), a corporation organized and existing under the laws of the State of Delaware, hereby promises to pay to
[                        ], or registered assigns, the principal sum of
[                                         
  ] Pounds Sterling (£[                        ]) (or so much thereof as shall not have been prepaid)
on November 23, 2028, with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 2.59% per annum from the date hereof, payable semiannually, on the 23rd day of May and November in
each year, commencing with the May 23 or November 23 next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, on any overdue payment of interest and, during the
continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the Default Rate, payable semiannually as aforesaid (or, at the option of the registered
holder hereof, on demand). 
 Payments of principal of, interest on and any Make-Whole Amount with respect to this Note are
to be made in Pounds Sterling or Dollars, as applicable, at the principal office of JPMorgan Chase Bank, N.A. in New York, New York or at such other place as the Company shall have designated by written notice to the holder of this Note as provided
in the Note Purchase Agreement referred to below. 
 This Note is one of a series of 2.59% Series R Senior Notes (herein
called the “Notes”) issued pursuant to the Note Purchase Agreement, dated as of October 31, 2016 (as from time to time amended, the “Note Purchase Agreement”), between the Company and the respective Purchasers named
therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and (ii) made the
representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement. 

This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration
of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the
name of, the transferee. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the
Company will not be affected by any notice to the contrary. 

  
 Exhibit 3-1 

 This Note is subject to optional prepayment, in whole or from time to time in
part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 
 If an Event of Default
occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall
be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State. 

 

					
	AMETEK, INC.	 	
			
	By:	 	  
	 	
		 	Name:	 	
		 	Title:	 	

  
 Exhibit 3-2 

 EXHIBIT 4 

[FORM OF SERIES S NOTE] 

AMETEK, INC. 
 2.70%
SERIES S SENIOR NOTE DUE NOVEMBER 23, 2031 
  

			
	No. RS-[    ]	 	[Date]
	£[                ]	 	PPN: 031100 H*4

 For Value Received, the undersigned, AMETEK, INC. (herein called the
“Company”), a corporation organized and existing under the laws of the State of Delaware, hereby promises to pay to
[                        ], or registered assigns, the principal sum of
[                                         
  ] Pounds Sterling (£[                        ]) (or so much thereof as shall not have been prepaid)
on November 23, 2031, with interest (computed on the basis of a 360-day year of twelve 30-day months) (a) on the unpaid balance hereof at the rate of 2.70% per annum from the date hereof, payable semiannually, on the 23rd day of May and November in
each year, commencing with the May 23 or November 23 next succeeding the date hereof, until the principal hereof shall have become due and payable, and (b) to the extent permitted by law, on any overdue payment of interest and, during the
continuance of an Event of Default, on such unpaid balance and on any overdue payment of any Make-Whole Amount, at a rate per annum from time to time equal to the Default Rate, payable semiannually as aforesaid (or, at the option of the registered
holder hereof, on demand). 
 Payments of principal of, interest on and any Make-Whole Amount with respect to this Note are
to be made in Pounds Sterling or Dollars, as applicable, at the principal office of JPMorgan Chase Bank, N.A. in New York, New York or at such other place as the Company shall have designated by written notice to the holder of this Note as provided
in the Note Purchase Agreement referred to below. 
 This Note is one of a series of 2.70% Series S Senior Notes (herein
called the “Notes”) issued pursuant to the Note Purchase Agreement, dated as of October 31, 2016 (as from time to time amended, the “Note Purchase Agreement”), between the Company and the respective Purchasers named
therein and is entitled to the benefits thereof. Each holder of this Note will be deemed, by its acceptance hereof, to have (i) agreed to the confidentiality provisions set forth in Section 20 of the Note Purchase Agreement and (ii) made the
representation set forth in Section 6.2 of the Note Purchase Agreement. Unless otherwise indicated, capitalized terms used in this Note shall have the respective meanings ascribed to such terms in the Note Purchase Agreement. 

This Note is a registered Note and, as provided in the Note Purchase Agreement, upon surrender of this Note for registration
of transfer accompanied by a written instrument of transfer duly executed, by the registered holder hereof or such holder’s attorney duly authorized in writing, a new Note for a like principal amount will be issued to, and registered in the
name of, the transferee. Prior to due presentment for registration of transfer, the Company may treat the person in whose name this Note is registered as the owner hereof for the purpose of receiving payment and for all other purposes, and the
Company will not be affected by any notice to the contrary. 

  
 Exhibit 4-1 

 This Note is subject to optional prepayment, in whole or from time to time in
part, at the times and on the terms specified in the Note Purchase Agreement, but not otherwise. 
 If an Event of Default
occurs and is continuing, the principal of this Note may be declared or otherwise become due and payable in the manner, at the price (including any applicable Make-Whole Amount) and with the effect provided in the Note Purchase Agreement. 

This Note shall be construed and enforced in accordance with, and the rights of the Company and the holder of this Note shall
be governed by, the law of the State of New York excluding choice-of-law principles of the law of such State that would permit the application of the laws of a jurisdiction other than such State. 

 

					
	AMETEK, INC.
			
	By:	 	  
	 	
		 	Name:	 	
		 	Title:	 	

  
 Exhibit 4-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}]]